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ABSTRACT 
Pronuclear microinjection to produce transgenic animals is now a 
widespread technique. However, with this method there is no control over 
where in the genome the transgene integrates or the structure of the array 
produced. It has long been known that the position within the genome can 
have a profound effect on transgene expression. Evidence that the copy 
number also has an effect has recently emerged. To test the hypothesis that 
high copy number arrays can be responsible for variegation, site-specific 
recombination was employed to reduce the copy number at the same 
genomic location, allowing a direct comparison of different copy number 
arrays at the same integration site. 
A BLG-loxP transgene was microinjected to produce transgenic mice. 
High copy founders were used to establish lines and their expression profiles 
were analysed using in situ hybridisation, Northern blots, and milk protein 
composition. Two out of five lines showed variegated expression with 
discreet patches of cells expressing within the mammary gland. 
The variegating lines and one uniform line were then bred to a line of 
mice expressing a BLG-Cre recombinase transgene in the mammary gland. 
The double transgenic animals were analysed for a mammary-specific 
reduction in copy number and their expression patterns were also studied. 
In all three lines, after the reduction of copy number there had been a 
reduction in the number of cells in the mammary gland that expressed the 
BLG transgene. This was contradictory to the hypothesis that suggested that 
the variegation should be relieved by a reduction in copy number. 
iv 
The same BLG-loxP lines were then microinjected with a PGK-Cre 
recombinase construct to produce a reduction of copy number early in 
development. 	Microinjected animals were analysed for reduced copy 
arrays, of which only one line showed evidence. These animals were bred to 
establish lines with reduced copy number arrays throughout the animal. 
Their expression profile was analysed as before. 	Animals that had a 
reduction to one copy showed no expression, while animals that showed a 
reduction to two copies showed limited patches of expression. This result 
mirrored that of the mammary-specific reduction. 
BLG transgenes may require a buffer zone provided by high copy 
arrays to allow some transgenes within the array to escape genome effects. 
When the copy number is reduced, the percentage of cells that can escape the 
silencing is also reduced. It is therefore clear that in some cases, transgenes 
may only efficiently express as a multicopy array. 
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CHAPTER ONE 
INTRODUCTION 
Recent advances of recombinant DNA technology and embryo culture 
techniques have underpinned an explosion in the production of genetically 
manipulated higher eukaryotes. The introduction of foreign genes, termed 
'transgenes', into the germline of organisms has enabled researchers to 
investigate the expression of foreign genes and their products. 	These 
transgenic organisms exhibit unique phenotypes and these characteristics are 
inherited by their offspring. The ability to alter the genome of organisms 
has opened up new fields of study and transgenic organisms provide unique 
opportunities to address many fundamental biological questions. 
The use of transgenics has become widespread; thousands of 
transgenic mice, plants and livestock now exist (Old and Primrose 1994). 
Transgenics have been established to provide improvements in commercial 
characteristics of livestock (Bullock et al 1997). Improvements to crops have 
allowed alterations to farming methods, improving efficiency and reducing 
losses (Gressel 2000). Transgenic livestock have been produced that express 
biomedically important proteins in their milk, which can be used in treating 
human disease (Rudolph 1999). Transgenic mice have been used as models 
of human disease to help gain understanding into the causes of the diseases 
(Petters and Sommer 2000). They have also been used to study biological 
questions of gene function and developmental pathways. 
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In some cases transgenic mice showed an appropriate expression 
profile for the transgene used. Transgenes such as herpes thymidine kinase 
were found to express in the liver (Brinster et a! 1981) and -globin 
transgenes were found to express in erythroid tissues (Chada et al 1985). 
However, it has become apparent that there are numerous examples of 
unstable or poor transgene expression. Both the genomic integration site 
and the structure/copy number of transgenic arrays can lead to unstable 
expression (Dobie et a! 1997). Work has been carried out that implicates high 
copy number in the silencing of transgenes, leading to variegated expression 
(Dorer 1997). This has profound implications for those researchers wishing 
to use this technology. A clearer understanding, therefore, of transgene 
regulation is required to allow this technique to be fully exploited. 
This chapter reviews the historical development of techniques used to 
produce transgenic animals and then focuses on how these transgenes 
express. Initially, the mechanisms by which transgenes integrate into the 
genome and their array structure are discussed. The roles of factors known 
to influence expression (i.e. intrinsic factors such as enhancers and 
promoters, and extrinsic factors such as the position within the genome) are 
examined. Furthermore, aberrant examples of transgene expression and 
transgene silencing are also presented. 	The mechanisms by which 
transgenes are silenced show similarities to the broader field of epigenetics, 
and common factors are considered. These issues are all reviewed in 
relation to transgene expression in the mammary gland, which is the tissue 
studied in this project. The chapter concludes with the aims and approaches 
of the project, which is to investigate the relationship between the copy 
number of transgenes and variegated expression. 
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1.1 	DEVELOPMENT OF TRANSGENIC TECHNIQUES 
1.1.1 First production of transgenic animals 
The ability to introduce genes into the germline of mammals is one of 
the most important recent advances in biology. The first transgenic mice 
were produced by microinjecting SV40 viral DNA into the blastocoel cavity 
of early embryos, which were then implanted into foster mothers. Some 
cells in the embryo incorporated the DNA, resulting in mosaic adult animals 
(jaenisch and Mintz 1974). This work did not test if there was germline 
transmission of the integrated DNA. 
The next attempts to produce transgenic animals involved infecting 
mouse embryos with retroviruses early in development. This resulted in the 
stable integration of Moloney leukemia retroviral DNA into the germ line 
(Jaenisch 1976). 	Several disadvantages exist with this method. 	The 
integration of the foreign DNA occurred at different stages of embryonic 
development resulting in mosaic animals. This method often generated 
animals that had more than one transgene integration site, because more 
than one cell in the early embryo was infected with the virus (Palmiter and 
Brinster 1985). Due to the occurrence of multiple integration sites, lines of 
mice had to be out-bred to segregate the various loci to produce single 
insertion lines. 
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1.1.2 Generation of transgenic animals by pronuclear injection 
In 1980 an extremely important advance in transgenic technology was 
reported. Gordon and co-workers described a technique whereby naked 
DNA was injected into the pronucleus of a newly fertilised mouse oocyte 
(Gordon et al 1980). This method was to become the standard means to 
manipulate the mouse genome for sometime. The experiment showed it 
was possible to transfer foreign genes directly into mouse embryos. The 
foreign DNA integrated into the genome and was inherited by offspring of 
the founder transgenic animal. Injection of one-cell embryos was important 
for obtaining early integration, so allowing the foreign DNA to contribute to 
the genome of all somatic cells and importantly, the germline. 	The 
discovery of pronuclear injection as a new means of altering the genome of 
animals spawned a revolution in the analysis of gene expression (Houdebine 
1997). 
The efficiency of pronuclear injection to generate transgenic animals is 
determined by a number of factors. Early studies by Brinster and co-
workers (Brinster et a! 1985) investigated the effects of a number of 
parameters on the efficiency of integration, but not on transgene expression. 
These early experiments established that the most critical factors affecting 
DNA integration were the concentration and form of the DNA injected. 
Integration efficiency improved as DNA concentration increased, with an 
optimal concentration of one nglj.il; large amounts of DNA however, were 
toxic. Comparison of cytoplasmic versus nuclear injection showed the 
efficiency of DNA integration after cytoplasmic injection was very low. No 
significant difference in integration efficiency was found when the male or 
female pronucleus was injected. However, in mice the male pronucleus is 
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favoured, being the larger of the two nuclei in this species. DNA molecules 
were injected in four different forms; supercoiled, restricted and blunt ended, 
restricted to form 'sticky ends', or restricted to form dissimilar ends. Linear 
DNA integrated five fold more efficiently than supercoiled DNA; it was also 
reported by these workers that linear DNA molecules with similar or 
dissimilar ends may integrate more efficiently than linear molecules with 
blunt ends. Hybrid strains of mice (i.e. C57 x SJL) were eight fold more 
successful than inbreds (i.e. C57) (Brinster et a! 1985). This is likely to be due 
to the overall improvement in vigour of hybrid animals compared to inbred 
animals. 
Pronuclear injection is currently the most commonly used technique 
for the generation of transgenic animals. It is however, an inefficient process. 
Of the embryos that survive the injection procedure only -10% produce 
offspring, of which -40% are transgenic (Boyd and Samid 1993). The success 
rate is variable between laboratories and between individual researchers due 
to the highly skilled nature of the technique. 
1.1.3 Production of transgenic livestock by pronuclear injection 
The technique of pronuclear injection has been used to generate 
transgenic livestock including pigs, cattle and sheep. It is less efficient in 
these species when compared to transgenic mice (Pursel and Rexford 1993, 
Maga and Murrey 1995, Eyestone 1994). In addition to the problems 
associated with the integration of new genes, there are inefficiencies 
associated with collecting and culturing fertilised eggs, as well as embryo 
transfer in livestock animals. Due to the increased generation time, smaller 
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litter size and the extra cost of caring for livestock, transgenic studies in 
livestock species are a major undertaking financially and logistically (Wall 
and Seidel 1992). 	Early studies investigated the use of transgenes 
controlling the productivity of the animal i.e. growth hormone transgenes to 
increase the rate of growth and the ratio of feed: growth (Pursel and Rexroad 
1993). These early studies showed the problems of pronuclear injection in 
relation to the control of gene expression. Levels varied between lines and 
transgene expression could be low. 	Because of the poor efficiency of 
pronuclear injection and lack of control of gene expression, other methods 
for transgenesis were sought. Later experiments developed biomedical 
applications such as bioreactors for the production of therapeutically 
important proteins (Houdebine 2000). Transgenic livestock are also being 
used to investigate methods to make xenotransplantation more viable (Logan 
2000). 
1.1.4 ES Cells 
The ability to grow pluripotent cells in culture has been central to 
developing other methods of transgenesis. So-called embryonic stem (ES) 
cells were derived from the inner cell mass of the mouse blastocyst. The 
cells could be maintained in an undifferentiated state in culture and 
displayed a normal karyotype (Evans and Kaufman 1981). If the ES cells 
remain pluripotent, after their return to recipient blastocysts, the cells can 
contribute to the formation of all tissues, including the germline (Bradley et al 
1984). 
ES cells can be manipulated in vitro without affecting their ability to 
contribute to the germline. It was demonstrated that ES cells could still 
generate germline chimeras after transfection with a resistance marker gene. 
Neomycin phosphotransf erase genes from bacterial transposons confer 
resistance to aminoglycoside antibiotics, allowing a selection strategy to be 
used (Berg 1981). ES cells, therefore, provided an exciting new method for 
introducing specific genes into the mouse genome. 
Exploiting homologous recombination in murine ES cells allows 
integration of transgenic sequences into the genome at a controlled site 
(Capecchi 1989). Point mutations, deletions and gene inactivation have all 
been achieved by gene targeting in ES cells (Jasin et a! 1996). Once the 
modification of the genome has been carried out in the ES cell, it is then 
injected into mouse blastocysts where it can contribute to the embryo 
producing a chimeric animal. 	If the ES cell has also contributed to the 
germline, the chimeric animals are used to establish lines of mice with the 
targeted alterations in their genome. ES cell transgenesis has now been used 
to produce mice with controlled sites of integration and single copy arrays of 
the transgene of interest (Bronson et a! 1996). ES cell manipulation in mice 
has allowed targeted integration of transgenes, allowing better control over 
the expression profile (Jasin et al 1996). At present, no ES cells are available 
for livestock species. 
1.1.5 Nuclear transfer 
Recent advances in nuclear transfer have expanded the means by 
which genetic modification of animals other than mice can be carried out. 
Nuclear transfer has now been achieved in a number of species including 
sheep, mouse, goat and cattle (Clark et a! 2000). Nuclear transfer involves 
7 
the enucleation of an oocyte followed by the electrofusion of this cell with a 
donor cell. The donor cell can be somatic in origin. This allows for easier 
manipulation of livestock genomes, circumventing the need for ES cells in 
these species (Wilmut et a! 1997). It is likely in the future that genetic 
modification to livestock animals will be carried out in somatic cells for 
subsequent use in nuclear transfer. Currently this route is not as well 
established as ES cell targeting. The first gene targeted sheep by nuclear 
transfer has been reported whereby the ovine a-1(I)procollagen locus was 
targeted with a human al-antitrypsin (AAT) contained within a BLG 
expression vector, which was designed to direct expression of the AAT to the 
mammary gland (McCreath et a! 2000). Other recent work produced lambs 
with a deletion in the PrP gene, which codes for prions, the causal agent in 
spongiform encephalopathies (Denning et a! 2001). 
1.1.6 Transgene manipulation 
1.1.6.1 Cre recombinase and loxP sites 
Cre recombinase (Cre stands for causes recombination) is a member of 
the integrase family of recombinases along with FLP from Sacchromyces 
cerevisiae (Kilby et a! 1993). Cre recombinase from bacteriophage P1 is a 
38kDA protein and it exists as a monomer in solution (Sauer 1993, Mack et a! 
1992). 	Cre recombinase mediates efficient intramolecular (excisive or 
inversional) and intermolecular (integrative) site-specific recombination 
between target recognition elements known as loxP sites. This system has 
now been used in a wide variety of experiments, and is a routine method for 
the manipulation of transgenes (Metzger and Feil 1999). 
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LoxP sites are 34bp long and consist of two inverted repeats 
surrounding an 8bp asymmetric spacer region. 	Cleavage and strand 
exchange of recombining loxP sites occurs within this spacer region. The 
loxP sites exhibit directionality as a consequence of the asymmetry of the 
spacer region (Hoess and Abremski 1984). If two loxP sites are integrated 
into the same DNA molecule in a direct orientation then excision occurs 
leaving one loxP site behind (figure 1.1). If the loxP sites are in opposite 
orientations then inversion of the intermediate DNA occurs. 
A single molecule of Cre is bound to each inverted repeat of the loxP 
site (Mack et a! 1992). Prior to strand exchange Cre recombinase cleaves the 
DNA to generate 6bp staggered cuts. The single stranded ends formed must 
then pair with the complementary single strand sequence of the other loxP 
partner in recombination (Hoess et al 1986). The crystal structure of Cre 
recombinase bound to a loxP site has been determined. The synapsed 
structure of four Cre recombinases and two loxP sites resembles the models 
of four way Holliday junction intermediates (Guo et a! 1997). 
Cre mediated recombination proceeds efficiently with supercoiled and 
linear DNA molecules (Sauer and Henderson 1989). 	In Sacchromyces 
cerevisiae the ability of Cre recombinase to perform precise recombination 
events on chromosomes is unimpaired by chromatin structure. However, 
Baubonis and Sauer (1993) found that in human osteosarcoma cells 
chromosomal position effects had a strong influence on the rate of targeting 
to a chromosomal loxP site. Cre recombinase is also very specific; the 
introduction of FLP recombinase will not recombine loxP sites, neither will 










Figure 1.1. Cre-loxP recombination. (A) The sequence of the loxP site, the 
spacer region is red. (B) Cre catalysed excision. Two Cre molecules bind to each 
loxP (red triangle). 	Intervening DNA between adjacent loxP sites is removed, 
leaving one loxP site still integrated in the genome. The reaction can occur in 
reverse. 
[D] 
The length of the loxP target size was thought to make it unlikely to 
occur at random in higher eukaryotic genomes, so preventing the possibility 
of recombination with an endogenous eukaryotic sequence (Kilbey et al 
1993). However, it has been shown that sequences from mammalian DNA 
that are divergent from the traditional loxP site can support Cre mediated 
recombination in mammalian cells (Thyagarajan et al 2000). Until recently 
no reports of loxP site infidelity in transgenic animals existed. However, 
Schmidt et al (2000) reported that expression of Cre driven by the protamine I 
promoter in postmeiotic spermatids led to Cre catalysed chromosomal 
rearrangements in the absence of loxP sites. All males derived from these 
transgenic mice were infertile due to abortion of early embryos whose 
chromosomes had been rearranged. 	The authors suggested that if 
chromosomal rearrangements were occurring in somatic cells that it may not 
be as easily detected. This report emphasised the removal of Cre after use 
and some self-excising vectors are now available (Bunting et al 1999). 
1.1.6.2 Applications of Cre recombinase 
The advantage of Cre-loxP is that host-specific functions are not 
required for their activity. Cre recombinase has been shown to catalyse site-
specific recombination in the genome of yeast and eukaryotic cultured 
somatic and ES cells, and has been shown to catalyse site-specific 
recombination in vivo in transgenic animals (Sauer 1987, Sauer and 
Henderson 1989, Fukushigi and Sauer 1992, Ludwig et a! 1996). It is now 
used as a powerful tool for genetic engineering in a wide variety of systems. 
The ability to excise precise pieces of DNA can be used for different 
purposes. 	For example, transgenes can be activated by removing an 
intervening stop sequence between the promoter and coding region of the 
transgene (Lasko et al 1992). It has been shown that Cre recombinase could 
be used in mice at high efficiency to excise an entire transgene in vivo or to 
reduce multicopy arrays to single copy. The authors suggest the frequency 
and extent of excision may depend on a variety of factors including the size 
of the fragment to be excised, the genomic site of Cre recombinase action, 
and the developmental point of Cre action (Orban et a! 1992, Lakso et a! 1996). 
Deletions of at least 200kb of DNA are possible when a Cre expressing 
plasmid is electroporated into ES cells (Li et a! 1996). Other groups have 
reported the generation of deletions of up to 3 - 4 centimorgans using Cre-
loxP (Ramirez-Solis, Liu and Bradley 1995). Cre expressing mice have also 
been used to produce cell type specific gene inactivation (Gu et a! 1994). 
Alternatively Cre-loxP can be used to target a transgene to a specific genomic 
site containing a loxP site. This catalyses the reverse reaction, whereby a 
fragment of DNA carrying a loxP site can be targeted to the genomic loxP 
site by intermolecular recombination (Kuhn and Schwenk 1997) 
1.1.6.3 Expression of Cre recombinasé in different tissues 
Cre recombinase has been expressed specifically in the mammary 
gland of transgenic mice (Wagner et al 1997, Selbert et al 1998). 	Cre 
controlled by the mouse mammary tumour virus (MMTV) long terminal 
repeat (LTR) showed recombination in all tissues and was not specific to 
mammary alone. However, Cre controlled by the whey acidic protein 
(WAP) or beta-lactoglobulin gene was expressed in a tissue-specific manner. 
The temporal pattern of expression mirrored that of the promoters used to 
drive Cre recombinase. 
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A number of groups have generated Cre recombinase transgenic mice 
strains that mediate deletion of floxed genes (alleles surrounded by two loxP 
sites) very early in development i.e. preimplantation embryo or in oocytes. 
One report described the expression of Cre recombinase under the control of 
adenovirus Ella promoter targeting expression to the early mouse embryo. 
This generated genetic changes to floxed alleles in all cells of the developing 
animal including the germ cells (Lakso et al 1996). 
Phosphoglycerate kinase (PGK) is expressed in all somatic cells (Adra 
et a! 1987). The PGK promoter has successfully been used to drive early and 
uniform Cre expression. When PGK Cre females are bred to males carrying 
a floxed reporter gene, recombination occurs even in offspring that do not 
inherit the PGK Cre gene. This suggested that the PGK Cre was already 
active in the diploid oogonium and that during meiosis the Cre transcript or 
protein was transmitted to both Cre- and Cre daughter cells (Lallemand et al 
1998). 
Transient expression of Cre has been achieved by pronuclear 
microinjection of either a circular Cre plasmid vector or cytoplasmic injection 
of an in vitro transcribed Cre mRNA (Araki et a! 1995, de Wit et al 1998). Both 
methods led to a very high level of recombination and avoided the 
integration of the Cre construct. This is a rapid method for Cre mediated 
recombination and avoids having to breed two transgenic lines together. 
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1.2 	STRUCTURE OF TRANSGENE LOCI 
1.2.1 Analysis of transgene integration 
With pronuclear injection neither the site of integration, nor the 
number of copies of foreign DNA can be controlled. The integration site is 
thought to occur randomly throughout the genome. Analysis of transgenic 
loci produced by pronuclear injection indicates that integration of a single 
transgene is a rare event: transgenes generally integrate as an array arranged 
in a head to tail manner (Wall and Burdon 1997). The number of copies 
within the array can range from one to several hundred (Brinster et al 1981, 
Palmiter et al 1982). This inability to control where in the genome and the 
number of copies that integrate is a drawback to the use of pronuclear 
injection. 
1.2.2 Production and integration of concatemers 
A multi-step model for the generation of transgene arrays has been 
proposed whereby an array of introduced genes is formed first, and then the 
array becomes incorporated into the genome at a break in the chromosome 
(Bishop and Smith 1989). It has been suggested that tandemly arranged 
concatemers of the input DNA are built up by a process of homologous, but 
non-conservative recombination. This predicts that a circularly permutated 
array is formed before integration (Bishop and Smith 1989). Recent studies 
have shown that some transgenes can integrate with nearly intact 5' and 3' 
copies (Cranston et a! 2001). This data, therefore, supports the theory that 
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injected transgenes concatermize to form multiple arrays and that a linear 
concatemer is then integrated into the genome. 
High levels of mosaicism are often observed in transgenic founder 
animals indicating that the DNA must have integrated after the fertilised 
oocyte has divided (Whitelaw et a! 1993). It may be that integration occurs 
into a replication loop, which may explain some of the duplications, 
insertions of flanking or filler sequence found at transgene integration sites 
(Bishop 1997). 
Integration appears not to be affected by chromosome morphology 
(i.e. acrocentric, metacentric or dicentric) or chromosome position even in the 
presence of homologous sequence in the genome (Dellaire and Chartrand 
1998). Hamada et al (1993) proposed that the integration of the transgenic 
array into the host genome occurs by end ligation of the transgene 
concatemer and chromosomal breakage, possibly stabilised by limited two to 
three nucleotide homologies occurring between the transgene and genomic 
ends. Indeed, some studies have found only very small regions of homology 
of 1-6 nucleotides at the junctions between transgenic and genomic sequence 
(McFarlane and Wilson 1996). 
1.3 	EXPRESSION OF TRANS GENES 
A transgenic experiment utilising pronuclear injection usually 
involves the generation of several lines containing the same transgene. Each 
transgenic founder is the result of a unique set of molecular events, and the 
integration site and transgene copy number will vary for each founder 
animal. Some of the initial transgenic animals showed that the transgenes 
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were expressed in the expected fashion. They appeared to show the tissue 
specific and developmental pattern that was predicted for them (Brinster et al 
1981, Chada et al 1985). 	However, this was not always the case and 
transgenes were often inappropriately expressed. This could manifest in a 
number of ways: 
ectopic expression whereby expression occurred in tissues other than 
the predicted ones 
incorrect timing of expression during development 
variation between lines, or individuals within a line 
variation within a tissue on a cell to cell basis 
Expression of transgenes is influenced by a number of factors: those 
extrinsic to the transgene i.e. the structure and genomic position produced at 
the integration event, and those intrinsic to the design of the transgene i.e. 
enhancers (Clark et al 1993) 
1.3.1 Extrinsic factors affecting transgene expression 
Position effects are thought to be due to the influence of the 
integration site on the expression of the transgene. The nature of the 
flanking host sequences (i.e. the state of methylation, acetylation and 
chromatin structure; see section 1.7) is important for the expression of foreign 
DNA. It maybe that a region is more permissive for expression due to the 
absence of repressors or the presence of activators (Clark et al 1994). Position 
effects have been used to explain poor levels of expression, ectopic 
expression and variability within a transgenic line (Dobie et al 1997). 
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Al-Shawi et al (1990) described a position effect on transgene 
expression in mice. A transgene containing the major urinary protein (MUP) 
gene promoter and the Herpes simplex virus thymidine kinase (HSV TK) 
gene was used to generate five transgenic lines. In four of these high TK 
expression was found in the liver, testes and preputial gland. Only one did 
not have expression in the preputial gland. The integration locus of the 
aberrant line was cloned and used to generate secondary transgenic animals. 
Very little surrounding genomic DNA was included in the cloned transgene. 
All of the secondary transgenic lines expressed the transgene at high levels in 
the liver, testes and preputial gland. This demonstrated that the unusual 
expression was a consequence of the transgene's original chromosomal 
location and was not due to a mutation in the transgene. 
Positive position effects can be utilised by using flanking 
chromosomal sequence isolated from actively expressing transgene loci, to 
enhance an alternative transgene's expression. A transgene containing the 
ovine BLG promoter sequence linked to al-antitrypsin (AATB transgene) 
gave high levels of expression in the mammary gland. One line with very 
high levels of expression was investigated. The locus of the transgene was 
cloned into cosmids and was used to construct secondary transgenic animals. 
The cloned murine sequence conferred substantially improved expression 
upon the AATB transgene, which now showed position independent 
expression (Cranston et a! 2001). 
Alternatively, once a permissive genomic location is identified it can 
subsequently be used to facilitate expression for a number of constructs 
(Wallace et a! 2000). In this work, the genome was scanned for "neutral" 
sites that were permissive for a number of transgenes. ES cell clones were 
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chosen for expression of a randomly integrated HPRT marker contiguous to 
an Oct4/lacZ transgene. The clones were assessed for appropriate regulation 
of the lacZ reporter upon differentiation. Clones that showed the correct 
regulation of lacZ also showed appropriate regulation of lacZ from three 
other developmental promoters that were subsequently targeted to the site. 
The copy number of the array and the structure are also known to 
play a role in transgene expression. Some constructs are found to be copy 
number dependent i.e. the more copies present the higher the level of 
expression. In a number of cases however, transgenes in mice have been 
found to decrease their levels of transcription as the copy number of the 
transgenic array increases (Davis and MacDonald 1988, Sharpe et a! 1992). 
Repeat sequences may also have a direct role in transgene silencing and this 
is discussed further in 1.4. 
Modifier genes within the genome have also been shown to influence 
transgene expression. 	These strain specific genes can influence the 
expression of an endogenous gene or transgene (Nadeau 2001). Modifier 
genes have been shown to influence disease severity in humans and many 
examples of modifier genes exist in Drosophila (Birchler et a! 2001). The 
expression of the modifier gene can have effects on a transgene at different 
levels. In one study a HSVtk lacZ transgene expressed at different levels 
depending on the genetic background of the mice (Allen et al 1990). If the 
transgene was placed in a DBA/2 or 129 background its expression was 
enhanced, whereas if it was placed in a BALB/c background its expression 
was decreased. The differences in expression correlated with differences in 
the methylation of the transgene, whereby the transgene was progressively 
silenced in the BALB/c background. The modifier genes from the BALB/c 
background were found to be dominant suppressors of the transgene 
expression. 
1.3.2 Intrinsic elements affecting transgene expression 
Factors intrinsic to the transgene also affect expression. The locus 
control region (LCR) is defined as a DNA segment that confers transgene 
expression that is independent of its integration site in the host genome, but 
dependent on its copy number. A locus control region (LCR) responsible for 
position independence was identified in the 13-globin cluster located -30kb 
upstream of the first gene and is characterised by erythroid specific DNAse I 
hypersensitive sites (Ellis et al 1996). 	Similar LCR elements have been 
identified in the 3' flanking sequence of the CD2 gene (Festenstein et al 1996). 
It is thought that the LCRs influence the chromosomal structure around a 
transgene allowing it to overcome position effects. In the case of the 13-
globin they also act as an enhancer of globin gene expression (Caterina et al 
1994). The incorporation of elements that overcome chromosomal position 
effects is an obvious strategy for improving expression from transgenes. 
Both the LCR from 13 globin and CD2 have been shown to confer position 
independent expression on heterologous genes, although the effect is seen 
only in the expected cell type. However, this approach does not always 
guarantee position independent expression on an unrelated but contiguous 
transgene (Guy et al 1997). Another drawback to this approach is that many 
genes do not have a defined LCR. 
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MARs (matrix attachment regions) are defined as DNA sequences that 
can interact with the nuclear matrix and are also implicated in regulation of 
gene expression (Cockerill and Garrard 1986). MARs can act in a number of 
ways in a transgenic situation. They can disrupt the interaction between a 
promoter and enhancer leading to poor expression (Stief et a! 1989). MARs 
have also been shown to insulate a transgene against position effects by 
acting as insulators (Namciu et a! 1998). It is thought that MARs naturally 
act to define chromatin boundaries, and by doing so shield genes within one 
gene domain from regulatory effects from elements in another domain 
(Bonifer et al 1997). 
A lack of introns has been shown to affect expression in a number of 
systems. Introns may affect expression because they contain regulatory 
elements required for expression. Both positive and negative regulatory 
elements have been discovered in introns. (Franklin et al 1991, Brooks et al 
1994). Generic introns have also been found to increase gene expression 
when used in transgenic mice (Choi et a! 1991). Introns may also act in a 
structural sense allowing transgenes to be processed as an endogenous gene 
would be. The use of genomic sequence may therefore help increase 
expression. 
Gene loci of higher organisms have complex structural features. 
Eukaryotic genes are regulated by a number of elements that can be spread 
over kilobases surrounding the coding region. The variation of transgenic 
expression may be due to the fact that transgenes lack the necessary distal 
elements. By introducing genes with large flanking regions this may help 
improve efficiency without needing to identify the elements involved. The 
development of P1 vectors, bacterial artificial chromosome (BACs) and yeast 
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artifical chromosomes (YACs) allow much larger DNA inserts to be 
manipulated in vitro. P1 vectors can take fragments up to 80kb in size, while 
YACs can have inserts several hundred kilobases in length (Clark et a! 1994). 
The mouse tyrosinase gene has been successfully expressed as a YAC 
transgene (Schedi et a! 1993). In this experiment the 250kb YAC contained 
80kb of the tyrosinase coding region and 155kb of upstream sequence. The 
YAC was microinjected into an albino mouse strain allowing expression to be 
determined by the amount of pigmentation in the skin and eyes of the 
offspring. The founders and their offspring exhibited a homogenous strong 
agouti coat colour, in contrast with previous mini-tryosinase transgenes, 
which had shown variegated expression. The use of YAC vectors may also 
allow the introduction of very large genes or linked gene families (Lamb and 
Gearhart 1995). 
1.3.3 Elements that interfere with expression 
Prokaryotic vector DNA has been shown to inhibit transgene 
expression if it is not removed before microinjection of the DNA (Townes et 
a! 1985, Chada et a! 1985). Prokaryotic sequence may have different GC 
nucleotide content, which may indicate to the cell that it is foreign DNA and 
be subsequently silenced as a defence mechanism for the cell. 
Elements such as mammalian cDNA or prokaryotic reporter sequence 
can silence transgenes (Clark et a! 1997, Cohen-Tannoudji et a! 2000). CAT 
and lacZ are often used as a reporter gene for transgenic studies but in some 
examples these can be silenced and can also silence associated transgenes. 
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1.4 	SILENCING EFFECTS 
As discussed in part 1.3.2, it is important to ensure that all the 
necessary elements are included in the design of a transgene to try and 
maximize its expression. However, in many cases the inclusion of all known 
regulatory elements is not enough to avoid silencing effects. These silencing 
effects can range from complete silencing of the transgene, variation within 
lines, to stochastic silencing of the transgene from cell to cell within the tissue 
of interest. It is therefore clear, that the lack of transgene expression can be 
considered from two different perspectives: either a failure to express due to 
intrinsic structure of the transgene or as an active silencing by the genome. 
If these two perspectives are combined, the lack of transgene expression can 
in many cases be thought of as the failure of the transgene to overcome the 
active silencing of the genome. In this section the idea of active silencing is 
reviewed with respect to transgene silencing prevalent within a number of 
systems from plants to mammals. The abundance of silencing effects found 
in the wide variety of organisms may indicate common mechanisms are 
employed throughout. 
1.4.1 Silencing in Plants and Fungi 
The drive to modify commercial crops using transgenic plants 
uncovered a plethora of gene silencing (Gallie 1998). This section will focus 
on silencing due to repeated transgenic sequences. 	When transgenic 
approaches were first used, more copies of a gene were expected to result in 
higher expression. Homology-dependent gene silencing (HDGS) in plants 
threw this notion on its head. Two types of HDGS have now been 
distinguished depending on the level of silencing. Transcriptional gene 
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silencing (TGS) is characterised by altered methylation and chromatin 
structure, while post-transcriptional (PTGS) involves RNA turnover 
aberrations (Kooter et al 1999). 
TGS in plants involves the methylation and condensation of the allele 
to be silenced. Currently there are numerous examples in plants where the 
insertion of multiple copies of a transgene leads to loss of expression in some 
or all copies of the transgene. Repeat induced gene silencing (RIGS) in 
Arabidopsis was found to be dependent on repeated sequence, was reversible 
and correlated with decreased steady state mRNA and increased DNA 
methylation. The authors propose that it reflects ectopic interactions of 
paired homologous DNA with flanking heterologous DNA, inducing 
condensation into a non-transcribable state by the exchange of chromatin 
components (Assaad et a! 1993). 
Alternative theories suggested that transgenes may physically interact 
or compete for non-diffusible essential factors i.e. the nuclear matrix. 
Alternatively, specific RNA degradation may occur due to either antisense 
RNA production or accumulation of RNA triggering degradation (Flavell 
1994, Baulcombe 1996, Matzke et al 1996). Recently evidence suggests 
homology dependent gene silencing in Arabidopsis is not occurring through 
an RNA mechanism (Luff et a! 1999). A promoterless inverted repeat 
construct produced homology-based methylation with no RNA from the 
transgene being found. This indicated that the inverted repeat structure 
itself was responsible and not an RNA or protein product. The authors 
suggest the methylation is induced by DNA-DNA pairing, possibly 
involving the formation of hairpin structures, which could be targeted for 
methylation. The data available at this time suggests that methylation is 
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necessary for silencing at some loci in Arabidopsis. An Arabidopsis ddml DNA 
hypomethylation mutant reduced the levels of methylation on a silenced 
gene (Jeddeloh et al 1998). 	The progressive loss of methylation was 
correlated with a loss of gene silencing. 
Co-suppression involves reciprocal silencing i.e. all copies are 
silenced, including the transgene and endogenous homologs (Flavell 1994, 
Matzke and Matzke 1995). Experiments showed that critical regions of 
homology for silencing could be the promoter, or the coding region or both. 
Repeated sequences that were silenced could be located in cis or on different 
homologous chromosomes. This appears to be a case of post-transcriptional 
gene silencing and is associated with enhanced RNA turnover in the 
cytoplasm (Matzke and Matzke 1998). 
In PTGS, RNA with sequence homology to the introduced DNA is 
found at lower levels than expected. 	It has been suggested that this 
sequence-specific effect at the post-transcription level is due to the expression 
of antisense RNA from the transgenes. The antisense RNA then duplexes 
with the target RNA, promoting its degradation or interfering with its 
translation. The theory of aberrant RNA expression or antisense RNA being 
expressed in cases of PTGS was supported by the finding that small antisense 
RNAs complemetary to the target mRNA have been found in PTGS plants 
(Hamilton and Baulcombe 1999). These 25 nucleotide antisense RNAs were 
never found in the absence of silencing, and possibly spread throughout the 
plant, thus explaining the previously reported systematic spread of PTGS 
from one infected leaf to the whole plant (Voinnet et al 1998). It was 
suggested that these RNA are transcribed from an RNA template. This 
would require the presence of an RNA-directed polymerase (RdRP). Indeed 
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a RdRP has since been cloned in plants (Schiebel et al 1998). Lending weight 
to this theory is the finding that PTGS mutants in Neuorspora encode for a 
protein showing homology to the plant RdRP (Cogoni and Macmo 1999). 
Paramutation in Maize plants occurs when a paramutable allele is 
converted to a new state of activity displayed by another silencing allele 
(paramutagenic), which may revert if the alleles segregate (Matzke and 
Matzke 1998). 	Other trans-silencing effects in transgenic plants have 
similarities with this phenomenon. For example, some methylated trans-
silencing loci can transcriptionally inactivate an unlinked loci that they share 
homology to, and methylate it. The target loses methylation only gradually 
after segregating from the silencing locus (Jakowitsch et a! 1999). 
Fungi also have a number of silencing effects which share some 
similarities to the processes found in plants (Irelan and Selker 1996). These 
processes avoid the duplication of repetitive sequences by inactivating or 
mutating them. Pairing of repeat sequences is implicated in RIP (Repeat 
induced point mutation) and MIP (Methylation induced premeiotically). In 
Neurospora crassa RIP modifies duplicated sequence by C - T transititions in a 
process often accompanied by frequent methylation, inhibiting transcription. 
In Ascobolus, the process of MIP shows repeat sequences become methylated 
but are not mutated. The methylation is found to be exactly co-extensive 
with the duplicated sequence, supporting the idea that DNA pairing is 
responsible (Matzke and Matzke 1995). 
All of the systems in plants that are involved in silencing repeats are 
thought to be part of a genome defence mechanism against invasive DNA 
sequences and viruses (Ratcliff et al 1997, Matzke and Matzke 1998). The 
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idea is that PTGS would defend against viruses with an RNA genome, while 
TGS would defend against transposable DNA elements (Kooter et al 1999). 
It has now been found that PTGS is suppressed by virus-encoding proteins 
which also suppress the anti-viral defense in the host (Anandalakshmi et a! 
1998). 
1.4.2 Silencing in transgenic Drosophila 
As with plants there are many examples in Drosophila where 
transgenes do not express as expected (Dorer 1997). Often the repeated 
nature of the transgene appears to be involved in the silencing. 
Closely linked repeats of a Drosophila P transposon carrying a white 
eye pigment transgene were shown to cause white variegation. More than 
three copies of the transgene in an array showed a variegating mutant 
phenotype that strengthened with increased copy number. The degree of 
variegation was affected by the relative distance of the transgene to 
constitutive heterochromatin (Dorer and Henikoff 1994). The transgenes 
were also responsive to protein components of heterochromatin (Powers and 
Eissenberg 1993). 	The authors suggested that pairing of these repeat 
sequences at a single locus may lead to the formation of chromatin structures 
that are preferentially recognised by heterochromatic specific proteins i.e. 
HP1 (James et a! 1989, Eissenberg 1990, Belyaeva et al 1993). 	These 
heterochromatic proteins would in turn exclude the transcriptional 
machinery from the locus (Dorer and Henikoff 1994). 
Sabi and Henikoff later presented a case where X-ray induced 
chromosomal rearrangement placed natural heterochromatin next to the 
genomic sequence of the brown eye pigment gene, which was subsequently 
manipulated with P transposase. This system allowed them to remove or 
increase the copy number (Sabi and Henikoff 1996). 
It was found that as the copy number increased a decrease in the 
frequency of expressing cells occurred, indicating that the variegation had 
increased. The copy number and orientation of the transgene determined 
the phenotype in this system. This observation paralleled those showing 
variegation increasing with increasing copy number described above in mini 
white transgenes (Dorer and Henikoff 1994, Sabi and Henikoff 1996). These 
effects were unlikely to involve any feature specific to both brown and white 
genes, indicating heterochromatic silencing is a general property of repeated 
arrays. HP1 containing complexes might specifically bind somatic paired 
structures that form at locally repetitive structures. Mini-white repeat arrays 
were later shown to be able to cause silencing of a vital gene close to the 
array in cis. This spreading of heterochromatic silencing correlated with the 
array size and the repeat array behaved like natural heterochromatin (Dorer 
and Henikoff 1997). 
More evidence for the involvement of heterochromatin in repressing 
repeated transgenes in Drosophila is presented by the selective accumulation 
of Polycomb group proteins at repressed loci (Pal-Bhadra et al 1997). 
Mutations in the Pc-C gene resulted in a 50% reduction in co-suppression. 
The recruitment of these proteins to repeated transgenes may help localise 
the DNA sequence to an inactive nuclear compartment i.e. the chromocentre 
of Drosophila where a number of heterochromatic domains are located 
together. 
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1.4.3 Silencing in transgenic mice 
Many examples of variegation in mouse transgene expression have 
been documented over the years. One early paper found that a tk gene 
integrated in mouse centromeric heterochromatin was affected by DNA 
methylation and cis effects from the flanking region. The repression of tk 
was thought to reflect position effect variegation (Butner and Lo 1986). In 
other cases, as discussed in 1.3.1, strain-specific modifiers influenced 
transgene expression (Allen et al 1990). 	Other papers documented 
variegation in coat colour from tryosinase transgenes (Bradl et at 1991, Mintz 
and Bradl 1991). 
1.4.4 Repeat Induced Gene Silencing in transgenic mice 
Recently data from mammalian systems have confirmed that repeat 
induced gene silencing is a widespread phenomenon (Wolffe 1997). Within 
certain high copy number transgenic lines, animals would exhibit variegated 
expression within a tissue (Dobie et at 1996). 	It was predicted that 
transgenes in animals would form heterochromatin and be silenced in a 
similar manner to repeats found in plants or Drosophila (Dorer 1997). Since 
the mid 1990s it has now become much clearer that the repeated nature of 
multicopy arrays may be as influential a cause of variegation in transgenic 
mice as position effects are. 
In some cases a correlation between the increasing copy number, and 
the increasing methylation of the transgenes promoter has been observed 
(Mehtali et at 1990). Methylation of DNA in animals is known to be involved 
in repression of transcription. 	In other cases, the variegated levels of 
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expression did not correlate with an increase in the methylation of the 
transgene, but did correlate with a restricted chromatin structure noted as a 
loss of DNAse hypersensitive sites (Garrick et al 1996). Both these epigenetic 
factors may have a crucial role in silencing repeats. 
Robertson et al (1995) produced transgenic lines expressing 3-
galactosidase controlled by globin promoters linked to the major tissue 
specific regulatory element of the ct-globin locus. This system permits the 
analysis of transgene expression in individual red blood cells. The analysis 
showed expression of transgenes within lines is heterocellular and suggests 
the variation in total transgene activity between lines is mainly due to the 
number of cells committed to transgene expression rather than different 
levels of promoter activity. 
As discussed in 1.4.1 and 1.4.2 Repeat Induced Gene Silencing (RIGS) 
was shown to decrease the proportion of cells that expressed the transgene in 
systems such as Drosophila and plants. In mice however, due to the use of 
microinjection for generation of transgenic lines, studies could not 
distinguish between position effects and the number of copies integrated. In 
1998, after this PhD project was started, it was formally established that the 
tandem repetition of transgenes could produce transcriptional silencing in 
mammals (Garrick et al 1998). High copy number lines were established by 
microinjection. The transgene used was a hybrid lacZ reporter construct 
driven by the human a-globin promoter and the aHS40 enhancer-like 
element, with a loxP site integrated. The loxP site did not interfere with the 
transgene expression. Using Gre/lox recombination transgene copy number 
was then altered at the same integration site. 	Expression levels were 
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analysed for the parental unreduced line and for the reduced line in 12.5 dpc 
embryos using lacZ staining. Two high copy lines (>100 transgene copies) 
showed a variegated pattern of expression with less than 1% of erythroid 
cells containing an active locus. Reduction in copy number to five or one 
copy resulted in a large increase in the transgene expression level. The 
reduction in copies correlated to suppression of variegation. Expression had 
increased over 1000-fold in the line reduced to five copies, while there was a 
180-fold increase in the other line reduced to one copy. This expression 
increase was correlated with a decrease in chromatin compaction and 
methylation at the transgene locus. 	Run-on analysis of the transgene 
indicated that the silencing in the unreduced line was at a transcriptional 
level. 
By contrast, other studies into RIGS have failed to find an increase in 
the proportion of cells expressing after reduction in copy number (Ramirez et 
al 2001). A keratin5-lacZ construct was shown to express mosaically. The 
transgene expression was studied in the basal layer of stratified epithelia. 
Six K5Zlox lines were generated; four of which variegated and two were 
silenced. Using Cre/loxP the transgene copy number was modified either by 
microinjection of Gre, or by breeding to a line of mice expressing Cre 
specifically in the stratified epithelia. Tissue sections of one parental line (14 
copies) showed no difference to the reduced line (1-2 copy). Another line 
showed a reduced intensity of 3-gal staining, but not in the proportion of 
cells expressing. These results indicated that copy number reduction had 
little effect on variegation of K5Z transgenes. This discrepancy between this 
work and that of Garrick was explained by the authors as differences 
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between the two systems studied; i.e. the cell types, the transgene structure 
or that different chromosomal sites may be more prone to repression. 
In all the situations discussed, there has been the suggestion that the 
genome has mechanisms that can identify foreign sequences, and can then 
silence them as a defence mechanism to maintain the gene expression pattern 
of that cell. How cells recognise foreign DNA is not clear, although the 
difference in codon usage, the CC content of a transgene relative to its 
chromosomal location or the repeated nature of inserts all may trigger the 
many diverse silencing mechanisms that exist. Bacterially derived sequence 
of the lacI repressor can be eliminated from somatic cells (Scrable and 
Stambrook 1999). However, the same sequence recoded for mammalian 
codon usage was expressed and was hypomethylated. Therefore, cells do 
seem to possess an ability to distinguish mammalian-like sequences from 
foreign sequence. 
The genome of vertebrates is made up of mosaics of isochores, which 
are very long stretches (>300kb) of DNA that are homogeneous in base 
composition and are compositionally correlated with the coding sequences 
that they embed (Bernardi 1995). Isochores can be partitioned in a small 
number of families that cover a range of CC levels. Insertion of transgenic 
DNA into isochores that differ in their CC content may be involved in 
helping cells to recognise foreign DNA. It has been found that there are tight 
constraints on base substitutions in CC rich isochors even if the region is non-
coding, indicating these sequences must be functionally important. The CC 
richness of the foreign sequence would alert the surveillance system, the 
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intruding DNA would become methylated and then in some cases removed, 
from the genome. 
The examples from Drosophila, mice and plants show how the 
repeated nature of transgene arrays plays an important role in transgene 
expression. It is argued that arrays in transgenic animals are subjected to 
similar mechanisms of silencing as discussed, because of their repeated 
nature. However these effects may still be dominated by the chromosomal 
context that the repeats find themselves in. 
1.5 	POSITION EFFECT VARIEGATION 
Given the stochastic nature of silencing in many transgenic systems 
comparisons have been drawn to position effect variegation, described in 
Drosophila in 1930 (Muller 1930). 	In these early classic experiments 
chromosomal rearrangements were induced by X-ray radiation and shown to 
lead to variegated expression of a gene. 	Thus, the translocation of a 
euchromatic gene close to a region of heterochromatin was thought to subject 
it to the spread of the heterochromatin and consequently silencing (Henikoff 
1990). This was thought to result in mosaic expression of translocated genes 
on a cell-to-cell basis depending on the extent of heterochromatization. 
PEV has been extensively studied in Drosophila leading to the 
discovery of genes suppressing or enhancing variegation, as well as 
implicating heterochromatic proteins in this phenomenon. Some suppressor 
mutations including Suppressor of variegation Su(var)205 and Su(var)3-7 
encode for HP1 and a zinc finger protein, both of which are heterochromatin 
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components, as predicted for genes that reduce silencing as their dose is 
reduced (Eissenberg et a! 1990). Several enhancers encode transcription 
factors, while one enhancer locus, D-Ubp-64E, encodes an ubiquitin-specific 
protease (Henchoz et a! 1996). 
Polycomb proteins (Pc) have been found to be closely associated with 
PEV. These proteins are involved in Drosophila development. They act to 
repress transcriptional activity by controlling the organisation of entire 
chromosomal domains. Polycomb silencing can spread along the chromatin 
fibre from the Polycomb response elements (Birchier et al 2000). It has also 
been suggested that Pc can spread in cis and in trans to produce co-
suppression of non-homologous transgenes (Pal-Bhadra et a! 1999). 
The properties of PEV discussed above, help highlight the similarities 
to transgene silencing. In both cases, the degree of variegation is affected by 
the relative distance of the gene to constitutive heterochromatin (Dorer and 
Henikoff 1994, Dobie et al 1996). The influence of heterochromatic proteins 
i.e. HP1, is shared between PEV and transgene silencing (Eissenberg et al 
1990, Festenstein et a! 1999). The stochastic manner in which PEV affects the 
gene expression also draws comparisons with transgenic examples (Henikoff 
1990, Robertson et al 1995). 
1.6 	EPIGENETIC EFFECTS 
Position effect variegation and repeat effects both fall in to a wider 
area of study, that of epigenetics. This field concerns itself with a wide 
number of phenomena which all affect gene expression at a level other than 
the DNA sequence (Gasser et al 1998). Common mechanisms may exist 
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between many diverse effects. Methylation, chromatin, histone acetylation, 
nuclear architecture and localisation all play various roles in the epigenetic 
regulation of gene expression (see 1.7). Given the need for tight control of 
gene expression throughout development and the various tissues of the 
body, it is not surprising that such a complex web of factors controlling gene 
expression has arisen. Imprinting and X inactivation are two of these effects 
discussed below. These are interesting epigenetic phenomena as both show 
some similarities to PEV and repeat effects; mainly 'counting' and the 
involvement of methylation. 
1.6.1 Imprinting 
Genomic imprinting is involved in gene regulation by ensuring 
imprinted genes express only one of the two parental copies in a parent-of-
origin specific manner (for review of imprinting, see Reik and Walter 2001). 
It provides a puzzling exception to Mendelian laws of inheritance as both 
parental sequences encode the same gene. A mark or imprint conferring 
memory must exist that differentiates between the parental genomes, be 
inherited during somatic cell division but is erased in the germline (Falls et al 
1999). 
One theory suggests imprinting arose due to parent—offspring conflict 
in the amount of maternal resources allocated to an embryo (Moore and Haig 
1991). 	This theory predicts that imprinted genes expressed from the 
paternal genome should enhance growth, while maternally expressed genes 
should inhibit growth, providing a conflict between the two parental 
genomes. Indeed many of the genes found to be imprinted are involved in 
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fetal growth, placental development or behaviour designed to gain maternal 
attention (Mochizuki et al 1996). 
Imprinted genes have been shown to be differentially methylated 
depending on the parent-of-origin. These differentially methylated regions 
or domains (DMR or DMD) are thought to control the expression of 
imprinted genes (Reik and Walter 2001). 
Mouse H19 and Ifg2 show inverse patterns of expression. The mouse 
H19 gene is maternally expressed, whereas Igf2 is paternally expressed which 
fits with the conflict theory of imprinting (Thorvaldsen et a! 1998). The 
paternal-specific methylation upstream of H19 appears to be an epigenetic 
mark required for imprinting and leads to the paternal suppression of H19. 
The deletion of the paternal H19 DMD activates expression in the normally 
repressed paternal H19. It also causes reduced H19 expression in maternal 
inherited transgenic mice, along with activation of 1gf2. 	The DMD is 
therefore required on both parental alleles for reciprocal imprinting of H19 
and Igf2 (Thorvaidsen et al 1998). It was later shown that this DMD 
contained an element that blocked enhancer function (Bell and Felsenfield 
2000, Hark et a! 2000). The enhancer blocking activity was found to be 
dependent on the protein CTCF. If the binding sites for CTCF were 
methylated, the enhancer blocking activity was lost. 
Imprinting at this locus is controlled by methylation of the paternal 
allele, which inhibits CTCF binding and the insulator element activity. From 
this natural situation it is clear that methylation plays an important role in 
imprinting. 	The control of imprinted gene expression by methylation 
reflects the situation found with transgene silencing where many examples 
exist whereby the transgene silencing is accompanied by an increase in 
methylation (Allen et a! 1990, Mehtali et a! 1990). 
1.6.2 X inactivation 
In mammals, due to heteromorphic sex chromosomes a mechanism is 
required for dosage compensation between females (XX) and males (XY). X 
inactivation occurs early in mammalian female development. 	This is 
achieved by global silencing of one X chromosome. This process requires 
that the cell counts the chromosome number, chooses which X chromosome 
to silence, initiates and then maintains inactivation (Marahrens 1999). Once 
inactive, the X chromosome becomes heterochromatin like and is condensed 
into a Barr body (Lyon 1998). 
In diploid cells one X chromosome remains active, regardless of how 
many X chromosomes exist in the cell. The choice of which X to inactivate is 
a random decision made by individual female cells. However, the Xce (X-
controlling element) can influence this decision. Once the decision has been 
taken, the inactive state is stably maintained in somatic cells. 	An X- 
inactivation centre (Xic) was discovered which is required for the initiation of 
silencing but not for the maintance of inactivation (Brown and Willard 1994). 
The Xist gene encodes a 15kb untranslated mRNA and maps to the Xic. This 
mRNA is expressed exclusively from the inactive X, is induced prior to onset 
of inactivation and is found to 'coat' the inactive X (Brown et al 1991). Tsix is 
a 40kb RNA that starts 15kb downstream of Xist and is transcribed across the 
Xist locus (Lee et al 1999). Before X inactivation, Tsix is expressed from both 
X chromosomes. At the onset of inactivation Tsix becomes monoallelic and 
is found to associate only with the future active X. It then persists until X 
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inactivation is established. Its antisense nature suggests the possibility that 
Tsix directly blocks Xist action on the X chromosome. Tsix is now thought to 
regulate Xist in cis and determines which chromosome is silenced without 
affecting the actual silencing (Lee and Lu 1999). 
The initiation of heterochromatin formation at X inactivation has been 
proposed to occur due to pairing of the homologous X chromosomes 
(Marahrens 1999). 	This hypothesis is supported by the fact that Xist 
transgenes will only inactivate autosomal sequences if they are integrated as 
tandem arrays, which fits with a model of pairing reactions between adjacent 
transgene copies (Heard et at 1999). Repetitive LINE elements on the X 
chromosome may be acting as boosters of the spread of Xist RNA. The RNA 
is thought to help bring the LINE sequences together, inducing a 'repeat 
response' from the cell, which heterochromatizes the X chromosome (Lyon 
1998). 
X inactivation is a natural example of gene dosage, which appears to 
involve counting and homology induced silencing. 	This has strong 
similarities to transgene silencing, which has been shown in many diverse 
systems (plants, Drosophila and mice) to involve homology based silencing 
effects (Wu and Morris 1999). X inactivation leads, as do many examples of 
transgene silencing to the heterochromatinization of the region (Assaad et at 
1993, Dorer and Henikoff 1994, Garrick et at 1998). The ability to 'count' 
either imprinted genes or X chromosomes and the systems to inhibit 
expression from them, i.e. methylation, pairing and heterochromatinization, 
show how transgene silencing may use silencing systems that already exist 
within the cell. 
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1.6.3 Epigenetic inheritance 
Genetically identical individuals show phenotypic variation, which 
has previously been described as 'developmental noise' or as variable 
penetrance due to multi-trait modifiers. Breeding strategies to discount 
genotypic and environmental differences have still shown variation in both 
endogenous and transgenic expression (Morgan et al 1999, Sutherland et a! 
2000). Evidence is accumulating to suggest that this phenotypic variation is 
due to epigenetic modifications of the genome being inherited (Rakyan et a! 
2001). 
These epigenetic modifications which include methylation, chromatin 
and histone acetylation, function to affect gene expression, which has a 
knock-on effect on the phenotype of an organism. It was previously thought 
that all epigenetic marks were erased and reset on passage through the 
germline. 	Recently, evidence has started to emerge that suggests that 
sometimes these epigenetic marks may persist, and be inherited in the next 
generation (Morgan et a! 1999). For example, inbred mice from over 20 
generations would be expected to be phenotypically indistinguishable. 
However, mice carrying the agouti yellow viable allele (AY"), show varying 
colour patterns from full agouti to full yellow. A trans-generational effect 
was present, coat colour of grandmother related to the coat colour of the 
second generation. 	However, due to the genetic background, genetic 
modifiers could be ruled out. Uterine environment was also excluded as a 
source of the variation. This leaves the inheritance of an epigenetic mark 
from generation to generation as the most plausible explanation. 
From the examples described in section 1.6, it is clear that in some 
cases transgene silencing shows similarities to the natural cases of gene 
silencing found in the genome, i.e. imprinting and X-inactivation. It may be 
that transgene expression is controlled by the existing systems of gene 
regulation within mammalian cells. 
1.7 	MECHANISMS OF EPIGENETIC REGULATION 
Epigenetic control of gene expression is a complex subject. Many 
diverse phenomena may have related mechanisms or involve the same key 
factors. In this section some of the 'biochemical' mechanisms involved in 
epigenetic regulation, which may have similar roles between a wide range of 
organisms, are discussed. 
1.7.1 Methylation 
Cytosine methylation of CpG dinucleotides has been suggested as a 
host defence against intragenomic parasites (Yoder et a! 1997). 	Active 
transposons threaten the regulated expression of the genome in a number of 
ways. Insertional mutagenesis, recombination between transposons causing 
translocations and rearrangement, aberrant RNA expression from a 
transposon or antisense RNA to an endogenous gene could all disrupt 
cellular expression. 
It has been suggested that high numbers of spontaneous mutations in 
Drosophila are due to transposable elements. It must be considered at this 
point that Drosophila melanogaster has no detectable endogenous methylation 
(Urieli-Shoval et al 1982). Drosophila, having no methylation appears unable 
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to defend its genome against these intragenomic parasites. The expression 
of mammalian methyltransferases causes genomic methylation and lethality 
in Drosophila. 	This lethality of genomic methylation suggests that 
methylation has functional consequences for Drosophila development (Lyko 
et al 1999). 	This data suggests Drosophila at some point had genomic 
methylation and has since lost it. 	It has been shown directly that 
transposable elements can be silenced by HDGS, providing a link to the 
mechanisms that silence transgenes and a 'defence' system (Jensen et al 1999). 
Methylation is necessary for proper embryonic development, as mice 
lacking a functional DNA methyltransferase fail to develop properly and die 
in mid-gestation (Li et al 1992). 	Methylation has been suggested as a 
mechanism to control inappropriate gene expression from a complex genome 
in a global manner. It is clear that it is just as important to selectively control 
the genes to be switched off, as it is to control the expression of genes 
through development. Given the number of genes active in a differentiated 
cell compared to the overall gene number, repression of genes must be a 
crucial role in gene control (Bird 1995, Siegfried and Cedar 1997). 
Methyl-CpG-binding proteins MeCP1 and MeCP2 interact specifically 
with methylated DNA and mediate transcriptional repression (Boyes and 
Bird 1991, Nan et al 1998). MeCP2 binds to chromosomes in a methylation 
dependent manner, and contains a transcriptional-repression domain (TRD) 
that can function in vitro and in vivo. It has subsequently been shown that a 
region of MeCP2 associates with a co-repressor complex including mSin3a 
and histone deacetylases (HDACs). This work showed that MeCP2 provides 
a bridge linking methylation to histone deacetylation and subsequently 
repression (Nan et al 1998). 
EEO 
More links between methylation, acetylation and chromatin have 
recently been found. Dnmtl (DNA methyltransf erase 1)is found to be 
associated with histone deacetylase activity in vivo (Fuks et a! 2000). HDAC1 
can bind to Dnmtl. A transcriptional repression domain in Dnmtl functions 
by interacting with the catalytic domain of HDAC. Two models exist for the 
transcription repression of these proteins: the Dnmtl associated deacetylase 
activity may be required to deacetylate newly formed nucleosomes, or the 
deacetylase activity may be needed first to remodel the chromatin to allow 
methylation to take place. 
The pattern of overall methylation involves the methylation and 
demethylation of DNA throughout development. Recently a demethylase 
was identified (Bhattacharya et a! 1999). The protein is a member of a 
conserved family of Methyl-CpG-binding domain (MBD) proteins, and 
shows homology to MeCP2 at the MBD. The enzyme was thought to 
convert 5-methylcytosine to cytosine and methanol. This demethylase is 
identical to MBD2b. However, the in vivo function of this demethylase has 
not yet been proven (Woiffe, Jones and Wade 1999). 
Currently four mammalian DNA cytosine methyltrarisf erases 
(DNMT5), five methyl-CpG-binding proteins and a demethylase have been 
found (Bird and Woiffe 1999). An alternative role for methylation is that the 
default setting of the genome is repression, and that demethylation is the key 
to expression. 	Investigations into the complex connections between 
methylation and expression are continuing. Nevertheless it is quite clear 
that methylation is an extremely important factor regulating endogenous and 
transgenic gene expression in mammals. The important role of methylation 
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is shown by the correlation of aberrant methylation with cancer and some 
other human diseases (McBurney 1999, Hansen et al 1999, Tycko 2000). 
Given the crucial role of methylation in controlling endogenous gene 
expression as discussed above, it is not surprising that there are numerous 
examples of transgene silencing involving methylation. 	Transgene 
sequences in mammals and plants, have been found to be methylated when 
silenced (Palmiter, Chen and Brinster 1982, Garrick et a! 1998, Assaad et a! 
1993). When repeated transgenes were reduced to single copy and showed 
expression, there was found to be a correlated change in the methylation 
status (Garrick et a! 1998). 	It may be that the methylation status of 
transgenes is crucial to their ability to express, similar to the control of 
endogenous gene expression (Thorvaidsen et a! 1998). 
1.7.2 Histone acetylation 
The eukaryotic genome is maintained in a DNA protein complex 
called chromatin. The main protein components of chromatin are the core 
histones. Histones associate to form a nucleosome, where 146bp of DNA is 
wrapped around an octomer of histones. Histones are post-transcriptionally 
modified in a number of ways including phosphorylation, ADP-ribosylation, 
methylation and acetylation (Brownell and Allis 1996). Histone acetylation 
results in the neutralisation of a single positive charge. Acetylated histones 
are associated with gene expression, while deacetylation associates with a 
repressed state. This is due to the fact that histone acetylation weakens the 
association of histones with DNA, allowing a more 'open' nucleosomal 
structure to occur (Struhi 1998). Under-acetylation of histone H4 has been 
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found to be a general property of heterochromatin and is thought to play a 
role in the stabilisation of the inactive X chromosome (Keohane et a! 1998). 
Histone acetylases have been found to be closely associated with Polil 
machinery. 	p300/CBP histone acetylase is found in a wide range of 
organisms and is found to be tightly associated with the PouT machinery 
(Nakajima et a! 1997). This provides a simple mechanism linking acetylation 
and transcription. HDAC have been found in large multi-protein complexes 
that include repressors (Struhl 1998). The targeting of histone acetylases and 
deacetylases to promoters most likely causes local modifications of 
chromatin structure. 
Histone acetylation has also been proposed as an epigenetic mark that 
could survive from one cell generation to the next (Turner 1998). The model 
predicts that a level of information could be encoded in the pattern of lysine 
specific acetylation on the nucleosome surface, and that this could be turned 
into structural and functional effects by non-histone proteins. 	If the 
acetylation can also locate an appropriate lysine specific acetyltransferase 
then this mark could be maintained through DNA replication. 
Histone acetylation provides a link between methylation and 
chromatin remodelling (Bestor 1998). Transgenes can often be condensed 
into heterochromatin (Dorer and Henikoff 1994, Garrick et al 1998) and it 
may be possible that histone acetylation has a role, not just in regulating 
endogenous gene expression, but also that of transgenes. However, at this 
time no studies have been carried out into the direct role of histone 
acetylation in transgene expression. 
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1.7.3 Chromatin remodelling 
When chromatin was first discovered it was thought to function only 
as a compaction mechanism for packaging the genome into the nucleus. 
More recently, as effects of methylation and acetylation have been studied it 
has been established that modulations in chromatin have direct roles in 
regulating transcription. 
An Arabidopsis gene DDM1 (decrease in methylation) was found to be 
required for maintance of normal methylation patterns. This gene was 
found to encode for a SWI2/SNF2-like protein. This discovery showed 
chromatin remodelling was an important process for maintaining DNA 
methylation (Jeddeloh et at 1999). Members of the SWI2/SNF2 family are 
involved in various functions including transcriptional co-activation or co-
repression, chromatin assembly and DNA repair. 
The SWI/SNF complex is a 2 MDa multi-subunit DNA dependent 
ATPase that regulates gene expression through changes in chromatin 
structure. 	SWI/SNF can alter nucleosome structure and may remodel 
nucleosomes in trans or in cis, by displacement or by sliding of the octomer 
(Peterson and Workman 2000). 	It is now thought that gene specific 
activators recruit the remodelling SWI/SNF complex directly to genes. This 
'activator model' is supported by evidence of direct interaction between 
SWI/SNF and transcriptional activators (Yudkovky et at 1999). SWI/SNF 
highlights the interaction between methylation, nucleosome structure and 
position and the remodelling of chromatin in relation to gene expression. 
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The chromatin formation surrounding transgenes can correlate with 
its expression profile (Whitelaw 2000). 	The precise localisation of 
nucleosomes and their remodelling may be crucial to the decision to express 
a gene (Kornberg and Lorch 1999). Therefore, the mechanisms by which 
chromatin is remodelled may help elucidate the higher order regulation by 
which transgenes are expressed. 
1.7.4 Nuclear localisation 
Functional domains within the nucleus are becoming apparent 
through FISH experiments. The compartmentalisation of a gene may be 
involved in its subsequent expression. 
Heterochromatic protein 1 is associated with heterochromatin but is 
not a histone (Eissenberg and Elgin 2000). HP1 plays a role in regulating 
gene expression through heterochromatin, but it may also play a role in 
nuclear localisation for gene expression. 	HP1 is encoded by a locus 
identified as a dominant suppressor of PEV, Su(var)2-5 in Drosophila. HP1 
was later shown to share a chromo domain motif with the homeotic gene 
silencer Polycomb (Pc) (Paro and Hogness 1991). Over-expression of HP1 
leads to a modification in PEV, specifically the number of cells expressing 
changes in a dose-specific manner but also in a chromosomal-context-
dependent manner (Festenstein et al 1999). 
HP1 can interact with the lamin B receptor (LBR), which is an integral 
membrane protein of the nuclear envelope (Jones et al 2000). HP1 has also 
been shown to interact with Maros, a transcription factor in mice. Ikaros has 
been used as a marker for centromeric heterochromatin, and has shown that 
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lymphoid specific genes are localised in the nucleus according to their 
expression status (Brown et al 1997). 
Transgenes have been shown to circumvent silencing by avoiding 
nuclear compartments in which expression would be suppressed (Francastel 
et al 1999). Nuclear localisation may therefore play an important role in 
cases of transgenic PEV, where the repeat structure is recognised by 
chromatin remodelling and heterochromatic proteins, which may then help 
localise the transgene to a nuclear compartment that helps maintain the silent 
state. 
1.8 	TRANSGENE SILENCING IN THE MAMMARY GLAND 
The mammary gland is an unusual tissue; it is only fully developed in 
the adult female after pregnancy, and undergoes involution after suckling 
has stopped, where upon it resembles the virgin gland (Mepham 1987). The 
expression of milk protein genes is controlled so that milk production is 
timed to coincide with the birth of pups. 	The production of milk is 
regulated by a number of hormones, including progesterone, prolactin and 
oxytocin (Hennighausen and Robinson 1998). The potential for foreign gene 
expression in milk, has led to extensive use of transgenes that express in the 
mammary producing animals termed 'bio-reactors' (Houdebine 2000). 
Eno 
1.8.1 	-1actog1obu1in 
-lactoglobulin (BLG) is the major protein in the whey of ruminants 
and is found in the milk of other animals including horses, dogs and 
dolphins. However, it is not found in humans or rodents (Pervaiz and Brew 
1985). The ovine gene encoding BLG is 7379 nucleotides long and is single 
copy in ruminants (Harris et al 1988). BLG protein exists as a dimer of two 
identical subunits of 162 amino acids each containing five cysteine, of which 
four form intra-chain disulphide bridges. Each subunit has a molecular 
mass of 18000 (18K). Approximately 5% of poly (A) RNA in the mammary 
gland of lactating sheep codes for BLG transcribed as an 800 nucleotide RNA 
(Mercier et al 1985). 
Mammary development, lactogenesis and involution are all controlled 
by a complex system involving hormones, growth factors and inter- and 
extra-cellular interactions. BLG was shown to have three sites for milk 
protein binding factor (later shown to be Stat 5). Mutation of these sites 
reduced expression of BLG transgenes, while mutation of all three resulted in 
loss of hormone response in vitro (Burdon et a! 1994). 	Prolactin is 
predominantly synthesised in the pituitary of vertebrates and is one of the 
main hormone regulators of milk expression along with estrogen, growth 
hormone and glucocorticoids (Tucker 2000). 	Prolactin activates BLG 
transcription through the JAK/STAT pathway. JAK2 is recruited to the 
prolactin receptor, phosphorylating the Stat5 isoforms 5a and 5b. The 
phosphorylated Stat then bind to BLG and the gene is expressed 
(Hennighausen and Robertson 1998). In lactating mammary the BLG 
promoter is found within a nuclease (DNase I) hypersensitivity site. This HS 
47 
site covers the Stat binding sites and its appearance correlates with the 
formation of a hormonally induced transcription complex (Whitelaw 1996). 
These changes in DNase HS at this region are not dependent on Stat5 
interaction at the binding sites (Whitelaw 2000). 
1.8.2 Lipocalins 
BLG belongs to a phylogenetically conserved group of more than 40 
proteins called the lipocalins (Flower 1996). Ovine BLG shows similar 
organization of exons and introns as retinol binding protein, major urinary 
protein, apolipoprotein D and alpha-1-acid glycoprotein. BLG and retinol 
binding protein show very similar three-dimensional structures (Ali and 
Clark 1988). 	These lipocalins function in binding and transportation of 
hydrophobic ligands, BLG has been shown to bind fatty acids and retinol. It 
is still unclear, however, what the biological role of BLG is. 
1.8.3 BLG transgenic mice 
BLG genes from a number of species including ovine, caprine and 
bovine have now been used to produce transgenic mice (Simons et al 1987, 
Ibañez et al 1997, Gutiérrez-Adán et al 1999). BLG is expressed at the highest 
levels using the ovine construct (23mg/mi; five times the estimated BLG 
concentration in sheep), followed by bovine (3mg/mi) and then caprine 
(0.5mg/mi). It may be however, that these differences are due to the varying 
amount of 5' and 3' sequence used in the different constructs, or the number 
of experiments sampled. 
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Expression of the BLG transgene in mice had no deleterious effects 
and the only difference between milk composition from control mice and the 
transgenic mice was the presence of BLG. Initially as with many transgenic 
systems, BLG was thought to be appropriately expressed. BLG expression 
in transgenic mice was shown to be very similar to the endogenous 3-casein 
in both temporal and spatial expression. Both expressed at low levels in 
virgin glands and then gradually increased in the first ten days of pregnancy. 
Beyond ten days there was high expression, which continued till after 
parturition. These levels grew from 5% at day 10 to 65-68% at parturition 
compared to the levels of mid-lactation. BLG transgenes were also restricted 
to expression in the secretory epithelial cells (Harris et al 1991). 
1.8.4 Bio-reactors 
A hybrid transgene consisting of the BLG promoter fused to an al-
antitrypsin mini gene was shown to be capable of driving expression in the 
mammary gland of transgenic mice (Archibald et a! 1990). This opened up 
the possibility of using transgenic animals as bioreactors for the production 
of pharmaceutically important proteins. The use of animals as bioreactors 
has become an extensive area of transgenic research and has been helped by 
recent advances in nuclear transfer (Clark 1998, McCreath et a! 2000). 
1.8.5 Determining intrinsic factors required for BLG expression 
Initial experiments with BLG transgenes helped define the required 
elements for expression. A BLG transgene containing 408bp 5' flanking 
region was sufficient to direct efficient expression of BLG to the mammary 
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gland (Whitelaw et a! 1992). The proximal 408bp region had some 
characteristics of an LCR: tissue specific DNAse hypersensitive sites, 
interactions with tissue specific and general nuclear proteins. However if 
the promoter was reduced below the 408bp region it showed highly 
unpredictable expression patterns with many lines being completely silenced 
(Whitelaw et a! 1992). 
The 5' flanking region of BLG contains all the necessary sequence to 
direct appropriate expression in transgenic mice (Webster et a! 1995). The 
region comprises a cluster of binding sites for a number of transcription 
factors, contained in a mammary specific DNase I hypersensitivity site, and 
in many ways it is similar to known enhancers (especially INFP enhancer; 
James et a! 2000). The large number of transcription factor binding sites, and 
the DNAseI hypersensitivity site in the BLG promoter has drawn 
comparisons to LCR (James et a! 2000). 	Experiments to determine if 
multiplying the number of transcription factor binding sites could function as 
a 'synthetic LCR' showed that the multimerisation of the BLG promoter 
failed to enhance expression, and in fact suppressed it. The multimer BLG 
promoter had failed to create a mammary specific DNase I hypersensitivity 
site. It was hypothesised that the transcription elements become targets for 
general repression if they fail to form the appropriate complexes required for 
activation (James et a! 2000). 
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1.8.6 BLG MAR sequence 
Although the minimal promoter can drive expression in some cases, 
regions downstream of the BLG promoter are required for efficient 
expression, as shown by the failure of the promoter to express a reporter gene 
in the mammary gland (Shani et a! 1992, Webster et a! 1995). It has now been 
shown that a single MAR exists within the BLG gene domain (Whitelaw et a! 
2000). The MAR was found in the proximal 3' flanking region, -95bp to - 
985bp to the polyadenylation signal. BLG is a GC rich gene (>60%) but the 
MAR is AT rich (average 55%). Removal of this MAR resulted in a lower 
basal level of expression in transgenic mice. By nuclear run-on assays, this 
reduction was determined to be due to a reduction in transcription. The 
reduced transcription was not due to the transgene failing to be induced by 
hormones. It was suggested the reduction corresponded to reduced activity 
from each transgene copy or possibly to a mosaic array were only a few 
transgene are active at any one time. 
1.8.7 BLG and variegation 
Early papers showed that BLG expressed efficiently in a tissue-specific 
manner and appeared to be free from position effects. The bovine BLG 
transgene has been shown to be position dependent and had an inverse 
correlation between copy number and expression (Gutiérrez-Adán et al 1999). 
When later studies looked at the expression of the ovine BLG transgene at 
the cellular level, variegated or mosaic expression patterns were discovered, 
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suggesting that position effects did indeed play a significant role in BLG 
transgene expression (Dobie et al 1996). 
Dobie et al (1996) studied expression levels in three BLG transgenic 
mice lines. Two lines, BLG 7 and 45 exhibited variable levels of transgene 
expression. In these lines low expressing animals showed discrete patches 
of cells expressing the transgene. The variegation at the cellular level was 
mirrored by variation in the expression levels of BLG in milk: there was wide 
spread between sibs of the same line. Line 45 expressed from 16 to 30mg/ml 
while line 7 had an eight-fold difference between the lowest expressor and 
the highest. BLG protein levels were found to be stable within individual 
mice in successive lactations. The copy number within the lines appeared 
stable and no evidence of transgene rearrangement was found. Both 
variegating lines had over 15 transgene copies in arrays while the stable line 
had only two. 	The overall transgene protein expression level in milk was 
deemed to reflect the proportion of epithelial cells in the mammary gland 
expressing BLG mRNA. Chromosomal in situ hybridisation showed that the 
transgenic arrays in both variegated lines were located close to the 
centromere. The relatively large contiguous patches of cells where the 
transgene was active or inactive was consistent with clonal expansion. It 
was thus suggested that epigenetic silencing of transcription occurs 
stochastically in individual progenitor cells, which then transmits to the 
daughter cells giving rise to the mosaic patchy expression. 
As discussed for other transgenic silencing effects the example of 
mosaicism or silencing in BLG transgenic mice has parallels to PEV in 
Drosophila, for example, integration of the transgene close to the centromere 
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is implicated in both examples. 	These studies however, could not 
distinguish between effects from the site of integration and the structure of 
the array. Dorer and Henikoff (1994) illustrated the importance of an 
increase in copy number in producing transgenic PEV like mosaicism, while 
both variable lines in the Dobie study had larger numbers of copies 
compared to the stable line. The data from many transgenic systems argues 
that mosaic expression and silencing can be due to both the location and the 
nature of the transgene array. 
1.9 	AIMS AND APPROACHES 
The work in this thesis follows on from the work of Dobie et al (1996). 
In particular it addresses the hypothesis that the silencing of BLG transgenes 
was directly linked to the copy numbers of the transgene arrays. 
This project attempts to address the issue of the importance of 
transgenic array structure in position effects and mosaic expression while 
avoiding the influence of the integration site. The Cre recombinase system 
enables the manipulation of an array in vivo - to reduce the copy number 
whilst maintaining the same integration site. With this approach it is 
possible to determine the extent to which the repeated nature of BLG 
transgenes contributes to silencing. 
The initial aim of this project was to produce high copy number BLG-
loxP transgenic lines by microinjection. These lines were used to investigate 
the transgene expression profile. Lines that showed variegation were used 
in further experiments. The study used the Cre-loxP system to produce a 
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reduction in copy number in two different ways. Firstly, BLG-loxP animals 
were bred to BLG-Cre animals, (which expressed the Cre recombinase 
specifically in the mammary gland) so producing a mammary gland specific 
reduction. Secondly, BLG-loxP fertilised oocytes were microinjected with a 
PGK-Cre construct, which produced a reduction throughout the animal and 
in its germline, allowing 'reduced lines' to be established. The expression 
profile of reduced animals was analysed to determine if any change in 
expression had accompanied the changes in copy number generated by this 
approach. These two approaches were compared and contrasted, and many 
of the issues related to Cre mediated recombination were addressed. My 
results show that reducing a tandem array of BLG repeats does not prevent 
stochastic silencing in the mammary gland but may, indeed, accentuate it. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 	TRANSGENIC MOUSE LINES 
2.1.1 Lox mouse lines 
Lox lines of mice contain a 7kb BLG-loxP construct derived from 
BLGADp (Whitelaw et al 1992) with a LoxP site inserted at the 3' end (see 
Chapter 3). The BLG-loxP construct was digested with Xho I (see 2.5.7) and 
gel purified (see 2.5.9) to remove vector sequences which are known to 
interfere with transgene expression. Pronuclear stage eggs were obtained 
from superovulated C57BL/6 x CBA Fl females mated to C57BL/6 x CBA 
stud males. Miss Roberta Wallace microinjected the construct into either 
pronucleus of fertilised eggs at 1.5ng4d, the cells were cultured, and cleaved 
embryos (2 cell stage) were transferred to pseudopregnant recipients 
(females that have been mated to vasectomised males), producing GO pups. 
PCR and Southern blotting were used to identify positive transgenic pups. 
A transgenic line is defined as the transgenic offspring from a founder 
animal. 	Five Lox transgenic lines were established from these 
microinjections and were maintained by systematic crossing to C57BL/6 x 
CBA Fl hybrid mice. 
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2.1.2 BLG-Cre 74 mice 
The generation of this line is described by Selbert et al (1998). Cre 74 
mice contain a 6.7kb Cre fusion transgene driven by the BLG promoter. The 
Cre recombinase gene was cloned as a 2.5kb Xho I fragment into the EcoRV 
site of 4.2kb BLG/SK+ plasmid. The plasmid was linerised by Not I prior to 
microinjection into fertilised CBA x C57BL/6 eggs. This line was maintained 
by systemic crossing to C57BL/6 x CBA Fl hybrid mice. 
2.1.3 GB mouse lines 
GB lines contain both a BLG-loxP and a BLG-Cre transgene. Seven 
GB lines were produced by systematic breeding of the Lox lines 4, 5, and 9 to 
the Cre 74 line. Double transgenics were identified by Southern blot probed 
for both BLG and Cre recombinase. These lines were not maintained. 
2.1.4 PLC mouse lines 
PLC (PGK-Lox-Cre) lines were derived by microinjecting a circular 
PGK-Cre construct into pronuclear stage eggs obtained from superovulated 
C57BL/6 x CBA Fl females mated to lox 4, 5 or 9 males. Microinjection was 
as per the Lox mouse lines except the construct was injected at 5ng/p.l. PCR 
and Southern blotting were used to identify positive transgenic pups. 
Transgenic founders were used to establish lines by systematic breeding with 
C57BL/6 x CBA Fl hybrid mice. 
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l3sphl 	 2kb 	 BspHl 
pPolylII 
vector 
Figure 2.1. BLG-loxP. This is a 9kb plasmid derived from BLGADp (Whitelaw 
et a! 1992) with the addition of a loxP site at the 3' end. It contains 406bp of 5' 
flanking region, the 4.7kb BLG structural gene and 1.9kb of 3' regions. Exons are 
represented by blue numbered boxes, with the whole BLG sequence represented 
as a thick black line. 	The loxP site is represented by a red triangle and was 
inserted at 10320bp (from BLG sequence; corresponds to 6567bp on BLGADp), 
which is 467bp from the 3' end of the BLGADp sequence. BspHl sites were used 
to verify the loxP had integrated. Xhol digestion produces a 7kb BLG fragment 
that was used to establish BLG-loxP mice by microinjection. The plasmid was 




EcoRl 	Xhol 	 Hind Ill 
Figure 2.2. 	PGK-Cre. This is a 5.5kb plasmid containing approximately a 
2.7kb fragment containing Cre recombinase and the MT-l(A)n sequence, cloned to 
a fragment of pSP72 vector and the 800bp PGK promoter. The plasmid was 
supplied by Dr. Doug Strathdee. 
2.2.3 BLG and -casein expression vectors 
The four expression vectors used for production of the riboprobes 
used for in situ hybridisation were supplied by Dr. Maggie McClenaghan 
(Dobie et al 1996). 
Pvull 	
51Obp 	 Pvull 
SP6 I 	
BLG antisense 





Pvull 	 . PvulI 
Pvull 
Figure 2.3. BLG expression vectors. pGEM4Z-(424)BLG contains a 424bp 
fragment of BLG cloned into pGEM-4Z in two directions relative to the T7 promoter 
(Dobie et a! 1996). The antisense construct produces a larger Pvull fragment 
compared to the sense construct. Constructs were linerised with BamHl before 
use in in situ experiments. 
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Figure 2.4. Casein expression vectors. pGEM4Z-(417) casein contains a 
417bp fragment of 13-casein cloned into pGEM-4Z in two directions relative to the 
T7 promoter (Dobie et a! 1996). The antisense construct produces a larger NdeIl 
fragment compared to the sense construct. Constructs were linerised with BamHl 
before use in in situ experiments. 
2.2.4 Plasmids used for probe production 
Hind Ill 	 EcoRl 
2729 2322 2249 1713 
pBJI4 
3.8 kb 
2.7kb pUC 18 vector 
Figure 2.5. pBJI4. This is a 3.8 kb plasmid containing approximately 1.1kb of 
BLG sequence corresponding to exon Ill and surrounding introns which was cloned 
into pUC18. Hind Ill I EcoRl digestion produces a 1.1kb BLG fragment which was 
used as a probe for Southern blotting. The figures given for restriction sites are 
from BLGADp sequence. The plasmid was supplied by Dr. Bruce Whitelaw. 
EcoRl 
Figure 2.6. pBJ7. This is a 5.5kb plasmid containing the extreme 3' end of the 
BLG-loxP fragment cloned into ptgpolylll. 	Blue boxes denote exons of BLG. 
EcoRl I Xbal digestion produces a 1kb fragment which was used as a 3' probe for 
southern blotting. 
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BamHl 	Pstl 	YhI 
Figure 2.7. pBJ58. This is a 3.3kb plasmid containing approximately 400bp of 
BLG sequence corresponding to the extreme 5' end of the BLG-loxP fragment 
which contains the transcription site (denoted by black arrow) and exon I fused to 
CAT which was cloned into ptgpoly III. 	BamHI digestion produces a 400bp 
fragment which was used as a 5' probe for Southern blotting. The plasmid was 
supplied by Dr. Bruce Whitelaw. 
213bo 	 440bD 
4 	 •1 	 10 
BamHll 	Xbal 	 BamHl 
Figure 2.8. pCFTR. This plasmid contains a 653bp fragment of CFTR cloned 
into Bluescript (M13). BamHl digestion produces a 653bp fragment that was used 
as a loading control probe for Southern blotting. The plasmid was supplied by 
Dr.Wei Cui. 
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A PCR product generated from BLG cDNA was used as a probe for 
northern blots (supplied by Dr. Romi Pena). 
pSX101 contains a 12kb HindlIl fragment of rRNA in pAT153 vector 
(supplied by Dr. Romi Pena). This was used as a loading control for 
Northern Blots. 
	
2.3 	BACTERIAL STRAINS 
E.coli DH5a competent cells (Genotype: F, 80dlacZAM15, A(1acZYA-
argF)U169, deoR, recAl, endAl, hsdR17(rk-,mk), supE44, 7cthil, gyrA96, relAl) 
were purchased from GIBCO BRL and stored at _700C. This strain was used 
for all plasmid transformation procedures. 
2.4 	PREPARATION OF MEDIA 
2.4.1 Plates containing antibiotics 
LB bottom medium (1% w/v tryptone, 0.5% w/v yeast extract, 0.8% 
w/v agar, 0.1M NaC1) was melted in a microwave and allowed to cool until 
"hand-hot". imi of appropriate antibiotic (e.g. ampicillin; stock = 50mg/ml) 
was added to 1 litre LB bottom (final concentration of 50pg/ml), swirl mixed 
and poured immediately into petri dishes with a bunsen flame close by to 
create a convection current. Once the plates had set, they were placed in a 
37°C oven, upside down, with the lids off, for 1 hour to allow excess 
moisture to evaporate off. Plates were stored at 4°C. 
63 
2.4.2 Liquid medium 
LB medium (1% wlv tryptone, 0.5% wlv yeast extract, 0.1M NaCl, 
10mM MgCl2) was used to grow all E.coli strains. 
2.5 	DNA MANIPULATION AND ANALYSIS 
2.5.1 Transformation of DH5a cells with plasmid DNA 
DH5a cells were thawed on ice and then gently mixed. 1-3j.xl (1-10ng 
DNA) of ligated DNA plasmid was added to 50tl of cells in a 
microcentrifuge tube and mixed using a pipette tip. The cells were placed 
on ice for 30 mm, heat shocked (37°C for 20 sec) and returned to ice for 2 min. 
900[d LB medium (without antibiotic) were added and incubated at 37°C for 
1 hour with vigourous shaking. A 1:10 dilution of cells in medium was made 
and 1001d of each sample was spread onto agar plates (see 2.4.1) using a 
sterile glass spreader. Plates were incubated at 37°C overnight. 
2.5.2 Preparation of plasmid DNA 
Plasmid DNA from large-scale bacterial culture (100-500ml) was 
prepared using Qiagen Plamid Maxiprep DNA purification columns 
following the manufacturers instructions (Qiagen). 
A single colony was lifted using a sterile toothpick and grown at 37°C 
for 6-8 hours in 5m1 LB with 50t1/ml ampicillin. This starter culture was 
64 
used to inoculate LB medium for a bulk preparation. For a low copy 
number plasmid (e.g.pPolyIII derived plasmids) 500m1 LB medium with 
50pgIml ampicillin was inoculated. For high copy number plasmids lOOmi 
LB medium with 50j.tglml ampicillin was used. The cultures were incubated 
overnight at 37°C with vigorous shaking. 
Overnight bacterial cultures were decanted into 2 x 250m1 bottles and 
the cells pelleted by centrifugation (5,000 rpm in Sorvall Dry-Spin centrifuge 
bottles in an F-16 rotor, 10 min at 4°C). After removing the supernatant, the 
pellet was resuspended by vortexing in 10m1 of buffer P1 (50mM Tris-HCl 
pH8.0, 10mM EDTA, lOjig/ml RNase A). lOml buffer P2 (200mM NaOH, 1% 
SDS) was added, mixed gently (the solution should become viscous due to 
cell lysis), and incubated at room temperature for 5 mm. lOml chilled buffer 
P3 (3M potassium acetate pH5.5) which precipitates cell debris and 
chromosomal DNA was added and incubated on ice for 20 mm. The 
bacterial lysate was centrifuged (7,000 rpm as above for 30 min at 4°C). 
Meanwhile, a Qiagen-tip 500 was equilibrated by applying lOmi Buffer QBT 
(750mM NaCl. 50mM MOPS pH7.0, 15% isopropanol, 0.15% Triton X-100) 
and allowing the column to empty by gravity flow. 
The supernatant from the centrifuged bacterial lysate was promptly 
filtered through a prewetted, folded filter and applied to the equilibrated 
column entering the resin by gravity flow. The column was washed with 2 x 
30m1 buffer QC (1M NaCl, 50mM MOPS pH7.0, 15% isopropanol) to remove 
RNA and protein. The DNA was salt-eluted with 15m1 buffer QF (1.25M 
NaCl, 50mM Tris-HCl pH8.5, 15% isopropanol) into a Corex tube containing 
10.5m1 isopropanol and mixed gently. The sample was centrifuged (8,000 
rpm in a Sorvall SS-34 rotor for 30 min at 4°C) and the supernatant removed. 
The pelleted DNA was washed with 5m1 70% v/v ethanol and centrifuged 
(8,000 rpm as above, 10 min at 4°C). After removing the supernatant the 
pellet was air dried, and resuspended in an appropriate volume of TE. 
2.5.3 Preparation of mouse tail genomic DNA 
1cm tail-tip biopsies were taken from 3 - 5 week old anaesthetised 
mice and digested overnight at 37°C in Tail Digestion Buffer (200.xg/ml 
Proteinase K, 0.3M sodium acetate, 10mM Tris-HC1 pH7.9, 1mM EDTA, 1% 
w/v SDS). Samples were vortexed before tissue debris and SDS were 
pelleted by microcentrifugation (13,000 rpm, 30 min at 4°C). The 700it1 
supernatant was removed to a tube containing an equal volume of 
phenol/chloroform and mixed. After microcentrifuging (13,000 rpm, 10 mm 
at room temperature) the extracted aqueous phase was added to an equal 
volume of isopropanol. The sample was mixed well and left at room 
temperature for 10 min to allow the DNA precipitate to form. The DNA 
was pelleted by microcentrifugation (13,000 rpm, 10 mm, room temperature), 
washed with 70% v/v ethanol, air dried and resuspended in 150 [11 TE buffer. 
The DNA was stored at —20°C. 
2.5.4 Preparation of high molecular weight mouse DNA 
Care must be taken when preparing high molecular weight genomic 
DNA to prevent shearing of the DNA. Shearing was miminised by avoiding 
vigourous pipetting or vortexing. 	Large bore pipettes also helped to 
prevent shearing of the DNA during preparation. 
Tissue was frozen in liquid nitrogen immediately after dissection from 
the animal. Mammary tissue was pulverised and ground to a fine powder 
under liquid nitrogen in a pestle and mortar before being transferred to a 
homogeniser due to the nature of the tissue. Liver tissue does not require 
this step. Two methods were employed during this thesis, because the yield 
was found to be greater when using method 2 as described below. 
Method One 
The tissue was added to a lOmi Wheaton homogenizer containing 3m1 
ice cold RSBE/NP40 (10mM Tris-HCl pH7.4, 10mM NaCl, 2mM EDTA, 0.5% 
v/v NP40) with 3p1 100mM PMSF added just prior to use. The tissue was 
liquidised using as few strokes as possible. 	The homogenate was 
transferred to a 13m1 centrifuge tube and centrifuged (4,500 rpm Jouan 
CR3000 swing bucket rotor, 5 min at 4°C). The supernatant was removed 
and the pellet resuspended in 3m1 RSBE/NP40 (this wash was repeated twice 
more). Finally the pellet was resupended in 3m1 RSBE (10mM Tris-HC1 
pH7.4, 10mM NaCl, 2mM EDTA) to which 3m1 SNET (1% SDS, 0.6M NaCl, 
10mM EDTA, 20mM Tris) was added. Proteinase K was added to a final 
concentration of 200tg/ml and the viscous solution was incubated at 37°C 
overnight (or until the solution was no longer cloudy). 	Two 
phenol/chloroform extractions and one chloroform extraction were 
performed (see 2.5.10). The DNA was precipitated with 6m1 isopropanol 
and the "stringy DNA was spooled out using a heat sealed pipette. The 
pipette was dipped in 70% v/v ethanol to wash the DNA, followed by air-
drying. The DNA was resuspended in lml TE and left at 4°C. 
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Method Two 
The tissue was added to a 40m1 homogeniser and disrupted in 15m1 of 
10mM NaCl, 20mM Tris-HC1 (pH8.0), 1mM EDTA, 0.5% w/v SDS and 100 
jig/ml proteinase K. The solution was transferred to a 50m1 falcon tube, 
mixed and then left overnight at 500C. The DNA was extracted by gentle 
inversion with an equal volume of phenol/chloroform for 10 min at room 
temperature. The DNA was then centrifuged (4000 rpm in an Eppendorf 
5810 R Swing bucket rotor, 20 min at 10-12°C). The upper aqueous layer 
was removed to a clean tube using a wide bore pipette. 1.5m1 3M Sodium 
Acetate pH5.5 was added and 30m1 100% ethanol was gently layered on top. 
The DNA was gently mixed for ten minutes by hand. The DNA was 
spooled out using a heat sealed pasteur pipette, washed in 70% v/v ethanol 
and air dried for approximately 5 mm. The DNA was then resuspended in 
2ml of TE and left at 4°C. 
2.5.5 Quantifying DNA and RNA 
Spectrophotometric measurements were used to determine both the 
quantity and quality of DNA and RNA prepared. Typically for genomic 
DNA a 20ji1 sample was diluted with 980[d distilled water and the 
absorbance read at 260 nm to give the concentration of nucleic acid in the 
sample. An OD of 1 corresponds to approximately 50tg/m1 of double 
stranded DNA. An OD of 1 corresponds to approximately to 40j.tg/ml of 
single stranded RNA. 
The ratio between readings at 260nm and 280nm provides an 
estimation of the purity of the sample. 	Pure DNA samples have a 
OD26o/OD28o ratio of 1.8, while pure RNA has a ratio of 2.0. Contamination 
of a DNA sample with protein produces a lower ratio. The DNA extraction 
methods used generally gave a ratio of 1.9. 
2.5.6 DNA sequencing 
The chain termination method was used to sequence part of the BLG-
loxP plasmid. A Sequenase Version 2.0 DNA sequencing kit (USB) was used 
according to the manufacturers instructions and all buffers used as supplied. 
This method requires single stranded DNA as its starting material. 
Therefore, double stranded plasmid DNA was alkaline denatured before use 
in the sequencing reaction. The DNA was mixed with 0.1 volume of 2mM 
EDTA and 0.1 volume of 2M NaOH. This was incubated for 30 min at 37°C. 
0.1 volume of 3M Sodium Acetate and 2-4 volumes of 100% ethanol were 
added to the plasmid DNA. This was precipitated at -70°C for 15 mm. The 
DNA was pelleted by microcentrifugation (13,000 rpm, 20 min at room 
temperature) washed in 70% v/v ethanol, air dried for 5 min and 
resuspended in 6jt1 dH20. 
2tl sequenase buffer and 2iil of 20mM primer (sequence: 
TCCTGTGGGTGTCTGCTTGC) was added to the denatured DNA and the 
mixture was annealed at 37°C for 30 min. It was then chilled on ice. While 
the annealing mixture cooled, 4 prelabelled tubes had 2.511 of termination 
mixture (either G,A,T, or C) added, and were prewarmed at 37°C. lp.l 
labelling mix was diluted with 4d distilled water. 	1t1 Sequenase 
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polymerase was diluted with 0.5jl pyrophosphatase and 6.5p.l enzyme 
dilution buffer. 
ipi 0.1M DTT, 2p1 diluted labelling mix, 0.5p1 35S dATP, lpJ of 
Manganese buffer and 2pi of diluted sequenase polymerase were added to 
the 10 p1 ice cold annealed DNA mixture. This was incubated at room 
temperature for 5 mm. 3.5pi of this labelling reaction was added to each 
termination tube (G,A,T,C) and incubated at 37°C for 5 mm. The reaction 
was stopped by adding 4p1 of stop solution to each termination tube. 
Before loading onto a gel, the samples were heated at 75°C for 2 mm, 
pulse centrifuged, and then 4p1 of each reaction was loaded onto a 
prewarmed denaturing polyacrylamide gel which was run in 1 x TBE for 1-2 
hours. After electrophoresis, the gel was removed from the plates by 
transfer to blotting paper soaked in fixative (5% acetic acid, 20% methanol) 
and then dried at 80°C for 2 hours. The gel was then exposed to X-ray film 
(AGFA-Curix Blue). 
2.5.7 Digesting DNA with restriction enzymes 
All genomic and plasmid DNA was digested using restriction 
enzymes and buffers according to manufacturers instructions (Roche) except 
that a 4-10 fold excess of enzyme was generally used. A general example of 
genomic and plasmid digests is given below. Table 2.1 details the enzymes 
and buffers used in this study. 
70 
Example 1 Incubated at 37°C overnight 
10 jig 	genomic DNA (in 30p1 distilled water) 
2j.il 	enzyme 40U/j.il (Roche) 
5jil 	10 x buffer (Roche) 
ipi 	Spermidine 60mM 
ipi 	BSA 10 mg/ml (if required for the enzyme) 
to 50pi 	distilled water 
Example 2 Incubated at 37°C for 1-2 hours 
ljtg 	plasmid DNA (in 5j.tl distilled water) 
ipi 	enzyme 10U/pi (Roche) 
2p1 	10 x buffer (Roche) 
to 20t1 	distilled water 
Enzyme Buffer BSA recommended 
BspHI B No 
EcoRl H No 
EcoRV B No 
Hind III B No 
KpnI L Yes 
NheI M No 
Not  H No 
SspI H No 
XbaI H No 
XhoI H No 
Table 2.1 	Restriction enzymes and conditions for digestion. 	All 
enzymes and buffers used were purchased from Roche. Buffer B=lOmM Tris-HCI, 
5mM MgCl2, 100mM NaCl, 1mM 2-Mercaptoethanol, pH 8.0. Buffer H50mM Tris-
HCI, 10 MM M9Cl2, 100mM NaCl, 1mM DTE, pH 7.5. Buffer L=lOmM Tris-HCI, 
10mM M9Cl2, 1mM DTE, pH 7.5. Buffer M=10mM Tris-HCI, 10mM M9Cl2, 50mM 
NaCl, 1mM DTE, pH 7.5 
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2.5.8 Running agarose gels 
Horizontal, buffer-immersed agarose gels containing EtBr (0.25 jig/mi) 
were run in 1 x TAE buffer. Two sizes of gels were run: 8 x 10 cm mini gels 
were used for probe preparation, while 20 x 20 cm gels were used for 
Southern blotting. Agarose concentration varied between 0.4 —2 % w/v 
depending of the size of fragments to be resolved. Before loading, 0.1 
volume of buffer II (Sambrook et al 1989) was added to each sample. Gels 
were run at varying voltages: Southern blot gels were usually run overnight 
at 30V, BLG PCR gels were run at 100V for 30 mm, while enzyme restriction 
digests were run at 100V for 1 hour. DNA was visualised using an UV 
transilluminator and images were captured using Multi-Analyst software 
(BioRad). 
2.5.9 Purifying DNA fragments from agarose gels 
DNA fragments were electrophoresed through an agarose gel, the 
fragment was excised from the gel with a clean sharp scaipal (visualised 
using long wavelength ultraviolet light) and transferred to a microcentrifuge 
tube. The gel slice was then processed using a QlAquick column (Qiagen) 
according to the manufacturers instructions. The weight of the agarose was 
determined and 3 volumes of buffer QG to 1 volume of gel was added (e.g. 
300 p1 buffer QG to 100mg gel). This was incubated at 50°C for 10 min to 
dissolve the gel slice. 1 gel volume of isopropranol was added, mixed and 
the sample applied to a QiaQuick column held within a 2mi collection tube. 
After 1 min microcentrifugation the flow through was discarded and the 
column recentrifuged (imin) with an empty collection tube. The column 
was washed with 0.75ml buffer FE by 1 min microcentrifugation, flow 
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through was discarded and the column recentrifuged (1 mm). The column 
was then placed in a clean 1.5m1 microcentrifuge tube, 30p1 elution buffer 
(10mM Tris-HC1 pH 8.5) was added, allowed to stand for 1 mm, and then 
microcentrifuged for 1 min to elute the DNA. 
2.5.10 Phenol/Chloroform extraction of DNA 
Phenol/chloroform extraction is used to deproteinise the aqueous 
phase containing the DNA. Mixing phenol with the DNA sample causes the 
dissociation of proteins from DNA. After centrifugation two phases are 
present: a lower organic phenol phase carrying the protein (much of which is 
found in the white interphase) and the aqueous phase which contains the 
DNA. Chloroform improves the efficiency of extraction due to its ability to 
denature proteins. The high density of chloroform also enhances the 
separation of phases facilitating the removal of the aqueous phase with little 
cross-contamination from organic material. 
An equal volume of phenol (equilibrated to pH7.6 by repeated 
extraction with Tris buffer; Fisher Scientific UK) was added to each sample in 
microcentrifuge tubes, mixed thoroughly to form an emulsion, and 
microcentrifuged (13,000rpm, 10 min at room temperature) to separate the 
organic and aqueous phases. The top aqueous phase was transferred to a 
clean tube taking care not to disturb the mnterphase. The process was 
repeated using a 1:1 mix of phenol/chloroform followed by chloroform (this 
removes any residual phenol which would inhibit future enzymatic 
reactions). 
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DNA was then precipitated with 0.1 volume of 3M Sodium Acetate 
pH5.5 and 2 volumes of 100% ethanol, mixed and then chilled to _700C for 30 
mm. The DNA was pelleted by microcentrifugation (13,000 rpm, 20 min at 
room temperature). The supernatant was removed and the DNA pellet 
washed twice (centrifuged for 2 min between washes) with 70% v/v ethanol 
to remove salts. The pellet was then air dried and resuspended in TE. Care 
was taken to dry the pellet sufficiently to ensure that all ethanol was 
removed since ethanol can inhibit certain enzymatic reactions. Care was 
also taken to ensure that the pellet was not too dry, as the DNA can be very 
difficult to solubilise, especially with genomic DNA. Generally, adding TE 
buffer when the edges of the pellet become "glass like" avoided the problem. 
Samples were stored at -20°C. 
2.5.11 Southern Blotting 
2.5.11.1 	Transfer onto Zetaprobe GT membrane 
Southern blotting allows the transfer of DNA from an agarose gel 
onto a membrane, which can then be analysed for the presence of specific 
sequences (Southern 1975). This aim can be achieved by the flow of liquid 
through the gel and membrane. The DNA is carried with the liquid but 
cannot pass through the membrane and this is followed by fixation of the 
DNA to the membrane. 
If the fragments are >4kb, the gel was soaked in denaturing solution 
(0.5M NaOH, 1.5M NaCl) for 2 x 20 min,neutralisation buffer (0.5M Tris-HC1 
pH8.0, 3M NaCl) for 2 x 20 min to facilitate transfer of all DNA regardless of 
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original size. Air bubbles between layers of the stack were avoided as they 
inhibit transfer. The gel was then placed on a sheet of 3MM Whatman paper 
(saturated in O.4M NaOH solution) with the ends of the paper resting in a 
reservoir of O.4M NaOH. Saran wrap was placed over the whole stack and a 
window was made, allowing only the gel to emerge (this avoids 'short 
circuiting' ensuring capillary action occurs only through the gel). Zetaprobe 
GT membrane (Bio-Rad) was cut to the size of the gel, prewetted in distilled 
water, and then placed carefully on top of the gel and flooded with O.4M 
NaOH. Two precut, prewetted (distilled water) 3MM sheets were placed on 
top, followed by two dry 3MM sheets. A stack of paper towels was then 
placed on top, followed by a glass plate to keep all the layers together and 
finally a small weight. Transfer was allowed to occur overnight. 
After transfer the stack was disassembled down to the membrane, the 
wells were marked with a soft pencil and the membrane was washed briefly 
in 2 x SSC. The DNA was fixed to the membrane by oven drying at 700C  for 
at least 1 hour. 
2.5.11.2 	Transfer onto Hybond - N membrane 
The process for transfer to Hybond-N membrane (Amersham Life 
Sciences) was identical to that described for Zetaprobe GT membranes except 
that 20X SSC was used as the transfer buffer. 
75 
2.5.12 	Preparation of radiolabelled DNA probes and 
hybridisation to Southern Blot membranes 
2.5.12.1 	High Prime DNA labelling method 
The High Prime (Roche) labelling method is based on "random 
primed" DNA labelling originally developed by Feinberg and Vogeistein 
(1984). It is based on the hybridisation of oligonucleotides of all possible 
sequences to the denatured DNA. The complementary DNA strand is 
synthesised by Kienow polymerase and modified deoxyribonucleoside-
triphosphates present in the reaction are incorporated into the newly 
synthesised cDNA strand. 
High Prime labelling mix contains: random primers along with 1U/jd 
Klenow polymerase, 0.125mM dATP, 0.125mM dGTP, 0.125mM dTTP and 
5x reaction buffer in 50% v/v glycerol. 25-50ng of probe DNA was made up 
to llj.il with distilled water and boiled for 10 min to denature the DNA. The 
mixture was spun briefly and then placed on ice for 2 mm. 4p1 High Prime 
labelling mix was added followed by 5j.tl of [a32P]dCTP [-110TBq/mmol]. 
The sample was mixed gently, spun briefly and then incubated at 37°C for 10 
-20min. 
To help with size estimation Southern blots were often probed with a 
labelled molecular weight ladder e.g. lambda cut with Hindill. To prepare 
this 25ng of ladder DNA was made upto lijil with distilled water and boiled 
for 10 mm. The mixture was spun briefly and then placed on ice for 2 min. 
ipi of [a32P] dCTP [--110TBq/mmol] and 9p1 of 'cold' dCTP were added, 
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followed by 4p1 High Prime labelling mix. This ensured the signal from the 
ladder did not swamp that from the genomic samples. The sample was 
mixed gently, spun briefly and then incubated at 37°C for 10-20 mm. 
	
2.5.12.2 	Purifying labelled DNA probe 
After the labelling of the probe unincorporated nucleotides were 
removed from the labelled probe using a Sephadex G50-Nick Column 
(Pharmacia Biotech). Removal of unincorporated nucleotides helped reduce 
background signal. 
The storage buffer was removed and the column was equilibrated by 
adding 2.5m1 TE buffer and allowing it to enter the resin by gravity flow. 
The 20jtl sample was added directly to the column and washed through with 
400[d TE buffer. This eluate was discarded. A further 400p1 TE buffer was 
used to elute the labelled probe. The sample was then quantified. 
2.5.12.3 	Quantifying 31P-labelled DNA probes 
2jtl of the 400tl purified probe mixture was spotted onto 2.5cm glass 
microfibre filter paper (Whatman) and placed in a scintillation vial (without 
scintillation fluid). A Wallac 1410 3-counter (Pharmacia Biotech) was used 
to analyse 3-emission levels. Probes with a total activity of at least 108 cpm 
were used. 
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2.5.12.4 	Hybridisation, washes and detection of probes 
Prehybridisation of membranes was performed in revolving glass 
cylinders (Techne) using 20m1 prewarmed hybridisation solution (0.25M 
disodium hydrogen orthophosphate [Na2HPO4] pH7.2, 7% w/v SDS, 1mM 
EDTA) in a Techne Hybridiser HB-1D oven set at 65°C for at least 10 mm. 
Prior to hybridisation, the probe was denatured with 30p1 5M NaOH. 
Denatured probe was added to the prehybridised membranes and 
hybridised with rotation overnight at 65°C. 
Membranes were washed to remove unhybridised probe and 
background signal: 2 x 20 min in 50 ml low stringency wash (20mM 
disodium hydrogen orthophosphate [Na2HPO4] pH7.2, 5% w/v SDS), 
followed by 2 x 20 min in 50 ml high stringency wash (20mM disodium 
hydrogen orthophosphate [Na2HPO4] pH7.2, 1% w/v SDS). The membrane 
was wrapped in Saran wrap to avoid it drying out between probings. 
Membranes were either exposed to Phosphor Screens (Bio-Rad) at 
room temperature (1 - 72 hr) or to X-ray film (AGFA-Curix Blue) between 
intensifying screens in autoradiography cassettes at -70°C (6hrs - 2 weeks). 
Phosphor Screens were processed using a Molecular Imager FX (Bio-Rad) 
and X-ray film was developed using an X-ograph Compact X2. 
If necessary, the membranes were stripped by placing them in boiling 
0.1% w/v SDS and allowing them to cool to room temperature before 
rewrapping in plastic wrap. The membrane was then ready for reprobing. 
2.5.13 Polymerase chain reaction analysis of tail biopsy DNA 
A PCR assay was used for rapid screening for the presence of the 
BLG-LoxP transgene during breeding programmes. The bench and pipettes 
were wiped with 100% ethanol and a separate bottle of sterile distilled water 
was used for PCR reactions to reduce the risk of DNA contamination leading 
to false positives. 
ljtl of centrifuged supernatant from digested tail biopsy was added to 
25p1 of PCR reaction mix. If a Hybaid Omnigene PCR or Techne PHC-2 
thermocycler was used the reaction was overlayed with a drop of mineral 
oil, if using a Perkin Elmer GeneAmp 9700 thermocycler with heated lid, no 
oil was needed. The PCR reaction mix comprises the following: 
2.50d lOx buffer (Roche) 
0.75p1 50mM MgC12 (Roche) 
0.25 jil 20mM BLG primers § 
0.25p1 20mM HPRT primers 
2.50 jtl DMSO 
4.00pi 1.25mM dNTPs 
14.60p1 distilled water 
0.15j.il 	Taq DNA polymerase (Roche) 
§BLG primers: 	5-GCT TCT GGG GTC TAC CAG GAA C-3 
5'-TCG TGC UC TGA GCT CTG CAG-3 
HPRT primers: 	5-GAG UC CCC AAC TGC CU TGG TG-3' 
5-CC TGC CAC CCC GCG CAT GG-3 
In both cases equimolar amounts of both primers are added together to make a 20tM 
working stock 
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Samples were placed in the PCR thermocycler: 
HybaidlTechne 
	 Perkin Elmer 
30 x 92°C for 30 sec 
	 30 x 94°C for 1.5mm 
65°C for 5 mm 
	
65°C for 2 mm 
1 x 	72°C for 7 mm 
Once the reaction was complete 10.tl of PCR loading dye (15% w/v Ficoll 400, 
0.05% w/v SDS, 20mM EDTA pH8.0, 0.125% w/v Orange C) was added to 
each sample, mixed and 30p1 electrophoresed in 2% w/v agarose gels. BLG 
primers amplify a 248bp segment of the 5!  end of the BLG gene, while the 
HPRT primers serve as an internal control by amplifying a 332 bp segment of 
the HPRT gene. Control positive, negative and blank samples were set up 
with every set of diagnostic PCR reactions. 
2.5.14 Long Range PCR 
A long range PCR sytem was used to amplify the transgene array 
from PLC A mouse DNA. A mix of thermostable Taq polymerase and a 
proofreading Pwo polymerase provide the means to amplify large genomic 
fragments. 	Expand Long Template PCR System (Roche) was used 
according to the manufacturers instructions. Pipettes were washed with 
70% ethanol before used and the PCR reaction mixes were made up in a 
fumehood using filtered tips to avoid contamination. Distilled water and 
negative DNA was always used as negative controls. 
The following was mixed together in an microfuge tube labelled A: 
10mM dATP 2.5tl 
10mM dCTP 2.5p1  
10mM dGTP 2.5p1 
10mM dTTP 2.5p.l 
5' junction primer 10tM 1.5pJ 
nested3' primer 10jtM 1.5pJ 
DMSO 1il 
Distilled water 10.i1 
5' junction primer: 	 5'-GAA TFC GAG CTC GGTACC CTC CCT TCA-3' 
nested 3' primer: 	 5'-TAG AGA GAA GCC TGC GCA CCG AAC-3' 
The following was mixed together in another microfuge tube labelled B: 
Enzyme buffer 3 (Roche) 	5jtl 
PCR enzyme (Roche) 	0.75p1 
Distilled water 	 15.25p1 
24j.il of mix A was added to a 0.2m1 thin walled PCR tube, mixed with lpJ of 
the sample, and 25.tl of mix B was added. The whole reaction was mixed by 
pipette action. 30p1 oil was added over the reaction and lids sealed over the 
tubes. The tubes were then placed in a Perkin Elmer GenAmp 9700 and 
cycled as below: 
3I 
lx 	2 min at 92°C 
lOx 	10 sec at 92°C 
30 sec at 65°C 
8 min at 68°C 
30x 	10 sec at 92°C 
30 sec at 65°C 
8 mm + additional 20 sec per cycle at 68°C 
lx 	7 min at 68°C 
Once the reaction was complete, 25p1 was electrophoresed on 0.7% agarose 
gels and then photographed. 
2.6 	MILKING OF MICE 
All milk samples were collected at midlactation (day 11). Litters were 
standardised to 5 pups per mother at birth and were separated from their 
mother 3 hours before milking. Mothers were injected with 0.3 International 
Units of oxytocin (Sigma) in 0.1ml of distilled water into the mntraperitonal 
space. 	After. 10 min an injection of anaesthetic was given 
(Hypnorm/Hypnovel; lOjiJ/g). After 10 min gentle massage was applied to 
the mammary glands and milk collected in 50j.il capillary tubes. Milk was 
dispensed into a microcentrifuge tube (typically 250 p1 per mouse) and stored 
at —20°C. 
M. 
2.7 	MILK PROTEIN ANALYSIS 
2.7.1 Preparation of milk proteins 
Defatted milk was prepared by adding 120pJ distilled water to 30i.tl 
thawed mouse milk, briefly vortexing, followed by a pulse spin in a 
microcentrifuge. Care was taken to disrupt any protein pellet that formed 
without disturbing any of the fat around the side of the tube. The defatted 
milk (supernatant) was transferred to a clean tube. A 50t1 sample of the 
defatted milk was further diluted in 200p1 reducing buffer (0.5M Tris-HC1 
pH6.8, 10% v/v glycerol, 10% w/v SDS, 5% v/v 13-mercaptoethanol, 0.1% w/v 
bromophenol blue). The samples were boiled for 4 minutes to denature the 
proteins. Any lost volume due to evaporation was replaced and a last 0.1 
dilution (e.g. lOpi sample and 90pi reducing buffer) gave a final dilution of 
1/250. Samples were stored at _200C. 
2.7.2 Preparation of SDS-polyacrylamide gels 
Quantitative milk protein analysis was performed using SDS 
polyacrylamide gel electrophoresis (SDS-PAGE). Gels were either hand 
poured using Bio-Rad equipment or pre-poured 18%/4% Tris-HC1 Criterion 
gels (BioRad). 
If gels were hand poured the following procedure was followed. 20 x 
20 cm, 20 x 18 cm glass plates and 1mm gel spacers were thoroughly cleaned 
using 70% v/v ethanol. They were then clamped into a vertical position to 
act as a gel mould. A 17.5% resolving gel was prepared by mixing 4.75m1 
distilled water, 7.5m1 1.5M Tris-HC1 pH8.8, 300pi 10% w/v SDS, 17.5m1 
Amerseco acrylamide solution (30% w/v acrylamide - 1.034% w/v bis-
acrylamide, a ratio of 37.5:1). The gel was polymerised by adding 150l of 
fresh 10% w/v APS and 15p1 TEMED, mixed and poured immediately into 
the 1mm space between the glass plates. A one cm layer of distilled water 
was layered on top to aid polymerisation and help produce a smooth edge to 
the gel. The resolving gel was usually allowed to polymerise overnight. 
Once the resolving gel had set the water layer was removed and a 4% 
stacking gel was prepared. 4m1 of distilled water, 1.66m1 0.5M Tris-HCl 
pH6.8, 67j.tl of 10% w/v SDS, 866p1 Ameresco acrylamide solution (see above) 
were mixed, then 34il of 10% w/v APS and 4p.1 TEMED were added. The 
gel was poured on top of the resolving gel and a comb was placed in the 
stacking gel to produce wells before polymerisation occurred. The stacking 
gel was allowed to polymerise for 1 hour. The comb was removed and the 
wells washed thoroughly with gel running buffer (25mM Tris, 0.2M glycine, 
0.4mM SDS) before samples were loaded. 
2.7.3 Electrophoresis of milk proteins 
50d of diluted defatted mouse milk in reducing buffer was loaded 
into polyacrylamide gels using a Hamilton syringe. After loading the hand 
poured gels were placed into Bio-Rad Protean II running apparatus with -41 
of gel running buffer in the lower reservoir and -300m1 in the upper 
reservoir. Samples were electrophoresed at 30mA (constant current) while 
in the stacking gel (-1 hour) and at 60mA while in the resolving gel (-5 
hours). Criterion gels were placed in a Criterion gel tank (BioRad) with - 11 
of gel running buffer in the lower reservoir and -50ml in the upper reservoir 
and run at 100V for approximately 3 hours. 
Milk protein gels were washed with gentle agitation overnight in 
fix/stain solution (50% v/v methanol, 7.5% v/v acetic acid, 2% w/v TCA, 
0.04% w/v Coomassie blue). Background stain was removed by washing 
with gentle agitation for 2 x 30 min in destain solution (23% v/v methanol, 
7% v/v acetic acid) or until background staining was removed. Gels were 
placed on glass plates, wrapped in Saran wrap and stored at 40C. Gels were 
analysed using Multi-Analyst software (BioRad). 	Milk BLG protein 
concentrations were standardised against the albumin band to control for 
loading differences. 
2.7.4 Western Blotting of protein gels 
After electrophoresis on SDS-PAGE gels, proteins were 
electrophoretically transferred to nitrocellulose membranes (Schleicher and 
Schuell) using the semi-dry method. A stack was constructed: three sheets 
of Whatman 3MM paper (soaked in transfer buffer: 48mM Tris, 39mM 
Glycine, 20% methanol, 1.3mM SDS, pH 9.2) onto the lower graphite anode 
plate, one sheet of nitrocellulose membrane (soaked in distilled water), the 
gel (soaked in transfer buffer), three sheets of Whatman 3MM paper (soaked 
in transfer buffer), followed by the upper graphite cathode plate. Transfer 
was performed at 20V for 1 hour in a BioRad Trans-Blot SD Semi-Dry 
Transfer Cell. 
After transfer the nitrocellulose membrane was washed in TBS-T 
(100mM Tris pH7.5, 150mM NaCl, 0.1% Tween 20) with 2 % BSA for 2 hours 
at room temperature, incubated with a rabbit antibody against BLG (a gift 
from Dr. Maggie McClenagahan) [1/200 dilution in TBS-T 1% BSA, total 
volume 15 ml] for 2 hours at room temperature, washed in TBS-T for 3 x 10 
mm, incubated with Horseradish peroxidase-conjugated donkey anti-rabbit 
immunoglobulin (Diagnostics Scotland) [1/200 dilution in TBS-T 1% BSA, 
total volume 15m1] for 1 hour at room temperature, followed by 3 x 10 mm 
washes in TBS-T. 	The secondary antibody was detected using ECL 
(Amersham) according to the manufacturers instructions. In darkroom 
conditions 8 ml each of reagent 1 and 2 are mixed, added to membrane for 
one min and then drained off. The membrane is wrapped in Saran wrap 
and exposed to X-ray film for the required time. 
2.8 	TISSUE IN SITU HYBRIDISATION 
2.8.1 BLG and -casein expression vectors 
Riboprobes of between 200bp and 1kb are recommended for tissue in 
situ experiments using 35S  labelled probe and paraffin embedded tissue. 
Probes less than 200bp give a reduced hybridisation signal and probes above 
1kb penetrate less effectively into fixed tissue (Angerer and Angerer 1992). 
A 424bp Pst I BLG cDNA fragment consisting of all of exons 3-6 and 
6bp of exon 2 and 81bp of exon 7 had been cloned in both orientations 
relative to the T7 promoter in pGEM-4Z (Dobie et a! 1996). Cloning the 
inserts in both orientations allows synthesis of anti-sense (probe) and sense 
(control for non-specific background) riboprobes from the same promoter. 
An off centre internal Pvu 11 was used to check the orientations. 
A 417bp Pst I -casein cDNA fragment consisting of 5bp of exon 6 and 
412bp of exon 7 had been cloned in both orientations relative to the T7 
promoter in pGEM-4Z (Dobie et al 1996). An off centre internal Nde I site 
was used to check the orientations. 
Plasmid DNA was prepared for each of the four vectors (2.5.2). The 
expression vectors were linerized using a Barn HI site (downstream of the 
inserts and the T7 promoter) so that transcripts were free from vector 
sequences (to reduce isotope usage and decrease background hybridisation), 
phenol/chloroform extracted, ethanol precipitated and stored in DEPC-
treated distilled water at -20°C. 
2.8.2 Preparation of tissue 
Paraformaldehyde is a cross-linking fixative used to retain mRNA in 
sections during hybridisation and wash procedures. 
Tissue was fixed in 4% w/v PFA in PBS pH7.2 overnight at 4°C with 
gentle agitation. The tissue was washed in PBS for 30 min at 4°C, 30% v/v 
ethanol for 15 min at room temperature, 70% v/v ethanol for 30 min at room 
temperature, followed by a final 70% v/v ethanol wash for 30 min at room 
temperature. The tissue could be stored (4°C) at this stage for upto several 
months with no noticeable deterioration in mRNA. The tissue was then 
transferred to a histocasette, labelled with pencil and further processed using 
a Shannon HyperCentre as follows: 
M. 
70% v/v ethanol room temp vacuum 30 mm 
70% v/v ethanol room temp vacuum 30 mm 
640P* 35°C vacuum 1.5 hr 
640P 35°C vacuum 1.5 hr 
740P* 35°C vacuum 1.5 hr 
740P 35°C vacuum 1.5 hr 
740P/CNP 30 35°C vacuum 1.5 hr 
CNP 30 35°C vacuum 1.5 hr 
CNP 30 40°C vacuum 1.5 hr 
CNP 30 45°C vacuum 1.5 hr 
Paraffin wax 53°C vacuum 1.5 hr 
Paraffin wax 60°C vacuum 1.5 hr 
* 640P is 64% over proof and is equivalent to approx 96% v/v alcohol 
*740P is 74% over proof and is equivalent to approx 99% v/v alcohol 
The tissue was finally embedded in a mould containing fresh molten paraffin 
wax and allowed to set. The tissue blocks were stored at 4°C (the tissue can 
be stored this way for several years). 
2.8.3 Coating slides with TESPA 
Tissue sections need to be fixed to the slides, otherwise they float off 
during subsequent processing. This is achieved by coating the slides with 
TESPA which acts as a tissue adhesive. The hydrophobic silane moiety of 
TESPA binds to the glass slide, while the amino group (activated by 
aldehyde) is crosslinked to the tissue section. 
Slides were placed horizontally in glass racks and oven baked 
overnight at 1800C. Batches of slides were washed for 10 sec in (10% v/v 
HC1, 75% v/v ethanol), DEPC treated distilled water for 10 sec, 100% acetone 
for 10 sec and air dried. 	The slides could be stored in a dust free 
environment for months at this stage. The slides were coated with TESPA 
by washing in 2% v/v TESPA in acetone for 10 sec, followed by 2 washes in 
100% acetone for 10 sec. The slides were air dried and stored in a slide box 
with silica gel for up to a month before use. 
2.8.4 Tissue sectioning 
The paraffin blocks of embedded tissue were kept chilled to 4°C. Any 
instruments that would come into contact with the tissue including the 
rotary microtome, steel blades, manipulation utensiles and empty water bath 
were wiped down with 100% ethanol. The water bath was filled with -21 of 
DEPC-treated distilled water and heated to 42-45°C. After trimming the 
blocks, 5im sections were cut to generate a ribbon of sections which were 
placed on a clean untreated glass slide. 	30% v/v ethanol was added 
underneath the ribbon to avoid creases in the sections. The slide was gently 
dipped into the water bath and the ribbon allowed to float off. The wax was 
allowed to melt slightly ('4 min) so that the tissue sections expanded to their 
original dimensions. TESPA coated slides were dipped vertically into the 
water to "catch" the section. Tissue sections were arranged onto slides in 
sets of 4 abutting sections. The slides were dried overnight in an oven at 
60°C. Slides were stored in a slide box containing silica gel at 4°C. The 
slides could be stored at this stage for a number of months. 
2.8.5 Prehybridisation 
The aim of this step is to partially remove proteins in order to increase 
target RNA accessibility to probes and to decrease background. Proteinase 
K is used to remove proteins, xylene removes residual paraffin (which traps 
probe), and acetic anhydride helps decrease positive charges on sections 
thereby reducing background signal. 
Slides were placed in a glass rack and treated with 200m1 of the 
following solutions using gentle agitation: 100% xylene for 2 x 5 mm (in fume 
hood), through a rehydrating ethanol gradient of 2 x 100%, 90%, 70%, 50% 
and 30% v/v ethanol solutions for 2 min each, PBS for 2 mm, 4% w/v PFA in 
PBS pH7.2 for 10 mm, PBS for 2 x 2 min, proteinase K solution for 7.5 mm 
(50mM Tris, 5mM EDTA, 5tg/ml proteinase K from Tritirachium album 
[Sigma]), PBS for 1 min, 4% w/v PFA in PBS pH7.2 for 2 min, DEPC-treated 
distilled water for 10 sec, 0.1M TEA pH8.0 for 30 sec, 0.1M TEA with 625 jii 
acetic anhydride for 2 x 5 mm (acetic anhydride added immediately before 
use; to inactivate proteinase K), PBS for 2 mm, 0.85% w/v NaCl for 2 mm, 
through a dehydrating ethanol gradient of 30%, 50%, 70%, 90% v/v ethanol 
solutions for 2 min each followed by 100% ethanol for 3 x 5 mm. The slides 
were air dried and then stored in a slide box (slides were generally 
hybridised the same week). 
2.8.6 Generation of 35SIabelled riboprobes 
rUTP labelled single-stranded antisense RNA probes and control 
sense RNA probes were generated by in vitro transcription from the T7 
promoter using a Riboprobe in vitro Transcription kit (Promega). 
The following mixture was prepared in a microcentrifuge tube at 
room temperature in listed order: 
6tl 	5x Buffer (Promega) 
lj.tl 	10mM rATP 
ipi 10mM rCTP 
lpJ 10mM rGTP 
ljtl 1M DTT 
12pi 3 S rUTP 
5p1 0.5 - 1 mg/ 5m1 DNA template 
1.2jl RNase block (40U/pi; Promega) 
0.8j.il T7 polymerase (19U/pi; Promega) 
The samples were vortexed briefly and pulse-centrifuged before incubating 
at 37°C for 25 mm. Another 0.8j.il T7 polymerase was added and then 
incubated at 37°C for a further 25 min. 2j.il tRNA (stock = lOmg/ml, Sigma) 
and 4pi DNase (lU/ui) were added and incubated at 37°C for 10 mm. 2p1 of 
100mM EDTA and 162pJ of TE buffer containing 50mM DTT were added 
giving a final volume of 200 jii. The riboprobes were purified by two phenol 
extractions and one phenol/chloroform extraction and precipitated at -20°C 
overnight with ethanol (see 2.5.10). 
The precipitated riboprobes were pelieted by microcentrifugation 
(13,000 rpm, 30 min at room temperature). Meanwhile, an 80% v/v ethanol, 
50mM DTT wash solution was prepared (lOOpi 1M DTT, 1.9m1 TE buffer and 
8m1 100% ethanol). RNA pellets were washed twice with 500m1 of the wash 
solution and then once in 100% ethanol, air dried and resuspended in 25pi of 
50mM DTT, TE buffer. 
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2.8.7 Quantification of 	labelled nboprobes 
1.t1 of the probe was added to 19pi  distilled water and lj.il of the 
dilution was spotted onto each of two 2.5cm glass microfibre filters 
(Whatman). One filter was washed three times with 5% w/v TCA and once 
with chilled 100% ethanol. The filters were placed in scintillation vials and a 
drop of scintillation fluid was added. The filters were then analysed using a 
Wallac 1410 n-counter (Pharmacia Biotech). The percentage incorporation 
was measured from the two filters using the counts per minute values. CPM 
were converted to disintegration per minute by assuming 50% counting 
efficiency; therefore CPM values were multiplied by two to give DPM 
values. An incorporation of 1X 10 dpm per lp.l probe was the target level 
of activity. 	To achieve this the probe was diluted with hybridisation 
solution. Given an average incorporation value four probes would require 
about 5m1 hybridisation solution. Hybridisation buffer was made at room 
temperature and comprises the following: 
50% formamide: 	to reduce the hybridisation temperature 
10% dextran sulphate: 	increase hybridisation rate 
1 x Denhardt's solution: reduces non-specific binding 
20mM Tris-HCl pH8.0 
0.3M NaCl: 	 reduces electrostatic binding of probe to tissue 
5mM EDTA 
10mM sodium phosphate 
0.5mg/mi tRNA: 	carrier RNA 
50mM DIT: 	 prevents probe from oxidising and inhibits Rnase 
Probes were stored at -20°C and used within one week of dilution. 
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2.8.8 Hybridisation 
The probes were denatured at 80°C for 2 mm, cooled on ice and 10j.il 
of probe was pipetted onto each prehybridised tissue section (being careful 
not to scratch the sections). A coverslip was placed over the sections 
avoiding air bubbles. The slides were placed coverslips upwards, in a 
hybridisation box containing tissue paper soaked in 50% v/v formamide, 5 x 
SSC. The box was then sealed with tape and placed into two water tight 
plastic bags. The water tight hybridisation box was placed in a water bath 
overnight at 55°C. 
2.8.9 Post-hybridisation washes 
The hybridisation box was removed from the waterbath and the bags 
were discarded. Forceps were used to transfer the slides to a slide rack 
which was then placed in a glass trough containing 5 x SSC, 10mM DTT for 
30 min at 55°C. The coverslips usually fell off at this stage, if they had not, 
they were gently removed. The slides were transferred into HS wash (50% 
v/v formamide, 2X SSC, and 0.1M DTT added just before use) for 30 min at 
65-68°C, NTE (0.5M NaCl, 10mM Tris, 5mM EDTA) wash for 2 x 5 min at 
37°C, NTE wash with 20tg/m1 RNase for 30 min at 37°C, NTE wash for 5 mm 
at 37°C, HS wash for 30 min at 65-68°C. The remaining washes were 
performed at room temperature: 2 x SSC for 4 x 10 mm, 0.1 x SSC for 4 x 5 
mm, 30%, 50%, 70%, and 90% v/v ethanol (each with 0.3M ammonium 
acetate) for 1 min each, 100% ethanol for 2 x 5 min and airdried. 
Slides were exposed to x-ray film overnight at room temperature to 
give an estimation of the length of time required for exposure to emulsion. 
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2.8.10 Coating slides with emulsion 
This procedure was carried out in a darkroom with a safety light on 
but at least im from the working area (the emulsion is extremely light 
sensitive). The LM-1 hypercoat emulsion (Amersham Life Science) was 
placed in a waterbath at 42°C for 15-20 mm. Once the emulsion had melted, 
it was poured into a dipping chamber (Amersham Life Science). Slides were 
dipped vertically into the emulsion and left for 5 sec. The slide was then 
slowly withdrawn keeping it vertical and the emulsion was allowed to drain 
for 5 sec. The slide was allowed to stand nearly upright (approx 80° angle) 
allowing the emulsion to begin to set (about five mm). Semi-set slides were 
placed in a slide rack and the rack was sealed into a light-tight box 
containing damp tissue paper (to avoid drying the emulsion too fast which 
leads to cracks). After -3 hour the slides were transferred to a slide box 
containing silica gel, which was taped and wrapped in two layers of 
aluminium foil. The slides were exposed at 4°C for 1-8 weeks. 
2.8.11 Development of emulsion-coated slides 
Slides were allowed to reach room temperature before proceeding 
(approximately 3 hours). The slides were unwrapped in the dark room with 
the safe light on. It is critical for the developing that all solutions were 
within 2°C of each other (15-20°C is optimum; above this and the emulsion 
may begin to melt). The slides were placed in glass racks and immersed in 
troughs of developer for 4 mm (1:4 dilution of Phenisol Developer to 
distilled water), Stop solution (0.5% v/v acetic acid) for 1 mm, Fixer (30% w/v 
sodium thiosuiphate) for 8 min after which the lights can be switched on, 
gentle running water for 15 min, followed by 2 x 15 min washes in distilled 
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water. The slides were carefully wiped to remove any remaining emulsion 
(especially on the back). 
Solutions for counter staining must be within 2°C of the developing 
chemicals. The slides were counter stained using Giesma (1:20 dilution of 
Giesma R66 stock and Gurr's buffer pH6.5) for 15 mm, running water for 15 
mm, 70%, 90% v/v and then 2 x 100% ethanol for 2 min each, followed by 
xylene for 2 x 2 mm. The slides were air dried. Slides were then mounted 
using DPX and clean cover slips (any residual liquid on the slides crystallises 
in the DPX; therefore it is important that the slides are dry). 
2.8.12 Photography of tissue in situ slides 
Tissue in situ slides were examined using bright-field illumination on 
an Olympus BH-2 microscope fitted with neutral density filters 25 and 6, an 
Olympus BH2-SC swing out condenser and a Splan x4,xl0 or x20 objective. 
An Olympus U-FT focusing telescope aided sharp focusing of the images 
which were recorded using an Olympus C-35AD-4 camera and Kodak 64T 
film. 
Tissue in situ slides were also examined under dark-field illumination 
at the Western General Hospital HGU Unit with the help of Dr. Paul Perry. 
A Zeiss Axioplan 2 microscope with Zeiss Plan-neofluar xlO objective was 
used with an HBO 100 Mercury arc lamp. The images were captured using 
IP Lab Software. Three images are generated from this: a normal light field 
image, the silver grains reflected by dark field, and a composite image of the 
two whereby the silver grains are visualised in yellow and overlayed onto 
the coloured image from the light field. 
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2.8.13 Quantification of in situ results 
Mammary gland sections were counted after in situ hybridisation to 
determine the percentage of the gland expressing. 10 fields of view at x 20 
magnification were counted per section with at least two sections per animal 
being counted. Alveoli were scored as negative, -/+ (when some cells within 
an alveolus were positive while others were negative) or positive. Statistical 
analysis was carried out using GenStat with advice from a Statistician, 
Caroline McCorquodale. A non-parametric test (Mann-Whitney) was used 
to analyse the data from the different copy number lines. A Mann-Whitney 
test does not require the assumption of normally distributed observations in 
the two groups being compared. 
2.9 	RNA ANALYSIS 
2.9.1 Preparation of total RNA from mouse tissue 
All glassware, pipettes and solutions used for RNA analysis were 
treated with diethyl pyrocarbonate (DEPC) to destroy ribonucleases and 
gloves were changed frequently. 
Tissue was frozen in liquid nitrogen immediately after dissection from 
the animal. Frozen tissue was homogenised in 2 ml RNAzo1 B (Biogenesis 
Ltd) for 30 sec using an ultra-homogeniser (Janke and Kunel). 2 x 1 ml 
aliquots were added to 2 ml screw-capped tubes containing lOOpi 
chloroform. These were inverted repeatedly for 15 sec, put on ice for 15 
mm, and then microcentrifuged (13000 rpm, for 15 min at 4°C). The aqueous 
phase was transferred to a fresh tube and the RNA was precipitated using an 
equal volume of isopropanol (4°C for 15 mm). 	The samples were 
microcentrifuged (13000 rpm, for 15 min at 4°C) to pellet the RNA. The 
pellets were washed twice with 70% v/v ethanol (microcentrifuged 13000 
rpm, for 8 min at 4°C between washes). The RNA was resuspended in 200.tl 
of deionised formamide and left at 4°C until in solution. 	The RNA 
concentration was determined by measuring the absorbance at 260nm of a 
0.01 dilution of each sample in TE buffer. 
2.9.2 Electrophoresis of RNA, Northern Blotting and hybridisation 
Messenger RNAs have secondary structures. 	Denaturing gels, 
therefore, are used for RNA electrophoresis. 
10.tg of RNA was added to 20jd sample buffer (3.5jxl formaldehyde, 
2p.l 10 X MOPS, 4j.xl loading dye [30% Ficoll, 0.1M EDTA, 0.25% w/v 
bromophenol blue], 0.5p1 10mg/mi EtBr, lOpi distilled water) before loading 
onto a denaturing gel. The samples were usually eiectrophoresed overnight 
at 35V or at 80 V for 3 hours in denaturing gels (1.5% w/v agarose, 1 x MOPS, 
12.5% v/v formaldehyde) using 1 x MOPS as the gel tank buffer. Northern 
blots were performed as described in section 2.5.11.1 except there was no 
pre-treatment of the gel before blotting onto Zetaprobe memebrane (Bio-
Rad). Preparation of probes and hybridisation conditions were identical to 
those described in section 2.5.12. 
2.10 QUANTIFICATION SOFTWARE 
The quantification software used for both Southern blotting and SDS-
PAGE gels was Quantity One (BioRad). Quantity One can be used to image 
and analyse data from phosphor imagers and gel documentation systems. 
Signals from biological samples are converted into digital data. A data 
object as displayed on the computer is composed of individual screen pixels. 
Each pixel has an X and Y co-ordinate, and a value Z which represents the 
signal intensity. Once an image has been captured, Quantity One Volume 
tools are used to quantify data (Quantity One User Guide 4, BioRad 2000). 
Essentially a 'volume rectangle' is drawn around each data object. If 
the data represents a known standard its concentration is included. Global 
background is subtracted from the volumes by defining a background 
volume which corresponds to a region where there is no data, and where the 
average pixel intensity appears to be the same as the background intensity 
surrounding the data. A volume analysis report is generated once all data 
have been given a defined volume. If bands from standards with known 
concentrations are included on the gel I blot, the report produces a 
concentration value as calculated from the named standards. A volume 
regression curve is also generated from the standards, with unknown 
samples being placed on the curve. 
CHAPTER THREE 
PRODUCTION OF LOX TRANSGENIC LINES 
3.1 INTRODUCTION 
As discussed in Chapter one, observations of BLG transgene 
variegation had been found and high copy number arrays were thought to 
be involved (Dobie et al 1996). There was a need to determine what effect 
copy number in its own right had on BLG expression patterns, without the 
involvement of position effects. 	This project's aim was to specifically 
address the relationship between variegation and transgene copy number. 
With this in mind a construct was made which would allow manipulation of 
copy number at a constant genomic integration site. This was accomplished 
by the use of the Cre recombinase I Lox system providing a site-specific 
deletion within an animal (figure 3.1). 
To investigate the relationship between high transgene copy number 
and variegation, high copy number lines were produced by pronuclear 
injection of a lox containing BLG transgene, and their expression profile 
analysed. Milk, RNA and DNA were all analysed to give an indication of 
variegation as discussed in this chapter. Animals from variegated lines were 
bred to a Cre recombinase line, or used to produce embryos for 
microinjection with Cre recombinase, and these lines were further analysed 
as discussed in Chapters 4 and 5. 
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Figure 3.1. Strategy for site-specific recombination to alter the copy 
number of a transgenic array. A. Production of high copy number lines. B. 
The reduction of copy number would be achieved by two different routes allowing 
comparisons between different developmental time points. 
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3.2 RESULTS 
3.2.1 Analysis of BLG-loxP construct 
The strategy of manipulating the transgene copy number required a 
number of prerequisites. The transgene used must contain a loxP site to 
allow Cre mediated recombination to occur, and the transgenes needed to be 
integrated in such a manner that the loxP sites were in the same orientation. 
If the transgenes had integrated in a head to tail array then after the 
expression of Cre recombinase, the transgenes between adjacent loxP sites 




bBLG 	bBLG H- 
Figure 3.2. Requirements for reduction in copy number strategy. (A) 
BLG-loxP transgene which would be a target for Cre recombinase. Red triangle 
represents a loxP site, blue box represents the BLG transgene. (B) Head to tail 
transgenic array integrated into the genome (black line). (C) This arrangement 
would produce a reduction in copy number after Cre recombination. The reduction 
could be to (i) a single copy or (ii) more copies could be retained depending on the 





The BLG-loxP construct involved had one loxP site inserted into the 3' 
end of the transgene (a gift from Dr. Douglas Strathdee; Roslin Institute). A 
loxP oligonucleotide had been cloned into site 10320 of the pPolyADp BLG 
construct. The oligonucleotide was designed such that once integrated it 
would provide a fourth BspHI restriction site, producing a new band of 
1.4kb. A diagnostic restriction digest confirmed that one loxP site had been 
introduced at the 3' end of the BLG construct (figure 3.3). 
pPolyAp 	BLG-loxP 
II 	I 
I kb 	uncut cut uncut cut 	1 kb 
Figure 3.3. Diagnostic restriction digest of BLG-IoxP construct. To 
determine the number of lox oligonucleotides integrated, the BLG-loxP construct 
DNA was digested with or without BspHl for 2 hours and compared with the original 
construct pPolyADp. The digests were loaded on a 1% agarose gel. The predicted 
band of 1470 bp was present (indicated by arrow). 1 k ladder from GibcoBRL with 
stated fragment sizes. The BspHI digestion also produced a 105bp fragment from 
both constructs which is not visible in this figure. 
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Cre recombinase is very site specific and even single base pair changes 
at the recognition site can prevent the reaction. 	To ensure that the 
introduction of the loxP site had not led to a point mutation within this area 
DNA sequencing was carried out (figure 3.4). This confirmed that only one 
loxP site had integrated, rather than two loxP sites at the same location and 
that the loxP site had integrated without mutation. 
tgatctcatg ataacttcgt ataatgtatg ctatacgaag 
ttatgatcag gatcaggacg atgggaagac tgtgagcacc 
ctgaaggcgg ggccaccccc gagtgtctgg tgactcatag 
gtgaaggctg gctccctgaa gcccctgagg cctggggagg 
agg 
Figure 3.4. Sequence data from BLG-IoxP construct. Underlined letters 
indicate the loxP site which has integrated into the BLG sequence with no mutation. 
The sequence starts at 10325 bp and finishes at 10212bp using the numbering 
from BLG sequence x12817. 
3.2.2 Microinj ection of BLG-loxP. 
Once the integrity of the loxP site was established, DNA was prepared 
for microinjection. The BLG-loxP construct was digested with XhoI to 
remove vector sequence before being used for pronuclear microinjection, as 
vector sequences have previously been shown to inhibit transgene 
expression (Townes et al 1985). 
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Xhol 	 EcoRl 	Hind Ill 	 Sspl 	EcoRl 	 Xhol 
19 1713 2759 5409 6059 7080 
Lcot-(I 	 I III IU III 
35 i 	 7045 
5' 	 { 	middle 	 3'1 
400bp 
	 11 00b 1 000b 
Figure 3.5 Probes used for Southern blotting. The plasmids from which the fragments were derived from are 
listed in Appendix One. The figures given for restriction sites are from BLGADp sequence. The diagram is not to 
scale. 
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3.2.3 Analysis of transgenic mice. 
Having established that the BLG-loxP construct contained an intact 
loxP site, it was now necessary to analyse founder animals for the structure 
and copy number of the integrated BLG-loxP transgene. For the project 
strategy to be successful, the transgenes needed to be integrated in a head to 
tail array. Of the 95 founders produced by microinjection, 14 were deemed 
positive by Southern blot (probes used for Southern blotting are found in 
figure 3.5). Five high copy number founders were then used to establish 
transgenic lines. These lines were maintained in a hemizygous state by 
testing with PCR/Southern Blotting. 
3.2.4 Analysis of transgene copy number 
Copy number estimates of the five established lines were made. The 
results were obtained by comparing the intensity of internal transgene 
fragments on Southern blots of Gi liver DNA to copy control standards from 
dilutions of the original 7kb microinjection fragment. The copy control 
standards were calculated using the following assumptions: that the haploid 
content of the mouse genome is 3 x 10 bp and secondly that the copy 
controls will be used in a 10tg digestion of genomic DNA (Camper 1987). 
Since the mice in this study are heterozygous: 
Mass of transgene DNA 
5 micrograms genomic DNA 
e.g. for BLG-loxP: 
Mass of transgene DNA 
5 micrograms genomic DNA  
= 	N bp transgene DNA 
3 x 10 bp genomic DNA 
= 	7080 bp transgene DNA 
3 x 109 bp genomic DNA 
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e.g. for BLG-loxP transgene: 11.8 picograms is equivalent to one copy. 
Once the amount of transgene DNA corresponding to one, 10, 20 
copies etc. had been determined, this amount was added to 10.ig of non-
transgenic DNA and digested as appropriate. The probed blots (figure 3.6) 
were scanned and quantified by Quantity One software. The copy controls 
were used as known standards to produce a standard curve which was then 
used to estimate the unknown transgenic copy number (see 2.10). From 
these blots the copy numbers were estimated as described in Table 3.1. 
Copy controls 
Figure 3.6. Analysis of lox transgene copy number by Southern blot. 
10tg genomic liver DNA was digested with EcoRl, electrophoresed on a 0.8% 
agarose gel and probed with a 1.1 kb BLG fragment. L indicates a ? Hindlil ladder 
with stated fragment sizes which was used for size estimation. - indicates lOj.tg of 
non-transgenic DNA. Copy controls were dilutions of the original microinjected 7kb 
BLG-loxP fragment added to lOjtg of non-transgenic DNA. 
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In figure 3.6 the EcoRI digest produced a fragment of 4.3kb in all of 
the transgenic lines which corresponded to an internal 4.3kb fragment of the 
BLG-loxP transgene (see figure 3.5). Lox 50 shows no other transgenic 
fragments. However, in four of the transgenic samples other fragments 
were present. 
In the lox 4 sample a faint fragment (approx 1.5kb) can be seen. This 
may represent a truncated transgene which has lost some of the sequence 
that corresponds to this probe, producing a fragment smaller than the 
expected 4.3kb. 
In the lox 5 sample a larger fragment (approx 4.6kb) is present at 
lower intensity than the internal 4.3kb fragment. 	This may represent 
another truncated fragment which contains the 4.3kb EcoRl fragment and 
additional sequence around it. 
In lox 9 multiple fragments are present. Given that one of these 
(approx 5.2kb) corresponds to the partial digestion fragments of the copy 
control, these may represent poorly digested bands or transgenes that have 
lost one of the EcoRI sites. There is also a band at approx. 7kb which would 
correspond with the undigested transgene length. The largest fragment 
(>10kb) in lox 9 may represent the junction fragment of this transgenic array. 
In lox 96 the 7kb fragment may represent undigested transgenic DNA, 
with the smaller fragments (approx 3.3kb, 2.4kb and 1.3kb) representing 
truncated regions of transgene or junction fragments containing only a part 
of the 4.3kb band. 
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The method of comparing copy controls against internal transgene 
fragments is however susceptible to a number of errors. Accurate results 
depend on a number of factors: the ability to accurately determine the 
concentration of the DNA, the ability to accurately dilute the copy control 
fragment and lastly accurate pipetting of genomic DNA. 	The ability to 
accurately 'box' a data point using quantification software may also lead to 
errors in the estimation of copy number. 	The copy controls are also 
'external', as they are not derived from the same biological sample as the 
unknowns and are electrophoresed on different lanes of the gel. 
3.2.5 Estimation of copy number by junction fragment 
comparisons and dilution blots 
An alternative method was used to estimate transgene copy number 
of the arrays, by comparing the transgene and its junction fragments. This 
represents an internal control as both are derived from the same sample and 
are electrophoresed on the same lane of a gel. An enzyme with a unique 
restriction site within the transgene was used to digest the DNA. If the 
array has more than one copy it produces a repeat length fragment and 
junction fragments. Comparisons can be made between the intensity of the 
internal repeat fragment and the junction fragment. As the 1.1kb probe can 
only hybridise to one site per transgene copy, the copy number of the 
transgene repeat can be determined by its intensity, relative to the junction 
fragment, which is used as a one copy control. The junction fragment 
between the transgene array and the genomic sequence is unique and is 
therefore only represented once per genome. 
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Southern blots were exposed to a Phosphoimager screen (BioRad) for 
quantification. Phosphoimager screens have a larger linear range than X-ray 
film (5 orders of magnitude; BioRad) and can also be used to determine if 
any bands have become saturated allowing another exposure to be used. 
This means that they can be used to compare bands of quite different 
intensities from the same gel as both will fall within the linear range of the 
phosphoimager screen. Quantification of copy number based on band 
intensity assumes that the probe hybridises equally to the transgenic 
sequence in both bands, and that it is not affected by fragment length or 
other genomic sequence. It also assumes that the junction copy is only 
present once per genome. Quantification may be hampered by errors in 
DNA concentration and dilutions, accurate boxing of data points and the 
sensitivity of the phosphor screen. 
Dilution blots provide another method of copy number estimation. 
The idea is to dilute the repeat fragment until the signal from it matches that 
of the junction fragments when hybridised with the same probe. The 
dilution factor required to bring the internal fragment to the same intensity 









Figure 3.7. Dilution Southern blots to determine lox copy number. 
Transgenic DNA was either left undiluted (U) or diluted (numbers give dilutions) 
with non-transgenic DNA to give 10tg which was digested with SspI, 
electrophoresed on a 0.8% gel and probed with a 1.1kb BLG fragment. Copy 
controls were dilutions of the original microinjected 7kb BLG-loxP fragment added 
to 1 Ogg of non-transgenic DNA. 
From these measurements the lines lox 4, 5 and 9 were determined to 
have copy numbers as described in table 3.1. The two methods used gave 
different estimates (especially for lox 5 or 9), which emphasises how difficult 
it is to precisely estimate copy number. An alternative method is to use the 
length of the transgenic array as an estimate of the number of copies. Pulse 
Field Gel Electrophoresis (PFGE) of a digest which does not cut within the 
transgenic array will give a transgenic array fragment of a certain length, 
which can be used to determine the number of copies present i.e. 18 copies of 
a 7kb transgene would be 128kb in total length. This method avoids any 
difficulties in comparing intensities of bands as discussed previously. 
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Line 	Estimated copy number Estimated copy number 
by comparison to copy 	by comparison to 
controls 	 junction fragments 
Lox  16 18 
Lox  13 26 
Lox 21 35 
Lox 50 11 NA 
Lox 96 40 NA 
Table 3.1. Estimates of lox transgene copy number by different 
methods. Copy control comparisons are from figure 3.6. Sspl digestions were 
used to determine copy number by finding the nearest dilution in intensity to the 
undiluted junction fragment. The ratio of repeat fragment counts/junction fragment 
counts was used to determine the number of repeats actually found in the array. 
Dilution blots were only carried out for lox 4, 5 and 9. 
In figure 3.7 there is the 7kb repeat length fragment and two other 
fragments: a 6kb fragment and a 5.5kb fragment. The 6kb was interpreted 
as the 5' junction fragment corresponding to genomic sequence and the first 
5.4kb of the transgene up to the SspI site. However, the 5.5kb fragment 
could not represent a 3' junction as the probe used in this blot would not 
hybridise to sequence 3' of the SspI site. 	Furthermore as discussed in 
Chapter 5 this 5.5kb fragment is absent after Cre mediated recombination. 
The site-specific recombination should result in the same junction fragments 
at the end of the transgenic array as before the introduction of Cre 
recombinase. Taken together, it is possible that the 5.5kb SspI fragment 
therefore, represents an internal truncated fragment of the transgene which 
is removed along with other copies of the transgene upon the introduction of 
the Cre recombinase. 
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3.2.6 Analysis of the transgenic array structure 
Critical to the strategy for the redution of copy number was the use of 
of transgenic lines that contained head to tail arrays. If the arrays are not 
head to tail, then the loxP sites are in the wrong orientation to produce a Cre 
mediated deletion between them. To determine if the lox transgenic lines 
had integrated as head to tail arrays the DNA was restriction digested with 
SspI, an enzyme that cuts once within the transgene. If the array comprises 
solely of head to tail repeats it will produce a 7kb fragment, while 10.5kb or 
5kb fragments would be produced if there were head to head, or tail to tail 





Head to tail array ___________________________________ (KD 
Head to head array 	5kb 
Tail to tail array 	10.5kb 
I 	 I 
Figure 3.8. Predicted SspI fragments from different transgenic array 
structures. The red lines represent where the Sspl site is on the transgene. 
The green arrow represents the repeat fragments expected from each type of 
array. 
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As seen from figure 3.9, lox 4, 5 and 50 contained head to tail repeats 
giving only the predicted 7kb repeat fragment and junction fragments. Lox 
9 had the 7kb repeat fragment from head to tail arrays, but it also contained 
three other transgenic fragment indicating that at the integration sites there 
may be other segments of DNA integrated between the transgene and the 
ends of the genomic sequence or rearrangements of the transgene. Lox 96 
has a complex structure, which may indicate that it contains two closely 
associated but separate integration events. Therefore this line was not used 
for reduction events due to its complex array. This blot could not determine 
if any head to head transgenes existed due to the location of the probe 
relative to the restriction site for Sspl No individual probe in this study 
could hybridise to all three arrangements. 
Copy controls 
- 1 5 10 20 40 80 4 	5 	9 	50 	96 
a 
Figure 3.9. Analysis of transgene array structure by Southern blot. 
10g transgenic genomic liver DNA was digested with Sspl, electrophoresed on a 
0.8% gel and probed with a 1.1kb BLG fragment. Sspl cuts once in the transgene 
producing a 7kb fragment if there are head to tail arrays, a 10.5kb fragment from a 
head to head array and a 5kb array from a tail to tail array. 	However, the probe 
used would only identify head to tail (black arrow) and tail to tail (green arrow 
indicates where this band would occur). Copy controls were dilutions of the original 





3.2.7 Expression Analysis 
3.2.7.1 In situ hybridisation 
To determine the cellular pattern of the transgene, in situ 
hybridisation studies using 35S  labelled BLG and -casein mRNA probes 
were carried out on abutting sections from mammary tissue collected at mid-
lactation from all five BLG-loxP lines. 
The structure of the mid lactation mammary gland tissue is shown in 
figure 3.10. An alveolus is composed of a single layer of secretory epithelial 
cells surrounding a lumen or alveolar space. The secretory epithelial cells 
are surrounded by a basket network of myoepithelial cells, which in turn are 
surrounded by a basement membrane (made of connective tissue proteins). 
Blood vessels and capillaries run through the stroma (inter-alveolar spaces). 
The stroma also contains fibroblasts, leukocytes (plasma cells) and other 
connective tissue cells. Secretory epithelial cells secrete milk proteins into 
the alveolar space. 	Myoepithelial cells on the outside of the alveolus 
contract to squeeze the milk out into the ducts and finally to the nipple 
(Mepham 1987). Sections of the mammary gland at mid-lactation produce 
cross-sections of alveoli and the ductal system (figure 3.10). The sections 
were stained with either Giesma or methylene blue, both of which give a 
blue counterstain to the cells with darker staining of the nucleus. The 
secretory epithelial cells have a simple 'cuboidal' shape. 	The slender 
myoepithelial cells surround the secretory epithelial cells and have an 
elongated shape. 	They are difficult to visualise with general staining 
methods at mid-lactation but can be seen by silver staining on goat 















Figure 3.10. 	Morphology of the mammary gland. 	(A) 
Diagrammatic representation of a cluster of mammary alveoli (adapted 
from Mepham, 1987), (B) Section taken through a mid-lactation mouse 
mammary gland, probed with hybridisation buffer only. Photograph taken 
after 2 week exposure using a xlO objective. Bar represents 300 p.m. 
a indicates an alveolus, d indicates the ductal system. 
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Different markers can be used to differentiate between the various cell 
types found within the mammary gland. Antibodies to a variety of cell 
markers now exist allowing an investigator to distinguish between the cell 
types. Myoepithelial cells are contractile elements showing a combined 
epithelial and smooth muscle phenotype. Immunohistochemical markers 
for this cell type include smooth muscle actin and cytokeratin 14 (Sapino et al 
1990). Different cytokeratins are found on different cell types: cytokeratin 14 
is found on myoepithelial cells, while cytokeratin 8 represents secretory 
epithelial cells. Secretory epithelial cells can also be identified using beta-
casein and alpha-lactalbumin (Sapino et a! 1990). A good resourse for 
histology of the mammary gland is found at http://mammary.nih.gov/ 
The mammary gland is a tissue composed of different cell types with 
the main constitutents being secretory epithelial cells and myoepithelial cells. 
A small number of studies have been carried out to determine the percentage 
of the gland represented by each type. However, it must be kept in mind 
that the mammary gland is an 'active' tissue, proliferating and involuting 
due to the varied influences of hormones and suckling, therefore the exact 
number of each cell type may vary depending on the different 
developmental stages it is sampled at. In one early study the DNA content 
of different cell types were estimated in C3HICrg1I2 mice (Nicoll and Tucker 
1965). It estimated that 89% of 10 day lactating mammary gland DNA was 
from mammary parenchyma. This figure would include both the secretory 
and myoepithelial cells. 	Subsequent studies have used 
immunohistochemistry to look at the percentage of cells and the 
proliferation of different cell types during development (Sapino et a! 1990). 
In lactating mice secretory epithelial cells represented 70% of the gland, 
while myoepithelial cells represented 30% (Sapino et a! 1990). In virgin mice 
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primed with estrogen and progesterone to mimic the changes to the 
mammary gland in early pregnancy, secretory epithelial cells represented 
71% of the gland, myoepithelial cells represented 21% of the gland and other 
cells represented 8% (Sapino et al 1993). These few studies that distinguish 
between myoepithelial and secretory epithelial cells suggests that 
approximately 70% of the mammary gland is comprised of secretory 
epithelial cells. 
In situ hybridisation was examined by both light and dark field 
microscopy. In light field images the 35S  labelled RNA when hybridised to 
target RNA in the cell causes a change in the silver grains of the 
photographic emulsion. These then appear as a dark black stain against the 
blue counterstain. If no RNA is present all that is seen is the counterstain. 
Under dark field microscopy only reflective particles are visible (i.e. only the 
the silver grains that have reacted to the 35S  labelled RNA) and these give a 
fuzzy silver appearance. When imaging software is applied, a dark field 
image can be overlayed onto a light field, allowing the silver grains to be 
visualised as a yellow 'paint'. 
Non-transgenic mammary gland sections showed the expected 
expression of the endogenous gene -casein (figure 3.11) while BLG mRNA 
was not detected even under dark field (figure 3.12). This demonstrated 
that the BLG mRNA probe did not hybridise in a non-specific manner to the 
tissue. Sheep mammary gland was used as a positive control and showed 
that as an endogenous gene the BLG mRNA is uniformly expressed, while 








.• - 4 $ — 
-•.r'• 	•• •. .. . '}.t. 	l 
,.. 	•-' - -' ç' f' '_ ' 	- . 




-, 	,.! g'..••.• 
.... P' 	.s4 
/-c•;.  
'(.• 	;d4 
.:...; •_• ';'; 
'•'-&L.• .'. 	'' 	•i' 
'% 	•:_ 	•' 





"I?' J4.• .. 	. -.".. 	- 
- 
S. 
. . 	•,•p'•'Z. AN4 .. 
- 	p • 	. 'S 
p 	•'. -.: 
••k- 
• ': .-.• -':'.' 	e ' ' - • 
'p 
'.--.. •• .' 
• ': I 5- .,_ I- 44. 
Figure 3.11. In situ hybridisation analysis of mRNA expression 
patterns in non-transgenic mice. (A) -casein, (B) BLG. 
Photographs were taken after 2 week exposures using a xlO objective. 
Bar represents 300p.m. 
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Figure 3.12. Dark field imaging of in situ hybridisation of non-
transgenic tissue. (A,B,C) probed with 13-casein. (D,E,F) probed with BLG. 
Photographs were taken after 2 weeks exposures using a xlO objective. (A) 
and (D) are light field images. (B) and (D) are dark field images. (C) and (F) 
are composite images of both light and dark field with the silver grains being 















Figure 3.13. Dark field imaging of in situ hybridisation of sheep 
tissue. 	(A,B,C) probed with 13-casein. (D,E,F) probed with BLG. 
Photographs were taken after 2 weeks exposures using a xlO objective. (A) 
and (D) are light field images. (B) and (D) are dark field images. (C) and (F) 
are composite images of both light and dark field with the silver grains being 
represented with a yellow paint. Bar represents 300pm. 
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Sections from all five lines probed with control BLG and 13-casein 
sense probes had no signal associated with them by light field, although 
some did show very weak signal by dark field in inter-alveoli areas (figure 
3.16, 3.19, 3.22, 3.25, 3.28). 
f3-casein mRNA was detected in a uniform manner throughout the 
secretory epithelial cells in all transgenic lox animals analysed. 	This 
demonstrates that essentially all the secretory epithelial cells had the capacity 
to express a milk protein gene. 
Sections from lox 4 animals indicate that the BLG mRNA is present in a 
variegated manner, where discreet patches of cells express the transgene 
beside areas of non expressing cells. These distinct patches of expression 
may indicate that the variegated patterns seen are clonal in origin. 
However, some alveoli contained both expressing and non expressing cells 
(figure 3.14; a mixed alveolus is noted with a red arrow). In dark field 
imaging (figure 3.15, panel E) only some areas show reflective silver grains 
while the rest is dark. 
Lox 5 showed a uniform pattern of BLG expression throughout the 
mammary secretory epithelial cells (figures 3.17 and 3.18). Although darkly 
stained with methylene blue (figure 3.19) lox 5 sense probes showed no 
hybridisation indicated by the lack of a yellow overlay in panel C. 
Sections from lox 9 animals showed that the BLG transgene mRNA 
was only present in discreet areas of the gland and was not uniformally 
expressed. 	Similarly to lox 4 animals some alveoli in lox 9 animals 
contained both expressing and non expressing cells (figure 3.20; red arrow). 
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Figure 3.21 shows that even by dark field imaging certain sections were 
completely silent for BLG expression (bottom left of panel E and F). Some 
background staining can be seen in ductal areas of lox 9 using a sense probe 
(figure 3.22). 
Sections from lox 50 and lox 96 animals indicated that both these lines 
were uniform expressors of the BLG transgene mRNA (lox 50: figures 3.23 
and 3.24, lox 96: figures 3.26 and 3.27). Because the photographic emulsion 
is at a slightly different focal plain than the tissue section, where there was 
high expression it was difficult to produce sharp images by normal light 
microscopy (i.e. 3.23). However, both showed uniform expression by dark 
field imaging (figures 3.24 and 3.27). 	Both these tissues showed no 




Figure 3.14. In situ hybridisation analysis of mRNA expression 
patterns in line BLG-lox 4. 
(A) 3-casein, (B) BLG. Photographs were taken after 2 week exposures 
using a xlO objective. Bar represents 300m. Red arrow indicates an 
alveolus with partial expression. 
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Figure 3.15. Dark field imaging of in situ hybridisation of Lox 4. 
(A,B,C) probed with 13-casein. (D,E,F) probed with BLG. Photographs were 
taken after 2 weeks exposures using a xl 0 objective. (A) and (D) are light 
field images. (B) and (D) are dark field images. (C) and (F) are composite 
images of both light and dark field with the reflective silver grains being 
represented with a yellow paint. Bar represents 300pm. 
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Figure 3.16. Control in situ hybridisation of Lox 4. (A,B,C) probed 
with sense probe. Photographs were taken after 2 weeks exposures using a 
xlO objective. (A) is a light field image. (B) is a dark field image. (C) is a 
composite image of both light and dark field with the reflective silver grains 
being represented with a yellow paint. Bar represents 300p.m. 
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Figure 3.18. Dark field imaging of in situ hybridisation of Lox 5. 
(A,B,C) probed with 3-casein. (D,E,F) probed with BLG. Photographs were 
taken after 2 weeks exposures using a xlO objective. (A) and (D) are light 
field images. (B) and (0) are dark field images. (C) and (F) are composite 
images of both light and dark field with the reflective silver grains being 





Figure 3.19. Control in situ hybridisation of Lox 5. (A,B,C) probed 
with sense probe. Photographs were taken after 2 weeks exposures using a 
xlO objective. (A) is a light field image. (B) is a dark field image. (C) is a 
composite image of both light and dark field with the reflective silver grains 




Figure 3.20. 	In situ hybridisation analysis of mRNA 
expression patterns in line BLG-lox 9. 
(A) 13-casein, (B) BLG. Photographs were taken after 2 week exposures 
using a xlO objective. Bar represents 300 jim. Red arrow indicates an 
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Figure 3.21. Dark field imaging of in situ hybridisation of Lox 9. 
(A,B,C) probed with 3-casein. (D,E,F) probed with BLG. Photographs were 
taken after 2 weeks exposures using a xlO objective. (A) and (D) are light 
field images. (B) and (D) are dark field images. (C) and (F) are composite 
images of both light and dark field with the silver grains being represented with 






Figure 3.22. Control in situ hybridisation of Lox 9. (A,B,C) probed 
with sense probe. Photographs were taken after 2 weeks exposures using a 
x1  objective. (A) is a light field image. (B) is a dark field image. (C) is a 
composite image of both light and dark field with the silver grains being 




Figure 3.23. 	In situ hybridisation analysis of mRNA 
expression patterns in line BLG-lox 50. 
(A) f3-casein, (B) BLG. Photographs were taken after 2 week exposures 
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Figure 3.24. Dark field imaging of in situ hybridisation of Lox 50. 
(A,B,C) probed with 3-casein. (D,E,F) probed with BLG. Photographs were 
taken after 2 weeks exposures using a xlO objective. (A) and (D) are light 
field images. (B) and (D) are dark field images. (C) and (F) are composite 
images of both light and dark field with the silver grains being represented with 





Figure 3.25. Control in situ hybridisation of Lox 50. (A,B,C) probed 
with sense probe. Photographs were taken after 2 weeks exposures using a 
xlO objective. (A) is a light field image. (B) is a dark field image. (C) is a 
composite image of both light and dark field with the silver grains being 
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Figure 3.27. Dark field imaging of in situ hybridisation of Lox 96. 
(A,B,C) probed with 13-casein. (D,E,F) probed with BLG. Photographs were 
taken after 2 weeks exposures using a xlO objective. (A) and (D) are light 
field images. (B) and (D) are dark field images. (C) and (F) are composite 
images of both light and dark field with the silver grains being represented with 







Figure 3.28. Control in situ hybridisation of Lox 96. (A,B,C) probed 
with sense probe. Photographs were taken after 2 weeks exposures using a 
x1  objective. (A) is a light field image. (B) is a dark field image. (C) is a 
composite image of both light and dark field with the silver grains being 
represented with a yellow paint. Bar represents 300 jim. 
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Steps were taken to estimate the degree of heterogeneity of expression 
detected by in situ hybridisation for lox 4, 5 and 9 animals. Alveoli were 
scored according to the area expressing BLG RNA; negative when no cells in 
the alveolus expressed, I+ when there was partial expression from an 
alveolus (an example is indicated in figure 3.20 by a red arrow), and positive 
when all the cells in an alveolus expressed. Two sections per animal were 
counted at x20 magnification using ten fields of view. This was to try and 
avoid bias in the areas analysed, as the ten fields generally covered the 
whole of the section. 	Other factors including orientation on the slide, 
parentage and litter number were assumed to have no effect on the outcome. 
Figures giving the percentage of alveoli in each group are given in 
table 3.2. The counts show that in the lox 4 and 9 lines, alveoli fall into all 
three categories. In these two lines there is variation between individuals 
within the same transgenic line, in the number of cells expressing. In lox 5 
all the alveoli counted showed uniform expression of BLG. 
The variation within lox 4 and 9 animals is shown in figure 3.29 which 
is a dotplot of the percentage of alveoli that are positive (partial and full 
expression) in each individual mouse. Lox 5 is in constrast with this, as all 
animals from this line are found to express BLG mRNA in all the alveoli 
examined and counted. 
The counts were analysed using GenStat software to produce Table 
3.3 combining the values of alveoli counted as partly positive and those fully 
positive. Standard deivations (s.d.) and coefficient of variance are both 
measures of the amount of variability within a group i.e. the differences 








Lox 4.1 40 36 24 
Lox 4.3 45 27 29 
Lox4a5.20.4 43 37 20 
Lox4a5.20.5 56 26 18 
Lox4a5.20.7 46 23 31 
Lox4a5.20.8 47 22 31 
Lox5.7 0 0 100 
Lox5.10 0 0 100 
GB2.9 0 0 100 
Lox9.2 23 24 53 
Lox9.4 44 27 29 
GBI1.5 55 21 24 
Table 3.2. BLG expression values by in situ hybridisation of lox lines. 
Ten fields per section and two sections for each animal were counted to derive a 
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Figure 3.29. 	Dotplot of combined positive alveoli for lox animals. 
Each dot represents an animal. The percentage of alveoli that were counted 
partial or fully positive were combined to give an overall view of expression in the 
mammary gland. 
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Line Range of n Mean s.d c.v 
percentages of 
positive alveoli 
Lox  44-60 6 54 5.5 10.3 
Lox  100-100 3 100 0 0 
Lox 9 45-77 3 59 16.2 27.1 
Table 3.3. Statistical analysis of lox in situ counts. Range is given as a 
percentage of the total alveoli which had some expression, n = number of animals 
per line, s.d. standard deviation, c.v. = 100 x s.d. I mean. 
As expected from the in situ figure 3.17 there is no variation among 
the individuals of the stably expressed lox 5 line. However, both lox 4 and 9 
show variation between individuals at a cellular level in the number of cells 
which express the BLG transgene, and this is reflected in a high coefficient of 
variance. Only three animals were counted for the lox 5 and 9 lines. 
However, despite the small sample size there are clear differences between 
the lines. More animals (n=6) were analysed for the lox 4 line as this was 
used more extensively thoroughout the other chapters, and therefore 
enabled more samples to be analysed. 
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3.2.7.2 Northern blot analysis 
Northern blotting was used to confirm the presence of BLG RNA 
found by in situ hybridisation. Total RNA isolated from mid-lactation 
mammary tissue from the five lines all showed BLG RNA (figure 3.30). As 
there were only a small number of samples per line statistical analysis would 
not have been informative. The Northern blot does however indicate that a 
BLG RNA of the expected size is produced in the lox transgenic animals. 





Figure 3.30. Northern blot of lox mammary RNA. Total RNA was 
electrophoresed on a denaturing gel, blotted to Zetaprobe, and then sequentially 
probed with a BLG cDNA PCR product and a 28S 12kb fragment to control for 
loading differences. 
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3.2.7.3 	Milk Protein analysis 
SDS-PAGE analysis was used to determine if BLG protein was present 
in transgenic milk samples from the five lox lines (figure 3.31). Mouse milk 
samples were prepared as described (see 2.7.1) and were loaded at 1/200 
dilutions along side ovine BLG standards (a gift from Dr. Maggie 
McClenagahan; Roslin Institute). Gels were photographed using Quantity 
One software (BioRad). From SDS-PAGE analysis it could be seen that all of 
the transgenic animals expressed BLG protein. As lox 4, 5 and 9 were to be 
used in the reduction experiments, a larger number of individual milk 
samples were each run on triplicate gels to give accurate measurements. 
Standard deviations and coefficients of variation were calculated in table 3.4. 
Line Range of BLG n Mean s.d. c.v 
protein in line 
Lox  0.7-1.5 8 1.2 0.3 24 
Lox 5 8.3-10.6 6 9.5 0.8 8 
Lox  3.0-8.1 7 5.2 1.9 37 
Table 3.4. BLG protein expression levels in lox 4, 5 and 9. BLG protein 
values are mg/ml, n = number of animals analysed per line, s.d. standard deviation, 
c. v. = 100 x s.d.! mean. 
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Figure 3.31. SDS-PAGE analysis of lox milk proteins. Mouse milk samples were electrophoresed in 18% polyacrylamide 
gels under reducing conditions and stained with Coomassie Blue. M indicates Rainbow marker (Amersham). -ye indicates a 1/200 
dilution of defatted control non-transgenic mouse milk sample. 1/200 dilutions of defatted milk from transgenic animals from each of 
the five lox lines was loaded along side 1 g and 2 p.g of BLG. 
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Figure 3.32. SDS-PAGE analysis of lox 4 milk proteins. Mouse milk samples were electrophoresed in 18% polyacrylamide 
gels under reducing conditions and stained with Coomassie Blue. M indicates Rainbow marker (Amersham). -ye indicates a 1/150 
dilution of defatted control non-transgenic mouse milk sample. 1/150 dilutions of defatted milk from transgenic lox 4 animals were 
loaded along side 1tg, 0.5jtg and 0.25 jtg of BLG. 
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These further investigations of lox 4 indicated that the BLG protein 
level did indeed vary between animals from that line (figure 3.32). The 
values from lox 4 showed a range of 0.70— 1.5 mg/mi. The levels between 
individuals in the lox 9 line also showed variation in the level of BLG protein, 
with over a 2 fold difference between samples. With more lox 5 samples 
available it was possible to show the stable nature of the BLG concentration 
in this line, as illustrated by the lower c.v from this line. All protein analysis 
confirmed the nature of the lox lines as established by the in situ data. 
Previous studies on BLG transgene variegation also analysed the BLG 
protein concentration within a line. One variegating line showed higher 
levels of protein expression than any of the lines analysed here (23.7mg/ml in 
BLG 45 line; Dobie et cii 1996). Higher levels of variation between sibs was 
found previously: BLG line 7 had a c.v. of 52 (Dobie et cii 1996), compared to 
lox 9 with a c.v. of 37 (table 3.4). 
The stable lox 5 line in this study, showed a lower amount of variation 
(c.v. of 8) compared with the uniformly expressed line 14 (c.v. of 17) in the 
previous work (Dobie et cii 1996). This may be due to the differences in the 
methods to quantify the visible bands from SDS-PAGE. In the previous 
study bands were quantified by scanning densitometry, print outs were used 
to cut out the peak representing the BLG band and these were then weighed 
with a fine balance; in this study gels were scanned using a BioRad 
Multilmager and Quantity One software. 
Western blotting of SDS-PAGE gels was carried out to confirm the 
identity of the novel band found in transgenic milk samples. 
Immunoblotting of the lox milk proteins confirmed that the novel band 
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found in the transgenic milk contained an antigen that reacted to BLG 
antibody (figure 3.33). In the lox 5 samples due to the higher level of protein 
the bands are diffuse due to overloading of the gel. 
BLG 
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Figure 3.33. 	Western blot of lox milk. 	1/200 dilutions of milk protein 
samples were run on a SDS-PAGE gel, electroblotted to nitrocellulose and probed 
with rabbit anti - BLG and then HRP conjugated anti rabbit lgG. 
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3.3 CONCLUSIONS 
A number of transgenic mouse lines were generated with a BLG 
transgene containing a single loxP inserted in the 3' flanking sequence. 
Southern blotting was carried out to determine the copy number and the 
structure of the transgenes integrated in each of the lox lines. All had more 
than 10 transgene copies integrated. In lox 4, 5 and 50 the array was 
determined to be a primarily simple head to tail arrangement. Lox 9 was 
more complex, while lox 96 had an extremely complex array which may 
have been generated by two separate but closely linked integrations. These 
transgenic arrays were stable; there was no change in copy number/structure 
between generations or within litters. 
In situ hybridisation analysis showed that out of the five high copy 
number lines generated, two (lox 4 and 9) showed variegated BLG 
expression, while the other three showed a uniform pattern of BLG 
expression. 
Data from the SDS-PAGE protein analysis correlated with the 
estimation of in situ expression, indicating that lines with the highest 
numbers of cells expressing BLG mRNA also showed the highest levels of 
BLG protein in milk samples. 
The transgenic mice studied for this project were of a C57BL/6 x CBA 
hybrid genetic background. Background modifiers have previously been 
identified that interfere with transgene expression (Allen et a! 1990). It is 
possible that the different levels of expression observed among individuals 
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within a lox line may be due to segregation of alleles of a modifier gene, 
which interferes with transgene expression. Previously variegating BLG 
transgenes on a mixed genetic background, when backcrossed to 97% CBA 
or C57BL/6 backgrounds showed no difference in the variability of transgene 
expression, indicating modifiers were not responsible for the varigation 
within a BLG transgenic line (Dobie et a! 1996). However, this thesis did not 
attempt to address whether genetic modifiers were influencing the BLG-loxP 
transgene expression patterns. 	Without conducting backcrossing 
experiments on the lox lines, modifier genes cannot formally be ruled out as 
a possible reason for the variegation within the lox lines. 
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CHAPTER FOUR 
TARGETED REDUCTION OF TRANSGENIC 
COPY NUMBER IN THE MAMMARY GLAND 
4.1 INTRODUCTION 
Having established five transgenic lox lines and analysed their 
expression patterns as discussed in Chapter 3, this chapter focuses on the 
reduction of transgene copy number specifically in the mammary gland and 
investigates the effect on the expression profile of the transgene. 
Cre recombinase is a site specific recombinase which causes the 
deletion of DNA between two loxP sites in the same orientation (Sauer and 
Henderson 1989). It has now been extensively used in transgenic animals for 
a variety of purposes as discussed in Chapter 1. Cre recombinase has been 
expressed by using a number of tissue-specific promoter to drive expression 
to the tissue of interest. In this case BLG-Cre (Cre 74) transgenic mice had 
previously been generated in this lab and had been tested against a lox 
reporter construct. Cre expression was shown to be specific to the secretory 
epithelial cells of the mammary gland and was expressed in a uniform 
manner when investigated using in situ hybridisation (Selbert et al 1998). 
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Due to the nature of the integrations of the lox lines as head to tail 
repeats, when Cre recombinase is introduced a deletion event should occur 
between the two loxP sites of the adjacent transgenes producing a reduction 
in copy number. To achieve this mammary-specific reduction in copy 
number of the lox lines, animals were crossed to a BLG-Cre line (Cre 74). 
Three lines were used for this further study; lox 4 and 9 which had 
variegated expression and lox 5 which had uniform expression. 
Double transgenic animals were analysed for changes in copy number 
by Southern blotting, while expression analysis was carried out as before 
using in situ hybridisation, Northerns and milk protein analysis. The results 
are discussed below. 
4.2 RESULTS 
4.2.1 Production of double transgenic animals 
Lox animals from lox 4, 5 or 9 were bred to Cre 74 animals and the 
resulting offspring were tested for the presence of both the BLG-loxP 
transgene and the BLG-Cre transgene by Southern blotting. Within litters 
animals could inherit neither transgene, the lox transgene, the Cre transgene 
or both transgenes (examples from the BLG-lox4 crossed with BLG-Cre are 
shown in figure 4.1; the same patterns were seen in the other two crosses). 
Double transgenic females were used for mid-lactation analysis, while a 





Figure 4.1. Southern blotting for presence of BLG-loxP and BLG-Cre 
transgenes. Progeny from crosses between BLG-loxP animals and BLG-Cre 74 
animals were analysed for the presence of both transgenes. 20 jig of tail DNA was 
digested with BamHl, the digests were electrophoresed on two 0.8% gels and 
blotted to Zetaprobe membrane. 	(A) One blot was probed with a 1.1kb BLG 
fragment, (B) the other blot was probed with a 1 kb Cre probe. 	-I- indicates 
negative for both transgenes, +1- indicates positive for BLG-loxP only, -1+ indicates 
positive for BLG-Cre only, +1+ indicates positive for both transgenes. 
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4.2.2 Analysis of copy number reduction 
The mammary gland is a complex tissue comprising more than one 
cell type. The mature adult mammary gland consists of secretory epithelial 
cells surrounded by a layer of contratile myoepithelial cells and supporting 
connective and adipose tissue (Mepham 1987). As the Gre recombinase used 
for this experiments is under the control of BLG, it is expressed in the major 
subset of cells in the mammary gland; the secretory epithelial cells (Selbert et 
a! 1998). Therefore a proportion of the mammary gland would maintain the 
'parental' transgenic array, while the majority of cells would have a 'reduced 
array'. This resulted in mosaicism within genomic mammary DNA which 
complicated the analysis of copy number reduction. 
EcoRV does not have a recogition site within the BLG-loxP sequence, 
therefore it cannot cut within the transgenic array, but would leave the entire 
transgenic array as one fragment within the digested genomic DNA. This 
fact was used to analyse the reduction in copy number. As a high copy 
number array, EcoRV digestion would produce a high molecular weight 
fragment, which was termed the 'parental array'. If after breeding to Gre 
mice there had been a deletion of copies from the array it should appear as a 
smaller fragment, termed the 'reduced array'. This is illustrated in figure 
4.2. As shown in figure 4.3 a 10kb EcoRV 'reduced array' fragment was 
found in lox 4 mammary gland DNA, and is referred to as the 10kb RV locus 
from this point. The parental array also showed a decrease in intensity. The 
liver tissue is used as a control for the parental state as Cre recombinase is 
not expressed in this tissue (Selbert et a! 1998). 
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A. 	BLG-loxP transgene 
	
B. 
No EcoRV sites 
EcoRV Southern blot 
P R MG 
'reduced array' 
Figure 4.2. Diagram of EcoRV digestion of double transgenic DNA. (A) The BLG-loxP transgene does not contain any 
EcoRV sites (red arrows represent the EcoRV sites, red triangles represent loxP sites) within it. 	The original lox lines contain 
multicopy arrays. The multicopy array would not be digested by EcoRV, and would present as a high molecular weight fragment 
termed the 'parental' array. This would consist of all the transgene copies plus the surrounding genomic DNA until the first genomic 
EcoRV sites. In double transgenic animals the Cre recombinase would be expected to remove BLG-IoxP transgenes to produce a 
'reduced' array. This would therefore produce a smaller EcoRV digestion fragment. (B) When EcoRV digested DNA is Southern 
blotted, there would be an expected size difference between the two types of arrays; P represents the parental array, R represents the 
reduced array. Because the mammary gland consists of a mixture of cell types, some of which do not express the BLG-Cre construct, 
there would be mosaic pattern of both arrays represented by MG (mammary gland). 
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The 10kb RV locus was only ever found in lox 4 animals carrying both 
BLG-loxP and the BLG-Cre constructs, and furthermore, was never found in 
the liver of these animals, indicating that it is generated by the presence of 
Gre recombinase. The size of the fragment was consistent with it comprising 
one copy of the lox transgene plus the surrounding genomic DNA up to the 
genomic EcoRV sites on either side of the array (figure 4.4). 
Copy controls 	+1+ 	+1- 
10 20 40 L M 	L M 
!UL 
Parental 





Figure 4.3. EcoRV digestion of lox 4 double transgenic DNA compared 
with lox 4 DNA. lOj.tg liver (L) or mammary (M) DNA was digested with EcoRV, 
electrophoresed on a 0.8% gel and blotted to Zetaprobe membrane, and then 
probed with a 1.1kb BLG fragment. Copy controls were dilutions of the original 
microinjected 7kb BLG-loxP fragment added to 10g of non transgenic DNA. +1+ 
indicates an animal containing both lox 4 and Cre transgenes, +1- indicates an 
animal containing only the lox 4 transgene. The blot was probed with CFTR probe 
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Figure 4.4. Diagram of 'reduced array'. (A) The 10kb RV locus is consistent 
with one copy of the lox transgene and the genomic DNA surrounding it until the 
first EcoRV sites (red arrows represent EcoRV sites, red triangle represent a loxP 
site). (B) If there were more than one transgene copy the 'reduced array' would be 
expected to be greater than 14kb. 
The ratio of the EcoRV fragments gives an indication of the percentage 
of cells that have undergone Cre mediated recombination. From the data 
discussed in Chapter 3, the lox 4 line was estimated to contain 18 copies of 
the BLG transgene within its array. As discussed above from the size of the 
10kb RV fragment it is estimated that it contains a single transgene. This 
means the 'reduced array' represents one copy per cell, while the 'parental 
array' represents 18 copies per cell. Therefore if the two EcoRV arrays were 
of equal intensity this would indicate that there were 18 reduced cells to 
every one unreduced cell in the mammary gland. However, the reduced 
array was less intense than the unreduced array in figure 4.3. The ratio of 
unreduced/reduced intensity was calculated using Quantity One Software to 
be 1.65. This meant that for every one unreduced cell there were 11 reduced 
II; 
cells. This estimates that 8% of the cells in the mammary gland did not 
undergo Cre mediated recombination. This is represented in figure 4.5. It 
was previously estimated that 70-80% of the cells within the lactating 
mammary gland underwent Cre mediated recombination in the BLG-Cre 74 
line (Selbert et al 1998). The 20-30% that failed were taken to represent the 
non-epithelial cells that do not express the BLG-Cre construct. 
18 1 1 1 
1 1 1 1 
1 1 1 1 
1 1 1 1 
1 1 1 
B. 
18 1 1 1 
1 1 1 1 
1 1 1 1 
18 copies in one cell 
= intensity I 
I copy in 18 cells 
18 copies in one cell 
= intensity 
1 copy in 11 cells 
1.63 
Figure 4.5. 	Estimate of percentage of cells that underwent Cre 
mediated recombination. 	Squares represent one cell, the number inside 
represents the number of BLG transgenes present. (A) If the ratio of intensity of 
the unreduced to reduced array was one, then the ratio of cells must be 1 
unreduced to 18 reduced. 	(B) From figure 4.3 the ratio of intensity of the 
unreduced to reduced array was 1.65, therefore the actual ratio of cells must be 1 
unreduced to 11 reduced. The unreduced cells represent 8% of the mammary 
gland. 
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However, if the intensities of the fragments in figure 4.3 are 
considered in light of the various estimates of the cell types of the mammary 
gland, different figures of lox 4's original copy number are derived. Studies 
investigating the percentage of each cell type in the mammary gland using 
immunohistochemistry have estimated that secretory epithelial cells only 
represent 70% of the total cell population (Sapino et a! 1990). Therefore only 
70% of the gland could express the Cre recombinase transgene. If this figure 
is used as the number of cells that have undergone recombination to a single 
copy array, then a much lower estimate of lox 4 copy number is derived: 
parental array in 30% of cells 
I copy in 70% of cells 
= 1.63 intensity 
parental array = 	1.63 intensity x 70% of cells 
30% of cells 
parental array = 	3.8 copies 
If the same calculation is carried out using an estimate that 80% of 
mammary cells undergo recombination, the original lox 4 copy number is 
shown to be 6.52 copies. These figures conflict with the 18 copies estimated 
by Southern blotting in Chapter 3. It must be considered that these figures 
rely on the ability to quantify the intensities of each band accurately using a 
Phosphorimager and its software. As discussed in Chapter 3 a number of 
issues may result in errors in estimating band intensities by this method. At 
best, this is a crude method to determine the percentage of cells that have 
undergone Cre mediated recombination. In the previous studies (Selbert et 
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al 1990) in situ PCR was used to identify cells that had undergone Cre 
mediated recombination of a reporter construct. This would not have been 
possible in this case, as no transgenic sequence differences existed between 
reduced and unreduced cells. 
Lox 5 and 9 also showed a reduction in the intensity of the parental 
array, however no 'reduced array' could be found in double transgenic 
animals from lox 5 or 9 (figure 4.6). 
Lox 	 Lox  
LM LM LM LM 
Parental 
array 
-. 	 Loading 
control 
Figure 4.6. Ec0RV digestion of lox 5 or 9 double transgenic DNA 
compared with lox DNA. 10ig liver (L) or mammary (M) DNA was digested 
with EcoRV, electrophoresed on a 0.8% gel and blotted to Zetaprobe membrane, 
and then probed with a 1.1kb BLG fragment. +1+ indicates an animal containing 
both lox 5/Cre or lox 9/Cre transgenes, +/- indicates an animal containing only the 
lox 5 or 9 transgene. The blot was probed with CFTR probe to control for loading 
differences. 	The faint shadow (*) found in the +1+ mammary of lox 9 is not 
consistent with a true fragment. 
If the Cre recombinase deleted different amounts of the array in 
individual cells, it maybe that the mammary is mosaic for a variety of 
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different copy numbers. These different arrays would all produce different 
sized fragments giving no one clear reduced array. This would however, be 
predicted to give a smear effect in Southern blots due to the presence of 
multiple fragments of different length. No smears of transgenic fragments 
were seen for double transgenic animals in either line 5 or 9. An alternative 
explanation is that in the cells expressing Cre recombinase the BLG-loxP 
array was completely deleted. This could account for the reduction in the 
'parental array' and also the lack of a 'reduced array'. Given that the 
transgene only contained one loxP site, the complete removal of all 
transgenic sequence seems unlikely, due to the fact that a loxP site would 
have to remain in the genome after Gre mediated recombination. It is 
possible that the explanation for the lack of a 'reduced array' is due to these 
arrays being 'trapped' within the parental array due to the resolution point 
of the gel, resulting in the lack of a clear 'reduced' band. This could mean 
that a 3-4 copy array (i.e 21-28kb fragment) would be co-migrating along 
with the parental array. It may be possible that discreet 'reduced' arrays for 
lox5/Cre and lox 9/Cre animals do exist but have not been detected by the 
methods used. Pulse-field electrophoresis could allow the resolution of 
'reduced' but not single copy arrays from the parental array. 
Ssp I digestion produces a repeat length fragment as well as junction 
fragments and was used to estimate the copy numbers of the lines in Chapter 
3. Comparisons between liver and mammary lox 4/Cre DNA showed a 
reduction in the amount of repeat fragment present, indicating a reduction in 
copy number had occurred (figure 4.7). 
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Figure 4.7. Sspl digestion of lox 4 double transgenic DNA compared 
with lox 4 DNA. lOjtg liver (L) or mammary (M) DNA was digested with Sspl, 
electrophoresed on a 0.8% gel and blotted to Zetaprobe membrane, and then 
probed with a 1.1kb BLG fragment. Copy controls were dilutions of the original 
microinjected 7kb BLG-loxP fragment added to lOj.tg of non transgenic DNA. +1+ 
indicates an animal containing both lox 4 and Cre transgenes, +1- indicates an 
animal containing only the lox 4 transgene. The blot was probed with CFTR probe 
to control for loading differences. The 6kb and 5.5kb fragments were thought to 
represent junction fragments. This figure is derived from the same Southern blot 
as figure 4.3. 
Sspl digestion was also carried out on the lox 5 and 9 double 
transgenic animals (figure 4.8). 	Comparisons between the liver and 
mammary gland in double transgenic animals shows a reduction of the 
repeat fragment intensity, suggesting there had been a reduction in copy 
number in these animals. This is in agreement with the EcoRV digests, 
which also had a reduction in intensity of the parental array from double 
transgenic animals. 
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Figure 4.8. 	Sspl digestion of lox 5 or 9 double transgenic DNA 
compared with lox 5 or lox 9 DNA. 10jtg liver (L) or mammary (M) DNA was 
digested with Sspl, electrophoresed on a 0.8% gel and blotted to Zetaprobe 
membrane, and then probed with a 1.1kb BLG fragment. +1+ indicates an animal 
containing lox 5/Cre or lox 9/Cre transgenes, +/- indicates an animal containing only 
the lox 5 or 9 transgene. The blot was probed with CFTR probe to control for 
loading differences. 
As illustrated in figure 4.4, from the size of the 10kb RV locus in the 
EcoRV digestion it was estimated that there was a reduction to one copy in 
lox 4/Cre animals. Due to the mosaicism of the mammary DNA it was 
impossible to carry out more detailed analysis of the transgene fragment, due 
to the contaminating presence of unreduced copies in the DNA, evident in 
Southern blots due to its identical sequence. To try and confirm the identity 
of this fragment the 10kb fragment was probed with a 5', middle and 3' 
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probe to determine if it hybridised to all of these (figure 4.9 describes the 
probes). Figure 4.10 shows that all three probes hybridise to the 10kb 
fragment indicating it was likely to comprise an intact BLG transgene in 
addition to its junction fragments The extra bands visible in the double 
transgenic liver and mammary gland after hybridisation to the 5' probe are 
due to this probe hybridising to the promoter of the BLG-Cre construct. 
10kb 'reduced' array 
'4. 
BLG-Cre transgene 	 Cr 
Figure 4.9. Probes and structures of transgenes. If the reduced array 
contains an intact BLG transgene then all three probes (5' probe orange box, middle 
probe green box, 3' probe yellow box) would hybridise to the 10kb fragment. 
Ec0RV sites are represented as red arrows, the loxP site is represented by a red 
triangle. The BLG-Cre transgene contains 4.2kb of the BLG promoter including the 
first exon (black line and white box). The 5' probe will also hybridise to the BLG-
Cre. If the BLG-Cre is a head to tail array the expected band would be 
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Figure 4.10. 	Multiple probing of Ec0RV digestion of lox 4 double 
transgenic DNA compared with lox 4. 10ig liver (L) or mammary (M) DNA 
was digested with EcoRV, electrophoresed and blotted to Zetaprobe membrane, 
and then sequentially probed with a 5', middle and 3' BLG fragment. +1+ indicates 
an animal containing both lox 4 and Cre transgenes, +1- indicates an animal 
containing only the lox 4 transgene. Red arrows indicate fragments (7kb, 6kb, 3kb) 
generated by the BLG-Cre transgenes. 
As far as could be determined by Southern blotting it appears that the 
lox4/Cre animals do have an intact transgene copy present in the reduced 
array. Attempts to clarify the results further were all hampered by the 
contaminating presence of unreduced arrays from cells in the mammary 
gland that did not express Cre recombinase. Techniques including building 
a lambda library for screening and cloning out the reduced array as well as 
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long range PCR were not possible due to the fact that identical copies of the 
transgene exist in the DNA, making it difficult to distinguish between the 
two arrays by these means. The Southern blotting cannot however, rule out 
the possibility of more subtle rearrangements or mutation of the lox 4 
'reduced array' which may inactivate the transgene. 
By EcoRV digestion there was a reduction in intensity of the parental 
array of double transgenic lox 5 and 9 animals. However, 5', 3' and middle 
probes all failed to detect any presence of a 'reduced' fragment in double 
transgenic lox 5 or 9 animals. There was also no smear effect to indicate 
multiple transgene arrays of different sizes. However, the use of 0.8% 
agarose gels may have precluded the identification of 3-4 copy reduced 
arrays, as these would be trapped within the parental array. The use of this 
type of gel electrophoresis cannot, therefore, formally exclude the existence 
of 'reduced' arrays. 
4.2.3 Expression Analysis 
4.2.3.1 In situ hybridisation 
Having analysed, as far as possible, the double transgenic animals for 
copy number reduction, the animals were then analysed for expression. To 
determine the cellular pattern of the transgene expression after the reduction 
of copy number in the mammary gland, in situ hybridisation was carried out 
as described in 2.8. 
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As with the in situ analysis discussed in Chapter 3, non-transgenic 
mammary gland was found to be negative for BLG expression, while 
expressing -casein in a uniform manner. Sections from the double lox/Gre 
transgenics or their lox sibs probed with sense probes had no signal 
associated with them (as seen in figures 4.13, 4.16, 4.19), indicating non-
specific hybridisation did not occur. 
Sections from reduced lox 4/Gre animals showed no BLG expression 
by light or dark field microscopy even after prolonged exposures of up to 6-8 
weeks (figure 4.11 and figure 4.12). -casein was still expressed uniformly as 
expected, therefore indicating the mammary gland still had the ability to 
express a milk protein gene in the normal manner. Although no completely 
positive alveoli was found in any lox 4/Gre animal, very rarely, some 
apparently partially expressing alveoli were found in lox 4/Gre animals. 
However, there was no consistent pattern of these dots of expression 
between sequential slides, it is most likely that these dots represent very low 
level background, rather than genuine expression. Sibs that contained only 
the lox transgene showed the parental variegated expression pattern, i.e. 
approx 50% of the mammary gland expressed. However, as the single lox 
sibs are of the same generation as the double transgenic animals, this 
indicated that the silencing in this case was not a progressive silencing of the 
array over generations, but was due to the presence of the Gre recombinase 
and therefore the reduced copy number. 
Sections from reduced lox 5/Gre animals showed only small patches of 
BLG expression (figure 4.14). The single lox 5 sibs mirrored the expression 
pattern seen in the parental lines, indicating that the reduction in the number 
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of cells expressing was due to the effects of Cre recombinase. The previously 
uniform lox 5 line now showed a high number of cells which were silenced. 
In figure 4.14, some of the alveoli are only weakly positive for 3-casein. 
When photographed by dark field (figure 4.15), all of the alveoli in that 
section showed expression of -casein as indicated by the even spread of the 
black mRNA stain in panel A and the yellow paint of panel C (composite 
image of dark and light field). This section however, when probed with BLG 
showed no patches of expression (panel D or F). This apparent variegation 
of f3-casein found by light microscopy may be an artefact of the in situ 
process, due to different areas being more firmly adhered to the slide, 
washing being different across a slide, or the amount of cells within a given 
area. Light microscopy is unable to detect lower levels of silver grain s 
compared with dark field microscopy, and this may also account for the 
differences seen between figures 4.14 and 4.15. 
Sections from reduced lox9/Cre animals showed that only small 
patches of the mammary gland expressed BLG mRNA (figure 4.17 and figure 
4.18). The patches of expression were often quite isolated and only 2-3 
patches were seen on any one section. As with the other two lines, when 
single transgenic lox 9 sibs were analysed they mirrored the parental lines 
pattern of expression, in this case as variegated expression. As with lox 5 / 
Cre animals the section of tissue probed with -casein showed variation 
between alveoli in the intensity of staining under light microscopy. 
However, other sections when examined under dark field show overall 
expression of -casein as depicted by the yellow paint showing where the 
reflective silver grains were found in figure 4.18 (panel C). 
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The in situ results did not fit with the hypothesis that the reduction in 
copy number would produce an increase in expression due to the removal of 
repeat sequences. These results are also in contrast with published work on 
the relationship between copy number and variegation (Garrick et al 1998). 
In fact, in all three lines with the expression of Cre recombinase there was a 
reduction in expression. Lox4/Cre animals had been shown, as far as 
possible that there was an intact copy of the transgene present. However, 
the data from the Southern blotting could not rule out that there was small 
rearrangements or mutations in the transgene which could have functionally 
inactivated the transgene. When the in situ results from double transgenic 
animals of lox 5 and 9 is considered in light of the Southern blotting data 
from these animals, the patchy expression may be explained as the deletion 
of transgenes by Cre recombinase in a variegated manner. 	The few 
remaining alveoli expressing BLG may represent cells that have failed to 
express Cre recombinase, leaving an intact parental array. 	The non- 
expressing cells may represent cells where deletion of some copies has 
produced a 'reduced' array of possibly 3-4 copies which no longer express, 
and which are not detectable using conventional agarose gel electrophoresis. 
Indeed the published data on the BLG-Cre line used in these experiments 
could not formally exclude the possibility that a small percentage of 




Figure 4.11. In situ hybridisation analysis of mRNA expression 
patterns in lox4/Cre. (A) 13-casein, (B) BLG. Photographs were taken 
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Figure 4.12. 	Dark field imaging of in situ hybridisation of 
Lox4ICre. 	(A,B,C) probed with 3-casein. (D,E,F) probed with BLG. 
Photographs were taken after 6 weeks exposures using a xlO objective. (A) 
and (D) are light field images. (B) and (D) are dark field images. (C) and (F) 
are composite images of both light and dark field with the silver grains being 




Figure 4.13. Control in situ hybridisation of Lox 4/Cre. (A,B,C) 
probed with sense probe. Photographs were taken after 6 weeks exposures 
using a xlO objective. (A) is a light field image. (B) is a dark field image. 
(C) is a composite image of both light and dark field with the silver grains being 
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Figure 4.14. 	In situ hybridisation analysis of mRNA 
expression patterns in lox5ICre. 	(A) -casein, (B) BLG. 
Photographs were taken after 4 week exposures using a xlO objective. 
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Figure 4.15. Dark field imaging of in situ hybridisation of Lox 
5/Cre. 	(A,B,C) probed with 13-casein. (D,E,F) probed with BLG. 
Photographs were taken after 4 weeks exposures using a xlO objective. (A) 
and (D) are light field images. (B) and (D) are dark field images. (C) and (F) 
are composite images of both light and dark field with the silver grains being 






Figure 4.16. Control in situ hybridisation of Lox 5/Cre. (A,B,C) probed 
with sense probe. Photographs were taken after 4 weeks exposures using a xlO 
objective. (A) is a light field image. (B) is a dark field image. (C) is a composite 
image of both light and dark field with the silver grains being represented with a 
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Figure 4.17. 	In situ hybridisation analysis of mRNA 
expression patterns in Iox9ICre. 	(A) 13-casein, (B) BLG. 
Photographs were taken after 4 week exposures using a x4 objective. 
Bar represents 750m. 
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Figure 4.18. 	Dark field imaging of in situ hybridisation of Lox 
9/Cre. 	(A,B,C) probed with 13-casein. (D,E,F) probed with BLG. 
Photographs were taken after 4 weeks exposures using a xlO objective. (A) 
and (D) are light field images. (B) and (D) are dark field images. (C) and (F) 
are composite images of both light and dark field with the silver grains being 





Figure 4.19. Control in situ hybridisation of Lox 9ICre. (A,B,C) 
probed with sense probe. Photographs were taken after 4 weeks exposures 
using a xlO objective. (A) is a light field image. (B) is a dark field image. 
(C) is a composite image of both light and dark field with the silver grains being 
represented with a yellow paint. Bar represents 300p.m. 
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As with the in situ analysis in Chapter 3, the amount of cells 
expressing BLG was quantified. Alveoli were scored according to the 
amount of area seen to be expressing BLG RNA; negative when no cells in 
the alveolus expressed, -1+ when there was partial expression from an 
alveolus, and positive when all the cells in an alveolus expressed. Figures 
giving the percentages of alveoli in each group are given in table 4.1. A 
dotplot of the combined positive alveoli for the double transgenic animals is 
compared to values for the parental lox lines (figure 4.20). 








GB 7.1 Lox 4/Cre 100 0 0 
GB 7.4 Lox 4/Cre 100 0 0 
GB 6.7 Lox 4/Cre 99.9 0.1 0 
GB 6.11 Lox 4/Cre 98.9 1.1 0 
GB 7.8 Lox 4/Cre 98.9 1.1 0 
GB 2.14 Lox 5/Cre 98.9 0.9 0.2 
GB 2.8 Lox 5/Cre 95.6 3.8 0.6 
GB 2.15 Lox 5/Cre 95.0 5.0 0 
GB 2.1 Lox 5/Cre 94.3 5.6 0.1 
GB 2.3 Lox 5/Cre 81.8 18.1 0.1 
GB 11.7 Lox 9/Cre 97.7 2.3 0 
GB 11.6 Lox 9/Cre 97.6 2.4 0 
GB 9.1 Lox 9/Cre 88.6 10.8 0.6 
GB 11.1 Lox 9/Cre 82.6 14.9 2.5 
GB 11.2 Lox 9/Cre 79.3 19.4 1.3 
Table 4.1. BLG expression values of double transgenic animals by in 
situ hybridisation. Ten fields per section and two sections for each animal were 
counted to derive a percentage for the three categories. 
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percentage of alveoli either partially or fully positive 
Figure 4.20. Dotplot comparing double transgenic animals with the parental lox lines. Each dot represents an animal. 
The percentage alveoli that were counted partial or fully positive were combined to give an overall view of the total expression from the 
mammary gland. 
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The counts were analysed using GenStat software to produce Table 
4.2 combining the values of alveoli counted as partly positive and those fully 
positive. Standard deviations (s.d.) and coefficient of variance are both 
measures of the amount of variablitity within a group i.e. the differences 
between individuals from the same transgenic line. 




Lox 4/Cre 0-1.1 5 0.5 0.6 124.3 
Lox 5/ Cre 1.1-18.2 5 6.9 6.6 95.8 
Lox 9/Cre 2.3-20.7 5 10.9 8.4 77.6 
Table 4.2. 	Statistical analysis of double transgenic in situ counts. 
Range is given as a percentage of the total alveoli which had some expression, n = 
number of animals per line, s.d. standard deviation, c.v. = 100 x s.d. / mean. 
It can be seen from table 4.2 that all the lines now show variation in 
expression between cells. Lox 5 had previously been uniform but after Cre 
recombinase expression, its mean value had dropped from 100% to 6.9% and 
had a high level of variation between individuals within the line. The 
percentage of expression in lox 5/Cre is similar to the percentage of cells that 
were calculated to have failed to undergo recombination in lox 4/Cre (figure 
4.5). This supports the theory that the patches of expression seen in lox 
5/Cre and lox9/Cre are due to unrecombined cells, which have retained the 
parental array and therefore express BLG. The other cells, although no 
'reduced' array was found, may not express from a possible 3-4 copy array, 
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leading to the patches of expression from unrecombined cells next to 
'reduced' but silent cells. 
Statistical analysis was carried out between the parental lox lines and 
the double transgenic lines to determine if there was a statistical difference 
between them (table 4.3). It is clear that there is a statistical difference in 
percentage of expressing alveoli between the parental and reduced lines in 
all three cases, with the lox4/Cre group showing the highest significance due 
to its large decrease in expression. 
Comparison 	Statistical significance 
P value 
Lox 4 to Lox 4/Gre 0.006 
Lox 5 to Lox5/Gre 0.036 
Lox 9 to Lox 9/Cre 0.036 
Table 4.3. 	Statistical probability analysis of parental and reduced 
lines. The two lines (parental and reduced) were compared for the percentage of 
total alveoli counted as positive using the Mann-Whitney test (a non-parametric 
test) to calculate the statistical probability. 
4.2.3.2 Northern blots analysis 
Northern blots were carried out to determine if the levels of 
expression shown by in situ analysis was mirrored in total RNA isolated from 
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mid-lactation mammary tissue. However, no BLG RNA was detected from 
the double transgenic animals even after long exposures. 	It must be 
considered that the in situ hybridisations had to be exposed for upto 8 weeks 
to produce a signal and it is therefore unlikely that northern blots would be 
sensitive enough for the amount of expression found in the reduced animals. 
4.2.3.3 Milk protein analysis 
SDS-PAGE analysis was used to determine if BLG protein was present 
in the double transgenic animals. Mouse milk samples were prepared as 
described (see 2.7.1) and were loaded at 1/200 or 1/100 dilutions along side 
ovine BLG standards. 	Single transgenic sibs showed levels of protein 
comparable to the animals analysed in chapter 3. Double transgenic animals 
from lox 4, 5 and 9 showed no detectable levels of protein by Coomassie 
staining (figure 4.21 shows lox 9/Gre animals). 
Western blots were carried out to determine if any detectable protein 
was present in the milk samples from the reduced animals. The detection 
level of Western blotting is approximately 1-10ng of protein, compared to 0.1 
- 0.5.tg per track with Coomassie Blue staining (Harlow and Lane 1988). 
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Figure 4.21. 	SDS-PAGE analysis of lox9/Cre milk proteins. Mouse milk samples were electrophoresed in 18% 
polyacrylamide gels under reducing conditions and stained with Coomassie Blue. M indicates Rainbow marker (BioRad). - 
ye indicates a 1/100 dilution of defatted control non-transgenic mouse milk sample. 1/100 dilutions of defatted milk from 
transgenic animals from lox 9/Cre animals and a lox 9 only animal (GBI 1.5) was loaded along side standards of BLG. 
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When milk samples from reduced animals were Western blotted there 
was a band present in only one reduced lox9/cre animal (GB9.1), but the 
signal was substantially weaker than the 0.1jg standard (figure 4.23). 
However, it must be considered that this was a 1/50 dilution, as compared to 
Westerns of the parental lox lines (figure 3.33) which were 1/200 dilutions. It 
is of note that GB11.1 had more positive cells by quantification of in situ, but 
it failed to produce a band by Western blotting. The absence of bands from 
the other animals shown to have limited expression by in situ, draws into 
question the validity of the band of GB 9.1. It may be that this is a false 
positive, however to confirm this more blotting would be required. The 
Western blotting and SDS-PAGE results both indicate that the reduction in 
the percentage of cells expressing has led to a dramatic decrease or complete 
abolishment of production of BLG protein 
BLG standards 




Figure 4.22. Western blot of milk proteins from double transgenic 
animals. 1/50 dilutions of milk protein samples were run on a SDS-PAGE gel, 
electroblotted to nitrocellulose and probed with rabbit anti - BLG and then HRP 
conjugated anti rabbit lgG. The BLG standards are in tg. The putative positive 
lane is indicated by a black arrow. 
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4.3 CONCLUSIONS 
The use of a BLG driven Gre recombinase resulted in double 
transgenic animals that had reductions in copy number of the BLG-loxP 
transgene. This was however, a mosaic pattern of deletion as some of the 
cells in the mammary gland do not express the Gre transgene. Previous 
studies have shown that the BLG-Cre is restricted to mammary epithelial 
cells (Selbert et al 1998). The breeding strategy used to cross BLG-loxP and 
BLG-Cre animals had resulted in a decrease in intensity of the parental array 
in all three lines. This was specific to the mammary gland and did not occur 
in sibs that contained only the BLG-loxP transgene. 
All the lines showed a decrease in intensity of the parental array, 
however only one line lox 4, contained a distinct fragment consistent with the 
presence of a reduced array containing an intact BLG transgene. Multiple 
probing of Southern blots indicated that it hybridised to both promoter 
sequence and parts of the coding sequence, suggesting that it was a single 
copy intact transgene. However, the Southern blotting data is unable to 
formally exclude the possibility of more subtle rearrangements or mutations 
which may have functionally inactivated the transgene. 
In the other two lines lox 5 and 9, although they showed a decrease in 
intensity of the parental array, no fragment consistent with a single copy 
transgene was found in any of the these double transgenic animals. One 
possibility was that the Cre recombinase was producing different sized 
reduced fragments in different cells. However, the Southern blotting data 
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does not show a smear to indicate that this is the case. One interpretation is 
that a complete deletion of the BLG-loxP array has occurred in Cre 
expressing cells, which would account for the decrease in intensity of the 
'parental array' and the lack of a 'reduced array'. Alternatively the lox 5 and 
9 animals may have undergone limited deletion to 3-4 copies. These would 
not have been identifiable from the Southern blots used in this chapter due to 
the resolution point of the agarose gels. 
The hypothesis for this project was that high copy number arrays 
often variegate and that a reduction in their copy number should lead to 
uniform and higher expression. This was not the case. The reduction in 
copy numbers led to a reduction in the number of cells expressing BLG 
mRNA at the in situ level. In fact with less copies present, a previously 
uniform line now expressed in a variegated manner. This was unexpected 
and was contrary to published work on reducing copy numbers (Garrick et al 
1998). The reduction in copy number also correlated to a decrease in the 
level of protein whereby no protein was detectable by Coomaisse staining of 
SDS-PAGE. Only one reduced animal showed expression by Western 
blotting. However, given that animals with comparable expression by in situ 
hybridisation did not show expression by Western blotting, it seems possible 
that this is an artefact and not a true positive. 
There are a number of possible explainations for this increase in 
silenced cells which can be thought of as technical or biological reasons for 
the result. 
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Technical explanations include the possibility that the transgenes have 
been rearranged. In lox 4/Cre, no expression was found. Lox 4/Cre was the 
only line that had a demonstrated fragment consistent with the presence of a 
single intact BLG transgene. The Southern blotting data could not however, 
formally prove the existence of a functional transgene within the 10kb RV 
locus. Thus it is a possibility that this 10kb RV locus has been rearranged or 
mutated. 
In lox 5 and 9 lines after Cre expression there was no data to support 
the existence of a 'reduced array'. It is therefore possible that in these 
animals there has been complete deletion or partial deletion of the transgene 
to a small array. Without the use of PFGE to resolve fragments of 20- 40kb, 
it cannot be stated that small reduced arrays do not exist in these cells. The 
areas of BLG expression could be explained as a failure to undergo Cre 
mediated recombination in these cells. This would mean that the expression 
of the BLG-Cre itself had been variegated. The BLG-Cre 74 line had been 
analysed previously, and had shown uniform Cre expression. However, the 
possibility that some of the epithelial cells did not undergo recombination 
was not formally exclude (Selbert et al 1998). No in situ hybridisation on the 
Cre expression pattern of the double transgenic animals was carried out in 
this study. Previous immunohistochemistry provide unreliable in detecting 
Cre expression (Selbert et al 1998), and as the use of in situ PCR would not 
have been informative in this study it was not carried out. 
Another technical reason could be that the reduction had removed 
only the active copies. 	There is no published evidence on how Cre 
recombinase removes sequences between multiple loxP sites; i.e. sequentially 
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or by removing the DNA between the extreme loxP sites in one reaction, so it 
may be possible that only active copies are removed. However, the patches 
of expression in lox5/Cre and lox9/Cre animals would mean that in some 
cases active copies were left behind, while in other cells the active copies had 
been rearranged. This would mean that were different recombinations 
occurring in different cells. 
If the reason for the decrease in expression is not a technical 
explanation, 'biological' reasons may be involved. The first model suggests 
that reduction in the mammary gland is too late developmentally to rescue 
the transgene silencing. This explanation assumes that some sort of 'mark' is 
placed on the transgene and once this has occurred, alteration of the 
structure (i.e. the copy number) will have no effect. 	The patterns of 
expression by in situ suggests that the patches could be clonal in origin. This 
may suggest that the decision to silence the transgene is an early one. It 
must be considered that the mammary gland is only fully differentiated after 
pregnancy in adult females. 	BLG transgenes, including the BLG-Cre 
transgene, have been shown to be regulated coordinately with endogenous 
mouse milk genes, with their expression increasing through pregnancy to 
reach the highest level of expression during lactation (Harris et a! 1991, 
Selbert et al 1998). Hence, deletion at a late stage, i.e. when the BLG-Cre 
transgene is activated, may not overcome silencing. 
A second biological explanation is that BLG copies provide a 'buffer' 
effect, insulating a number of copies from genome silencing effects. If the 
position within the genome was suppressive to expression of the transgenes 
and this occurred by the spread of heterochromatin, then the large arrays 
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may allow some internal copies to escape this spread. If there were less 
copies then the genome effects would spread through the whole array, 
silencing the single copies left. Therefore the reduction in copy number 
would actually increase the number of cells that are silenced. 
CHAPTER FIVE 
REDUCTION OF TRANSGENIC COPY NUMBER 
BY MICROINJECTION 
5.1 INTRODUCTION 
In Chapter 4, high copy number BLG-loxP lines underwent Cre 
catalysed recombination in the mammary gland and the consequences for 
transgene expression were analysed. After reduction of copy number, the 
expression levels were lower, and the percentage of the gland that expressed 
had considerably decreased. 
Microinjections of Cre recombinase constructs or mRNA have both 
been used successfully to produce early recombinations in embryos (Araki et 
al 1995, de Wit et a! 1998). This method has an advantage over deletion in the 
mammary gland, in that all the cells within the animal should carry the 
reduced transgene array, allowing for clearer analysis without the 
contaminating presence of unreduced arrays from non-Cre expressing cells. 
The other main advantage of this is that it allows the establishment of 
reduced lines, allowing larger numbers of animals to be investigated. In 
addition, the mammary gland is a late developmental organ, and it is only 
fully developed in the adult female after pregnancy. It differentiates in 
response to a number of factors present during pregnancy and lactation 
(Hennighausen and Robinson 1998). Given that the BLG-Cre recombinase 
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expression profile is co-ordinately expressed with other milk proteins, the 
Cre expression only occurs at substantial levels in the adult mammary gland 
during lactation (Selbert et a! 1998). One possible explanation for the results 
in Chapter 4 was the reduction in copy number had occurred beyond a 
developmental checkpoint, which would allow the 'rescue' of expression 
from the reduced arrays. Work in this chapter was meant to create a 
reduction in copy number at a much earlier developmental time point, and to 
investigate the consequences of this modification on the expression pattern 
after reduction. This would be a reduction before differentiation of the 
mammary gland, which contrasts with the reduction in Chapter 4, which was 
after the tissue had started to differentiate. 
Phosphoglycerate kinase (PGK) is expressed in all somatic cells and 
has been used to drive early and uniform Cre recombinase expression (Adra 
et a! 1987, Lallemand et a! 1998). PGK-Cre was therefore chosen to produce a 
Cre catalysed reduction early in development by microinjection of a circular 
plasmid carrying the PGK-Cre construct. 
Microinjection of a circular plasmid may reduce the chances of it 
integrating into the genome. Continued Cre recombinase expression may be 
detrimental, as there are now indications that in some situations Cre 
recombinase may target pseudoloxP sites within the genome, leading to 
illegitimate recombination events to occur (Thyagarajan et a! 2000, Schmidt et 
a! 2000). This method therefore avoids any complications from continued 
Cre expression. 
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The three lines discussed in Chapter 4 were used for microinjection of 
a PGK-Cre construct; lox 4 and 9 which had variegated expression and lox 5 
which had uniform expression. Microinjected transgenic animals were 
analysed for changes in copy number by Southern blotting and lines were 
established. Expression analysis was carried out as before using in situ 
hybridisation, Northerns and milk protein analysis. 	The results are 
discussed below. 
5.2 RESULTS 
5.2.1 Analysis of copy number reduction 
Founders from the microinjection were analysed for the production of 
a 'reduced array' by EcoRV digestion, which cannot cut within the BLG-loxP 
transgene (similar to the situation in Chapter 4). A number of animals from 
the lox 4/PGK Cre line (termed PLC A) showed an EcoRV fragment, which 
when compared with lambda fragments of known size was estimated to be 
10kb in size (figure 5.1). This fragment co-migrated with the 10kb RV locus 
from Chapter 4 lox4/Cre animals. Some animals also contained longer 
fragments by EcoRV digestion (i.e. PLC A58; an estimated 17kb fragment). 
These animals were therefore likely to be mosaic for different copy number 
'reduced arrays'. This was probably due to Cre mediated recombination 
occurring after the embryo had started to divide. The larger fragments were 
thought to represent a 'reduced array' of more than one full transgene plus 
its junction fragments, due to its size. The 10kb fragment is referred to as the 
10kb RV locus, while the 17kb fragment is referred to as the 17kb RV locus. 
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Figure 5.1. Ec0RV digestion of microinjected PLC A founder mice. 
1 Ogg tail DNA from PLC A founders was digested with EcoRV, electrophoresed on a 
0.7% gel, blotted to Zetaprobe and hybridised to a 1.1kb fragment of BLG 
(described in Chapter 2). 	Lox4/Cre DNA also produced a 10kb fragment as 
described in Chapter 4. X indicates a lambda Hind Ill ladder with stated sizes. 
Four of these positive animals were used to establish lines; PLC A67, 
PLC A58 which was mosaic for two arrays, PLC A53 and PLC A23. The 
multiple arrays of PLC A58 segregated upon breeding to the next generation 
as shown later in figure 5.4. The ratio of segregations is shown in table 5.1. 
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Animal 	Generation 	Sex 	10 kb 	17kb  
EcoRV Ec0RV 
PLC A58 Founder M Yes Yes 
PLC A58.2 GI M No Yes 
PLC A58.3 GI M No Yes 
PLC A58.4 GI M No Yes 
PLC A58.5 Gi M No Yes 
PLC A58.6 GI M No Yes 
PLC A58.8 GI M No Yes 
PLC A58.11 Gi F No Yes 
PLC A58.12 GI F No Yes 
PLC A58.13 GI F Yes No 
PLC A58.15 G1 F No Yes 
PLC A58.17 G1 F No Yes 
PLCA58.18 GI F No Yes 
PLC A58.19 GI F No Yes 
PLC A58.23 Gi M No Yes 
PLC A58.25 Gi F No Yes 
PLC A58.28 GI F Yes No 
PLC A58.29 GI F No Yes 
Table 5.1. Segregation of multiple arrays. The PLC A58 founder contained 
two 'reduced arrays' which when this animal was bred to the next generation, some 
animals inherited the 10kb RV locus and some inherited the 17kb RV locus. No G1 
animal inherited both. 18 out of the 29 G1 tested were transgenic (transmission of 
62%). 
The animals were also screened for the presence of the PGK-Cre 
construct but no animals were found to have an integrated copy of the PGK-
Cre construct (data not shown). Therefore, the strategy of microinjection of a 
circular plasmid to avoid integration of the construct, appears to have been 
successful in these animals. 
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Animals from the lox 5 line microinjected with Cre were termed PLC B 
animals. Only one animal from lox 5/PGK Cre (PLC B) showed reduced 
arrays, PLC B31. The array was estimated to be approximately 17kb, which 
is equivalent to the larger arrays found in the PLC A58 and A39 animals 
(figure 5.1). Other animals appeared to have smears of fragments that may 
indicate that the Cre recombination was producing different sized arrays in 
different cells throughout the animal. 	The reduced animal was used to 
establish a line but this has presently been unsuccessful, as only one positive 
Gi animal out of 18 screened has inherited the reduced array (figure 5.2). 
The inability to produce large numbers of animals with 'reduced 
arrays' in the microinjected lox 5 animals (from 43 positive animals that had 
been microinjected only one, PLC B31, showed a 'reduced array') is 
interesting in the context of the results from Chapter 4. When lox 5 animals 
were bred to a BLG-Cre line there was no evidence of a 'reduced array' in 
any animal. However, there had been a reduction in the intensity of the 
'parental array' suggesting that reduction in copy number had occurred. 
The inability of lox 5 animals to generate 'clean' reduced arrays after Cre 
expression, suggests that there is something inherent to the original 
structure of the lox 5 array which may have produced unpredicted Cre 
mediated recombination. 
Due to the inability to establish a line of reduced animals from the 














Figure 5.2. Ec0RV digestion of PLC B GI mice. 10pg tail DNA from PLC B 
mice was digested with EcoRV, electrophoresed on a 0.7% gel, blotted to Zetaprobe 
and hybridised to a 1.1 kb fragment of BLG (described in Chapter 2). Copy controls 
were dilutions of the original microinjected 7kb BLG-loxP fragment added to I Op.g of 
non-transgenic DNA. 	—ye indicates non-transgenic DNA. X indicates a lambda 
Hindlll ladder with stated sizes. PLC B31.1 was a non-transgenic sib to the only 
reduced Gi PLC B animal, PLC B31.2. 
Similar to the majority of the lox 5/PGK Cre animals, lox 9/PGK (PLC 
C) animals showed no clear reduced array (figure 5.3). These animals 
showed complex smears of fragments. The smear may be due to different 
recombinations occurring in different cells. This may also reflect continued 
expression of Cre recombinase over a period of development allowing some 
cells to undergo several rounds of recombination. The use of a 0.7% gel may 
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have reduced the ability to resolve fragments of similar size. This 'smear' 
could theoretically represent non-specific degradation of the DNA by EcoRV. 
However, the samples of figure 5.1 were digested with the same batch of 
enzyme under the same conditions, making this seem unlikely. As with lox 
5 animals, in both types of Cre recombination (in the mammary or the 
embryo) lox 9 animals failed to produce a 'reduced array'. The structure of 
this line may mean that recombination to a single copy array is not possible. 
Due to the failure to find any animal with a 'reduced array', these animals 
were not further investigated. 
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Figure 5.3. EcoRV digestion of microinjected PLC C founder mice. 
1 Otg tail DNA from PLC C founders was digested with EcoRV, electrophoresed on a 
0.7% gel, blotted to Zetaprobe and hybridised to a 1.1kb fragment of BLG. X 
indicates a lambda Hind Ill ladder with stated sizes. 
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Southern blotting with 5', middle and 3' probes was carried out to 
determine whether the 'reduced array' fragments contained an intact BLG-
loxP transgene. If the 'reduced arrays' carried an intact transgene it would 
be predicted that all three probes would hybridise to the fragment. From 
figure 5.4, it is clear that the 10kb RV locus and the 17kb RV locus both 
hybridise to all three probes. This indicates that both the 'reduced arrays' 
contained the sequences corresponding to the transgene probes. Although 
the 10kb locus animals were derived from different founders, because they 
showed the same EcoRV pattern they were assumed to contain the same 
'reduced array'. All the 17kb RV locus animals were derived from the same 
founder. 
Putative maps of the structure of the 'reduced arrays' are shown in 
figure 5.5. However, this data could not formally exclude the possibility that 




? 40 1 
23.1kb 



















aD GD cc 
LO LO W. 
N-. 
GD < < <<< < <<<< 




_i a.QQ _j _J _I O _i 	- a.QaQ.. _J 
9.4kb 	P 
6.6kb 














	 3' probe 
Figure 5.4. Multiple hybridisations of Ec0RV digested PLC A DNA. 10 
pg of tail DNA was digested with Ec0RV, electrophoresed on a 0.7% gel, blotted to 
Zetaprobe and hybridised sequentially with 5', middle and 3' probes to BLG. 	2 
indicates a lambda Hindlil ladder with stated sizes on left hand side. The 10kb RV 
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Figure 5.5. Putative maps of Ec0RV Southern blot for 10kb RV and 17 
RV locus. If either the 10kb RV locus (a) or 17kb RV locus (b) contain a whole 
transgene they would be expected to hybridise to all three probes (5' probe: orange 
box, middle probe: green box, 3' probe: yellow box. Probes detailed in figure 3.5 
and Chapter 2). 	The red triangle represents the loxP site. 	The red arrows 
represent the EcoRV sites within the genome, and the blue arrows represent the 
SspI site within the BLG transgene (discussed in reference to figure 5.7). The sizes 
given for the arrays are those determined from figure 5.1. 
Further Southern blotting was carried out to determine more about the 
structure of the 'reduced arrays'. SspI cuts only once in the BLG-loxP 
transgene and had been used in both Chapter 3 and 4 to estimate the copy 
numbers of the transgenic lines. If there are two copies of the transgene 
present in a head to tail repeat, SspI digestion should produce a 7kb fragment 
and the transgene junction fragment. If the fully 'reduced arrays' only 
contained one transgene no repeat length fragment would be produced 
(figure 5.6). This was used to determine the structure of the BLG transgene 
in the 10kb RV locus and the 17kb RV locus (figure 5.7). 
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Figure 5.6. Diagram of production of a repeat length fragment from a 
transgenic locus (A) If there is only one transgene within the reduced array it 
cannot produce a repeat fragment. (B) If there are two or more transgenes within a 
'reduced array' in a head to tail manner it will produce a 7kb repeat fragment after 
Sspl digestion. 	The black line represents genomic sequence, the blue arrow 
represents the Sspl restriction site (there is only one within the BLG-loxP 
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Figure 5.7. SspI digestion of PLC A DNA to determine the copy number 
of the reduced array. 	10jg of liver DNA was digested with Sspl, 
electrophoresed on a 0.7% gel, blotted to Zetaprobe. Copy controls were dilutions 
of the original microinjected 7kb BLG-loxP fragment added to 10ig of non-
transgenic DNA (panel A, hybridised with the middle probe). The transgenic DNA 
was hybridised to the middle probe (panel B) or the 5' probe (panel C) described in 
figure 3.5 and Chapter 2. The blot was stripped between probes and exposed to X- 
film to confirm the removal of the original probe. 	X indicates a lambda Hindlll 
ladder with stated sizes. The 6kb is a presumed junction fragments. The 5.5kb 
fragment is thought to be an internal truncated fragment as discussed in figure 5.9. 
From figure 5.7 the SspI digestion shows that the 10kb RV locus does 
not contain a repeat length fragment. This also correlates with its EcoRV size 
(figure 5.1 and 5.5), if there were two transgenes within the EcoRV fragment 
it would be predicted to be above 14kb (the transgene is 7kb long). This 
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confirms that there are less than two intact copies of the transgene present in 
the array, as the repeat length fragment is only present when at least two 
input transgenes integrate in a head to tail array. The 6kb Sspl fragment 
hybridises to both the 5' probe and the middle probes. The Sspl site cuts 
5.4kb from the 5' end of the BLG transgene. Therefore, the fact that the SspI 
fragment is longer than 5.4kb suggests that it contains the whole transgene 
fragment up to the Sspl site as well as some genomic sequence. This is 
shown in figure 5.8. 
5.4 kb of transgene 
from 5' to Sspl site 
10 
BLG transgene 
6kb Sspl fragment 
Figure 5.8. Putative model to account for the 6kb Sspl fragment from 
10kb RV locus animals. The reduced transgenic locus was originally defined by 
the size of the EcoRV fragment (genomic EcoRV sites are represented by red 
arrows, the lox P site is represented by red triangle). Within this, there is a BLG 
transgene which contains only one Sspl site 5.4kb from the extreme 5' end of the 
transgene (blue arrow). Sspl digestion produces a 6kb fragment from the 10kb RV 
locus (double headed black arrow). This 6kb fragment hybridises to both the 5' 
probe and the middle probe (orange and green boxes, probes described in figure 
3.5 and Chapter 2). As the Sspl fragment is longer than 5.4kb this suggests that 
the transgene is intact from the 5' to the Sspl site. 
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Animals containing the 17kb RV locus (i.e. PLC A58.8) showed that 
they had a 7kb repeat length fragment from SspI digestion (figure 5.7). The 
presence of one intact transgene is confirmed by the presence of a repeat 
length fragment. This indicates that there may be at least two transgenes 
present in a head to tail array. Comparisons between the intensity of the 
repeat fragment and the 6kb fragment shows that they are of comparable 
intensity. If the 6kb fragment represents a junction fragment, given that 
junction fragments are presumed to exist only as a single copy per genome, 
this suggests that there is only one repeat unit present in the array. 
In figure 5.7, the 5.5kb fragment is also lost after the Cre reduction, 
which may indicate that within the array there exists a truncated copy of the 
transgene that is removed upon Cre recombination. A model of a possible 
structure to account for this is shown in figure 5.9. 
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1*---* 
Junction a 	repeat 	truncated 	repeat 
Figure 5.9. Possible structure of lox 4 transgenic loci. If there was a 
truncated transgene (red box) that still contained the SspI site (blue arrow) and a 
IoxP site (red triangle) then after Cre mediated recombination it would be completely 
removed. This would leave junction a, and a repeat length fragment if the array 
contained more than one complete 7kb transgene. The green box represents the 
middle probe used for figure 5.7. 
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5.2.2 Long Range PCR 
Although the data from figure 5.7 suggested that there was an intact 
transgene present within the 'reduced array', more work was carried out to 
confirm the integrity of the transgenes within the 10kb RV locus and the 17kb 
RV locus. Long range PCR was used to determine if there was a continuous 
7kb intact BLG-loxP transgene present within the reduced arrays. If there 
was a PCR product this method could also provide the possibility of cloning 
the product allowing it to be analysed further. The cloned PCR product 
could be sequenced to determine if it was rearranged or mutated. 
Alternatively it could be used in transient transfections of mammary cells in 
vitro to formally prove if it was still capable of expressing after being reduced 
by Cre recombinase. 
Primers were designed for the extreme ends of the 7kb BLG-loxP 
injection fragment (figure 5.10) and long range PCR was carried out on the 
10kb RV locus and the 17kb RV locus. PCR was also carried out on the 
original microinjection 7kb fragment, lox 4 parental DNA, and double 
transgenic lox4/Cre DNA. Distilled water and negative DNA were used to 
control against contamination. If the array contained an intact BLG-loxP 
transgene, a 7kb fragment would be predicted as the product. 
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GAATTCGAGCTCGGTACCCTCCCTTCA 
BLG-loxP 7kb transgene 
CAAGCCACGCGTCCGAAGAGAGAT 
Figure 5.10. Primers used for long range PCR of reduced array DNA. 
The red arrow represents the 5' junction primer, which was designed to prime from 
12bp from the 5' end of the transgene sequence. The green arrow represents the 
3' primer which was designed to prime 79bp from the 3' end of the transgene. The 
sequence of the primers is given beside the arrows. 
A 7kb fragment was derived from the 17kb RV locus, but no visible 
product was produced by the 10kb RV locus. The PCR products were also 
blotted to determine if there was low-level product but no fragment was 
detected from the 10kb RV locus (figure 5.11). 
The failure to successfully PCR a 7kb fragment from the 10kb RV locus 
suggests that this 'reduced array' does not contain an intact BLG-loxP 
transgene. Interestingly no 7kb product was found from lox 4/Cre double 
transgenic DNA (GB6.7; figure 5.11). 	This may indicate that the 10kb 
'reduced array' in Chapter 4 also did not contain an intact transgene. 
Although the Southern blotting with the 10kb RV locus was consistent with 
the 'reduced array' containing all the BLG transgene sequence it is possible 
that the 'reduced array' does not contain an intact transgene. However, the 
17kb RV locus does appear to contain an intact BLG-loxP transgene, not only 











































Figure 5.11. Long Range PCR on reduced transgenic DNA. (a) Ethidium 
bromide staining of long range PCR products. (b) Southern blot of the same gel 
showing hybridisation of a 1.1kb fragment to the 7kb PCR product in 17kb RV locus 
DNA. . indicates a lamda Hindlil ladder with stated sizes. 	Distilled water and 
negative DNA are used as a control against PCR contamination. BLG-loxP refers 
to the plasmid used to derive the BLG-loxP transgene. The 7kb fragment was the 
original microinjected fragment. Mammary DNA was used from lox 4, a lox4/Cre 
double transgenic (GB6.7) and either 10kb RV or 17kb RV locus animals. 
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5.2.3 Expression Analysis 
5.2.3.1 In situ hybridisation 
To determine the cellular pattern of the transgene expression after the 
reduction of copy number by microinjection of Cre recombinase, in situ 
hybridisation was carried out as described in 2.8. 
Controls against background (sense RNA probes) and negative 
mammary section were always negative for BLG expression even when 
photographed using dark field microscopy (figures 5.14 and 5.17), indicating 
as in other chapters there was no non-specific hybridisation. 
Sections from 10kb RV locus animals showed only occasional spots of 
BLG expression (figure 5.12). These spots covered only single cells and were 
found very infrequently. Figure 5.12 represents the strongest collection of 
dots found in any section of the 10kb RV locus animals analysed. During in 
situ hybridisation sequential sections were placed on a slide so that for each 
probe there were two sections per slide. In previous experiments with the 
lox lines there was always a consistent pattern between the sequential 
sections. This was not the case in these animals, the patterns of dots was not 
mirrored between sections, indicating that it may be an artefact of the in situ 
technique rather than genuine expression of the transgenic mRNA. Figure 
5.13 shows that in another area of section no BLG expression could be found 
by dark field microscopy. 
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A. 
Figure 5.12. In situ hybridisation analysis of mRNA expression 
patterns in a 10kb RV locus animal. (A) 3-casein, (B) BLG. Photographs 
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Figure 5.13. Dark field imaging of in situ hybridisation of 10kb RV 
locus tissue. 	(A,B,C) probed with 13-casein. (D,E,F) probed with BLG. 
Photographs were taken after 2 weeks exposures using a xlO objective. (A) 
and (D) are light field images. (B) and (D) are dark field images. (C) and (F) 
are composite images of both light and dark field with the silver grains being 




Figure 5.14. Control in situ hybridisation of 10kb RV locus tissue. 
(A,B,C) probed with sense probe. Photographs were taken after 6 weeks 
exposures using a x1  objective. (A) is a light field image. (B) is a dark field 
image. (C) is a composite image of both light and dark field with the silver 
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Figure 5.15. In situ hybridisation analysis of mRNA expression 
patterns in a 17kb RV locus animal. 	(A) 3-casein, (B) BLG. 
Photographs were taken after 6 week exposures using a xlO objective. 
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Figure 5.16. Dark field imaging of in situ hybridisation of 17kb RV 
locus tissue. 	(A,B,C) probed with 3-casein. (D,E,F) probed with BLG. 
Photographs were taken after 2 weeks exposures using a xlO objective. (A) 
and (D) are light field images. (B) and (D) are dark field images. (C) and (F) 
are composite images of both light and dark field with the silver grains being 




Figure 5.17. Control in situ hybridisation of 17kb RV locus tissue. 
(A,B,C) probed with sense probe. Photographs were taken after 6 weeks 
exposures using a AO objective. (A) is a light field image. (B) is a dark field 
image. (C) is a composite image of both light and dark field with the silver 
grains being represented with a yellow paint. Bar represents 300 jim. 
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Figure 5.18. In situ hybridisation of sequential sections in a 
17kb RV locus animal. Both sections were probed with BLG. 
Photographs were taken after 2 week exposures using a xlO 
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Figure 5.19. 	Dark field imaging of in situ hybridisation of 
sequential sections from a 17kb RV locus animal. (A,B,C) probed 
with BLG. (D,E,F) probed with BLG. Photographs were taken after 2 weeks 
exposures using a xlO objective. (A) and (D) are light field images. (B) and 
(D) are dark field images. (C) and (F) are composite images of both light and 
dark field with the silver grains being represented with a yellow paint. Bar 
represents 300pm. 
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By contrast, sections from 17kb RV locus animals showed patches of 
expression (figure 5.15). These patches of expression were also visible by 
dark field microscopy (figure 5.16). 	The pattern was consistent across 
sequential sections indicating that the expression was genuine (figures 5.18 
and 5.19). These patches of expression were found in all of the 17kb RV 
locus animals examined (n=6). The dark spotting in figure 5.15 under light 
field may be due to clumps of cells that have become more heavily 
counterstained. This effect is not seen under dark field (figure 5.16). 
Like the results discussed in Chapter 4 this result contradicts published 
work (Garrick et al 1998). The finding that the 10kb RV locus are silent while 
17kb RV locus shows only limited patchy expression may suggest that there 
is a requirement for more than one BLG transgene at this genomic location to 
allow expression. The alternative explanation for the lack of expression from 
the 10kb RV locus is because it is functionally inactivated. However, the 
17kb RV locus by Southern blotting and PCR analysis appears to show an 
intact transgene and it is still expressing at a much lower level than the 
parental lox 4 line. It is clear that this BLG transgene at this genomic location 
expresses more efficiently as a multicopy array rather than a two copy array. 
As with the in situ analysis in Chapter 3 and 4, the amount of cells 
expressing BLG was quantified. Alveoli were scored according to the 
amount of area seen to be expressing BLG RNA; negative when no cells in the 
alveolus expressed, -/+ when there was partial expression from an alveolus, 
and positive when all the cells in an alveolus expressed. Figures giving the 
percentages of alveoli in each group are given in table 5.2. The rare spots 
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from the 10kb RV locus animals was taken to represent background and these 
animals were not used for quantitative analysis. 
The counts were analysed using GenStat software to produce Table 5.3 
combining the values of alveoli counted as partly positive and those fully 
positive. Standard deviations (s.d.) and coefficient of variance are both 
measures of the amount of variability within a group i.e. the differences 
between individuals from the same transgenic line. 
Animal ID Status Negative Partly Positive 
PLCA58.11 17kb RV locus 93.2 5.4 1.4 
PLCA58.12 17kb RV locus 93.7 5.3 1.0 
PLCA58.15 17kb RV locus 95.5 4.1 0.4 
PLCA58.17 17kb RV locus 99.3 0.6 0.1 
PLCA58.18 17kb RV locus 95.4 4.6 0.0 
PLCA58.19 17kb RV locus 98.5 1.4 0.1 
PLCA58.25 17kb RV locus 92.0 6.9 1.1 
Table 5.2. BLG expression values by in situ hybridisation of 17kb RV 
locus animals. Ten fields per section and two sections for each animal were 
counted to derive a percentage for the three categories. The status refers to the 
type of 'reduced array' carried by the animal. 
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17kb RV locus 0.7-8.0 7 4.6 2.7 58.7 
Table 5.3. 	Statistical analysis of 17kb RV locus transgenic in situ 
counts. Range is given as a percentage of the total alveoli which had some 
expression, n = number of animals per line, s.d. standard deviation, c.v. = 100 x s.d. 
/ mean. 
The range of total positive alveoli (partial or complete) for the 17kb RV 
locus animals is shown graphically in figure 5.20. It also compares the 
'reduced array' animals to the parental lox 4 line. There is a significant 
decrease from the parental lox 4 line which expressed in approximately 50% 
of the alveoli, to the 17kb RV locus animals which all express at less than 10% 
of the alveoli. The 10kb RV locus animals only expressed at less than 1% of 
the alveoli counted, which is more consistent with background rather than 
genuine expression. 
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Figure 5.20. Dotplot comparing the 17kb RV locus reduced animals 
with the parental lox line. Each dot represents an animal. The percentage 
alveoli that were counted partial or fully positive were combined to give an overall 
view of the total expression from the mammary gland. 
W. 
The microinjected lines were statistically compared with the parental 
line lox 4 to see if there were differences. 	There is a strong statistical 
difference (p=0.003) between the parental lox 4 line and the 17kb RV locus 
animals in the percentage of alveoli that express the transgene. 
5.2.3.2 Northern blots analysis 
Northern blots were carried out to determine whether or not 
the levels of variegation shown by in situ analysis was mirrored in total RNA 
isolated from mid-lactation mammary tissue. As with the case of the double 
transgenic animals in Chapter 4, no BLG RNA could be detected by this 
method. 
5.2.3.3 Milk protein analysis 
SDS-PAGE analysis was used to determine if these reduced animals 
expressed BLG at the protein level. Mouse milk samples were prepared as 
described (see 2.7.1) and were loaded at 1/250 or 1/100 dilutions along side 
ovine BLG standards. Reduced transgenic animals from PLC A lines showed 
no detectable levels of protein by Coomassie staining (figure 5.21) or silver 
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Figure 5.21. SDS-PAGE analysis of PLC A milk proteins. Mouse milk samples were electrophoresed in 18% polyacrylamide 
gels under reducing conditions and stained with Coomassie Blue. -ye indicates a 1/250 dilution of defatted control non-transgenic 
mouse milk sample. 1/250 dilutions of defatted milk from from either 10kb RV or 17kb RV locus transgenic animals was loaded along 
side standards of BLG. 
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As discussed in Chapter 4 the lowest level of protein detectable by 
Coomassie staining is approximately 0.1.ig, while the lowest detection level 
of silver staining is approximately 1 —10 ng (Harlow and Lane 1988). 
Western blots were carried out to determine if any detectable protein 
was present in the milk samples from the reduced animals. No protein was 
found in any 10kb or 17kb RV locus animal even when a 1/50 dilution of milk 
was used (figure 5.22). Therefore if any BLG protein was present it must be 
below the detection level of Western blotting (approximately ing; Harlow 
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Figure 5.22. Western blot of milk proteins from 17kb RV locus animals. 
1/50 dilutions of milk protein samples were run on a SDS-PAGE gel, electroblotted 
to nitrocellulose and probed with rabbit anti - BLG and then HRP conjugated anti 
rabbit IgG. The BLG standards are in g. 
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5.3 CONCLUSIONS 
The microinjection of Cre recombinase had led to a decrease in the 
number of copies of the transgene throughout the animal. In animals from 
the lox 4 lines there were obvious 'reduced arrays' corresponding to a 10kb 
RV locus, a 17kb RV locus and larger arrays. When animals were bred for 
either the 10kb RV locus or the 17kb RV locus no 'parental array' was found, 
indicating that these Gi animals carried only one type of array in all their 
cells. The PGK-Cre construct was not detected in any of the 'reduced array' 
animals indicating it had failed to integrate. 
The multiple probing of EcoRV southern blots showed that both the 
10kb and 17kb RV loci hybridised to the promoter and coding sequence of 
the transgene. This suggested that there was an intact copy of the BLG-loxP 
transgene in both 'reduced arrays'. When SspI digests were carried out, the 
17kb RV locus showed that it had an intact repeat fragment. Therefore as far 
as could be shown by Southern blotting, the 17kb RV locus had an intact 
transgene fragment. 
Although the 10kb RV locus hybridised to all the transgenic probes 
used, the Southern blotting data could not confirm the presence of an intact 
transgene in these animals. The remaining fragment after Cre recombination 
(6kb by SspI disgestion) hybridised to both the 5' probe and an internal 
probe. This fragment is large enough to include all the transgene from its 5' 
end to the SspI site (the distance between the 5' end and the SspI site is 
5.4kb). The failure to produce a 7kb product from PCR of the 10kb RV locus 
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may indicate that there are rearrangements or deletions of the transgene, 
suggesting that the 10kb RV locus has been functionally inactivated. The 
17kb RV locus does however, produce a 7kb PCR product which along with 
the Southern blotting data, strongly suggests that these animals contain at 
least one intact transgene. 
In situ of these 'reduced array' animals showed that after the reduction 
in copy number there was a reduction in the percentage of cells that 
expressed in the mammary gland. Protein analysis failed to detect any 
protein from either the 10kb or 17kb RV locus animals indicating that the 
percentage of the mammary gland expressing protein is below available 
detection limits. 
The 10kb RV locus animals only showed isolated dots of expression by 
in situ hybridisation, which were never found consistently between 
sequential sections. This was assumed to represent background as an 
artefact of the in situ technique rather than genuine expression. When taken 
in context with the failure to PCR a 7kb fragment, the most plausible 
explanation for the results in this chapter is that the 10kb RV locus does not 
contain a functional intact transgene. This also agrees with the data in 
Chapter 4, which failed to find any expression from the lox 4/Cre 10kb array 
animals. 
In constrast, the 17kb RV locus animals showed discrete patches of 
expression which could be shown to exist across sequential sections. 
Therefore as these animals did express in some cells, they must contain a 
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functional transgene. The failure to find any protein expression or mRNA 
from the total mammary RNA indicates that although the 17kb RV locus can 
express, it is expressing at a level below the detection limit of these 
techniques. This result shows that when a multicopy BLG array is reduced 
to two copies the expression has also decreased. In Chapter 4, a model was 
proposed whereby the timing of deletion could be too late to rescue the 
transgene array. As this deletion occurred at a very early timepoint in 
development it is unlikely that the reduction in expression is due to the 
timing of deletion being too late. 
The 17kb RV locus animals are dramatically different from their 
parental line, lox 4. The parental lox 4 animals express in approximately 
50% of the alveoli examined, while the 17kb RV locus animals express in less 
than 10% of the alveoli examined. This is therefore counter to the hypothesis 
that the high copy number transgenes can be responsible for variegation. In 
this example, the high copy number lines express more efficiently than low 
copy number lines. 
The fact that the 17kb RV locus does express the transgene but only in 
very discreet patches of the mammary suggests there maybe a threshold of 
copies required for uniform expression. 	This supports the model put 
forward in Chapter 4, that there is a 'buffer' effect allowing some transgenes 
within a multicopy array to escape silencing effects from the surrounding 
genome. If the number of copies is reduced, the buffer is removed leading to 
more cells failing to express the transgene. More PLC A lines are being bred 
currently that contain higher copy arrays (possibly 3 and 4 copies) which 
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would be of great interest to see if there is indeed a threshold above which 
uniform expression could be expected. 
Alternatively, if there is inactive version of BLG contained within the 
17kb RV locus it may act as a silencing element. If this inactive copy was 
targeted by silencing machinery, then it may have a direct effect on the full 
7kb transgene associated with it. The proximity of the two may mean that in 
the majority of cells the functional 7kb has be repressed by the copy before it. 
It may be targeted to a repressive domain within the nucleus or maybe 
condensed into heterochromatin due to the interaction of the inactive copy 
and silencing machinery. The only way to determine if the inactive copy 
silences the 7kb would be to isolate the functional 7kb from the inactive 
version and determine if without the 'silencing' action if it can express in a 





The advent of pronuclear microinjection was a major development in 
molecular biology. Transgenic animals are now common tools to investigate 
many biological questions (Petters and Sommer 2000). It has become clear 
however, that not every transgene will express in the expected manner. 
Many factors influence the expression of the transgene: from those intrinsic 
to the construct i.e. enhancers, to those extrinsic to the construct which 
includes a wide variety of genome effects (as discussed in Chapter 1). In 
some lines of mice variegation reminiscent of PEV in Drosophila had been 
found as a consequence of the genomic location of the transgene (Dobie et al 
1996). 	These position effects, whereby the surrounding genome can 
stochastically silence a gene were proposed to occur by a spread of 
heterochromatin from silenced regions to the gene (Henikoff 1990). 
This project was initiated in mice to determine the relationship 
between the copy number of a transgenic array and its expression profile. 
Specifically, did high copy arrays lead to stochastic silencing of the transgene 
in different cells? The use of a site-specific recombinase, allowed a direct 
comparison of different copy number arrays at the same genomic location. 
If the hypothesis that the repeat nature of the high copy array induced a 
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genomic silencing effect, then upon reduction of copy number there would 
be expected to be a more uniform pattern of expression. From the results in 
this thesis, using a loxP containing BLG transgene, this was not the case. 
After reduction in copy number, the number of cells within the mammary 
gland that expressed was reduced. 
6.2 	BLG TRANSGENES AND COPY NUMBER 
Many lines of mice have been created that carry a BLG transgene 
(Simons et al 1987, Harris et al 1991, Whitelaw et-al 1992). In many cases it 
was established that there was a link between copy number and the levels of 
expression, and that the more copies present within an array the higher the 
BLG protein levels within milk (Whitelaw et cii 1992). 	In the early 
experiments BLG expression levels were determined by the BLG 
protein/mRNA levels within milk or mammary gland RNA samples, and did 
not address the pattern of cellular expression. 
When the cellular patterns of three BLG lines were investigated, two 
lines showed discreet patches of expression (Dobie et cii 1996). 	This 
variegation within a tissue was thought to be due to the position within the 
genome of these two lines, i.e. centromeric, which was close to facultive 
heterochromatin. It was however noted that these two lines were also high 
copy number, and so this effect could not be ruled out. The two variegating 
lines 7 and 45 had approximately 25 and 17 copies each. 
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6.3 	BLG-LOXP LINES 
To determine what effect different transgene copy numbers had at the 
same integration site, BLG transgenic lines that could be manipulated by Cre 
recombination were designed. In chapter 3, five high copy lines containing a 
BLG-loxP transgene were generated. The expression profile was analysed 
using in situ hybridisation, Northern blots and milk composition analysis. 
Two of the lines showed patchy BLG mRNA expression in the mammary 
gland. The other three lines showed a BLG mRNA pattern consistent with 
an endogenous gene, 13-casein. The lines with patchy expression showed 
variation in the levels of BLG protein found in the milk. This variation in 
milk protein correlates with the variation between animals, in the number of 
cells that express the transgene in the mammary gland. 
Comparison between the five lines cannot be drawn as the integration 
site of each will be different, given the randomness of integration using 
pronuclear microinjection. However it is interesting that three of the five 
BLG-loxP lines chosen for their high copy arrays showed uniform expression. 
This indicates that BLG high copy number lines are in some cases able to 
express efficiently. The location of the transgene within the genome of these 
lines is obviously permissive to uniform expression, regardless of the copy 
number of the array. Other examples of genomic locations permissive of 
transgene expression, regardless of the structure or the transgene have been 
reported (Wallace et a! 2000). 
228 
One issue that was not addressed in this study was the possibility that 
genetic modifiers of variegation exist within the genetic backgrounds of the 
mice. The original BLG-loxP construct was injected into hybrid mice. The 
BLG-loxP animals are therefore not all on the same genetic background. If 
one of the strains used to create the hybrids contained a genetic modifier 
locus this would segregate to different animals. From the small number of 
mice used, no segregation between uniform and variegating animals was 
found within a lox line. However, modifiers may be expected to affect the 
levels of variegation and no extensive backcrossing was done to determine if 
the loxP lines were influenced by modifiers. A previous study on BLG 
variegating lines found no evidence that the genetic background had an 
effect on the variegation (Dobie et a! 1996). 
One limitation within the project was the use of quantification 
software to determine the copy number of the lines and the protein 
expression levels. As the project relied on the generation of high copy 
number lines to start with, the estimation of copy number was important. 
Several areas may lead to problems: the use of external controls may lead to 
pipetting errors, the accuracy of quantification software is determined by the 
ability to accurately box the data points, the sensitivity of the phosphor 
screens, and whether the samples fall within the dynamic range of the screen. 
Alternative methods exist to determine copy numbers of transgenes, i.e. 
pulse field gel electrophoresis. The use of PFGE for copy number is based 
on size of the fragments, not the intensities so it avoids these problems. 
Protein expression levels were determined from multiple sampling to try and 
reduce any human errors in boxing data points. 
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6.4 	TRANSGENE REDUCTION IN THE MAMMARY GLAND 
In chapter 4, BLG-loxP lines 4, 5 or 9 were crossed with a BLG-Cre line 
to produce a mammary-specific reduction in copy number. The mammary 
gland contains more than one cell type, and the BLG promoter used to drive 
Cre recombinase is expressed only in the secretory epithelial cells (Harris et a! 
1991). A major drawback to this method was that the mammary gland was 
then mosaic for two types of transgenic array; parental and reduced. From 
Southern blotting of the double transgenic animals all the lox lines showed a 
reduction in copy number based on the intensity of the 'parental array'. 
However, only lox 4/Cre showed a discrete restriction fragment smaller than 
the 'parental array'. When analysed further using multiple probes, this 
reduced fragment appeared to comprise an intact transgene. However, the 
Southern blotting data could not exclude the possibility that the transgene 
had been rearranged, making it functionally inactive. 
No reduced fragment could be found in the double transgenic animals 
of the other two lines, even though the intensity of the parental array was 
significantly reduced. It is possible that reduced but not single copy arrays 
were trapped within the parental arrays due to the percentage agarose gels 
used. The remaining parental arrays would be derived from non Cre-
expressing cells. This would suggest that the Cre expression was not fully 
penetrant within the mammary gland. The BLG-Cre line had been reported 
to express in a uniform manner in the secretory epithelial cells, although the 
original studies suggested it only expressed in 80% of the gland (Selbert et a! 
1998). It did not formally exclude the possibility that a small fraction of the 
secretory epithelial cells failed to undergo Cre mediated recombination. 
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The inability to distinguish between parental and reduced arrays due 
to their shared sequence precluded further molecular analysis. 
When double transgenic animals were analysed by in situ 
hybridisation, it was clear that in all three lines crossed to a Cre recombinase 
expressing line there had been a substantial reduction in the number of cells 
within the mammary gland that expressed the transgene. There was also a 
correlation between the reduction in copy number and a reduced level of 
BLG protein found within the milk. 
If the Southern blotting and in situ results are examined together, the 
data from the lox 5 and 9 double transgenic animals suggests that the areas of 
the mammary gland that still express the transgene, are due to non Cre-
expressing cells still containing the parental arrays. In the lox 4 double 
transgenics, on the basis of Southern blotting data, there appeared to be an 
intact transgene after reduction. However, given the fact that no lox 4/Cre 
animal showed expression means that the 'reduced array' failed to express or 
that it had been inactivated in some way. 
If the transgenes had not been inactivated or deleted by the reduction, 
then two other possible explanations could explain the decrease in 
expression after reduction in copy number. One model was that the deletion 
had occurred too late to rescue the expression. This was based on the fact 
that the mammary gland is an unusual tissue; it is only fully differentiated in 
adult females after pregnancy. The BLG-Cre transgene is expressed co-
ordinately with other milk protein genes and only reaches its maximum 
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expression during lactation (Harris et iii 1991, Selbert et a! 1998). The Cre 
mediated recombination in these animals would therefore only occur in the 
differentiated mammary tissue. 	The reduction in copy number could 
therefore occur after a developmental mark had silenced the transgene, and 
after this point the modification of copy number would have no effect. 
Interestingly, the patterns of expression in these variegated lines and others 
previously studied (Dobie et a! 1996) suggests that the variegation may be 
clonally derived. By the intensity of in situ hybridisation, the expression did 
not appear to vary in the level per cell, only the number of cells expressing 
varied. 	This may suggest that during differentiation, a process of 
commitment to either an active or silent state is undertaken and that this is 
then maintained during the further growth and development of the 
mammary gland. Such patterns would indicate that the decision to silence 
an array may be taken at an early developmental stage. An alternative 
model was that a 'buffer' zone in the multicopy arrays allowed some 
transgenes within that array to escape genomic silencing effects. After 
reduction this 'buffer' zone would had been removed, making the remaining 
transgenes more prone to silencing. 
6.5 	TRANSGENE REDUCTION BY MICROINJECTION 
Having created a reduction of copy number in the mammary gland, 
the same three lox lines were then used to create a reduction by 
microinjection of a PGK-Cre construct. This reduction was therefore much 
earlier in development than the mammary gland reduction discussed in 
Chapter 4. This method provided animals that were not mosaic for two 
transgenic arrays within the same tissues, and allowed lines to be established. 
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Clearer analysis could then be carried out without the interference from non-
reduced cells, unlike the situation in Chapter 4. 
Southern blotting again failed to show any evidence for a identifiable 
'reduced array' in the lox 9 animals. All the animals analysed showed a 
smear of reduced arrays. From the lox 5 line only one animal was detected 
carrying a 'reduced array'. The rest showed smears indicating that the 
transgene had undergone Cre mediated recombination to varying degrees in 
different cells. Taken together with the results from Chapter 4 it seems 
likely that these two transgenic loci are unsuitable for recombination to a 
single intact transgene. Alternatively, it maybe that the Cre recombinase is 
less efficient at recombining the structures of these loci, given the complex 
patterns of fragments found in the lox 9 animals after microinjection of Cre. 
By constrast, microinjected lox 4 animals did produce identifiable 
'reduced arrays' by EcoRV digestion. The smallest of these arrays co-
migrated with the 10kb 'reduced array' from the double transgenics of 
Chapter 4. The next sized array was estimated to be 17kb by EcoRV 
digestion, which suggests an increase in copy number of one given that the 
transgene is 7kb long. Other arrays were larger and were proposed to carry 
more transgenes. 	Interestingly, the two reports in the literature that 
specifically used Cre recombinase to reduce transgene copy number both 
resulted in two distinct arrays after recombination from the one parental line 
(Garrick et cii 1998, Ramirez et cii 2001). Two arrays are consistent with only 
partial deletion in some cells. 	Thus Cre recombinase may frequently 
catalyse different amounts of recombination in different cells of the same 
animal. 
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Further Southern blotting was used to examine the structure of the 
'reduced array'. It was established that the 10kb RV locus did not contain a 
repeat length. 	The 10kb RV locus from both lox4/BLG-Cre and the 
microinjected Gre failed to produce a 7kb PCR product. Although the 
Southern blotting data suggested the 10kb RV locus contained both promoter 
and coding sequence, the PCR result suggests it may not be in the correct 
arrangement, although further work is required to confirm this. The failure 
to find expression from this array in either experiment, therefore, is most 
likely due to inactivation of the transgene during recombination. 
The 17kb RV locus contained a repeat length by SspI digestion 
indicating that the 'reduced array' had a minimum of two transgene copies in 
a head to tail repeat, and confirmed that it had at least one intact transgene. 
The 17kb RV locus also produced a 7kb PCR product. This correlates with 
the SspI digestion which showed a repeat fragment of similar intensity to the 
junction fragment, suggesting that there is only one repeat fragment present 
within the 17kb RV locus. 
In situ data from the 10kb RV locus showed very infrequent dots of 
hybridisation. However, these were extremely rare, and were not shown to 
be consistent between sequential sections. The in situ data showed no 
genuine expression, which when considered in parallel to the Southern 
blotting and PCR data support the theory that the 10kb RV locus did not 
express because it was in some way functionally inactivated after 
recombination. 
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In contrast, the 17kb RV locus showed distinct patches of expression 
which were found in all the animals examined and were consistent between 
sequential sections. The level of expression however, was dramatically 
different to the parental lox 4 array. The multicopy lox 4 animals expressed 
in approximately 50% of the alveoli, while the 17kb RV locus animals 
expressed in less than 10% of the alveoli. Although, Western blotting is able 
to detect approximately 1-10ng of protein (Harlow and Lane 1988), no BLG 
protein was found in the 17kb RV locus animals. This compares with the 
original lox 4 animals that had a mean BLG protein level of 1.2 mg/mi. The 
level of expression had therefore, decreased to a point undetectable by 
Western blotting or Northern blotting. 
Real time PCR may be one technique that could determine gene 
expression from the 17kb RV locus animals, given the failure to find any 
RNA by Northern blotting. Real time PCR allows the quantification of gene 
expression by the use of fluorescent probes that are in direct proportion to 
the amount of PCR product in a reaction. 	In a PCR reaction the 
amplification initially proceeds at an exponential rate, moving into a linear 
phase followed by a plateau phase. Real time PCR quantitates the amount of 
product produced every cycle, allowing quantification over a broad range. 
The use of different fluorescent reporters for different genes allows multiplex 
PCR to be carried out in a single tube. Real time PCR can therefore be used 
to compare expression from a transgene relative to an endogenous gene 
within the same biological sample. Given the sensitivity of PCR and the 
ability to quantitate the products, it could be used as an alternative method 
to in situ hybridisation for quantifying BLG transgene expression. 
235 
It is clear from the 17kb RV locus animals, that a reduction in copy 
number led to a decrease in expression, due to a decrease in the number of 
cells that expressed the transgene. From these results, at this genomic 
location a high copy number (16-18 copies) of BLG transgenes actually 
express significantly more efficiently than a lower copy number (one copy). 
This contradicts the original hypothesis of the project and shows that the 
variegation of this BLG line was not directly related to its high copy number. 
6.6 	OTHER TRANSGENE REDUCTIONS 
Previous investigations into copy number effects have provided 
conflicting reports. In one case, reduction of copy number led to an increase 
in the number of cells that expressed the transgene (Garrick et a! 1998). This 
study used a hybrid construct which contained an cc-globin promoter driving 
a lacZ reporter and the a-HS 40 enhancer-like element. This construct 
previously showed variegated expression and was not thought to express in 
a copy number dependent manner (Robertson et a! 1995). When this 
transgene was reduced by microinjection of Cre recombinase, in one line 
there was a 1000-fold increase in the number of cells expressing. Another 
line showed a 180-fold increase after reduction to one copy. Therefore, at 
two genomic locations with the a-globin transgene, high copy arrays were 
directly associated with silencing of expression. A number of differences 
exist with this case and the examples in this thesis. The globin transgene 
contains part of the globin locus and an enhancer. Given the complexity of 
the natural globin locus these sequences when present as single copies may 
be unusually dominant in controlling the effects of the surrounding genome. 
As discussed in Chapter 1 variegation can be thought of as a complex result 
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of the effects from the position within the genome, the repeated nature of the 
transgene and the intrinsic elements of the transgene. It is possible that after 
removal of effects due to the repeated nature of the transgene, that this a-
globin transgene contains elements strong enough to overcome only position 
effects, allowing it to express in a position independent manner. 
In the other case, reduction in copy number had no effect on the 
expression profile of the transgene (Ramirez et a! 2001). In this study a 
Keratin K5 construct was linked to the lacZ reporter. The construct was very 
prone to variegation, indeed in the 6 lines used to study copy number, two 
were silenced and the other four variegated. This is unlike BLG transgenes, 
which of the eight lines studied at a cellular level only half displayed 
variegated expression, while the other half were uniformly expressed. If the 
lacZ reporter was replaced with other sequences (i.e. Human epidermal 
growth factor reporter; HEGFR) uniform expression occurred using the same 
Keratin K5 regulatory sequences. 	In this study, no quantification of 
variegation before and after Cre reduction was carried out. This study also 
did not state if the transgene after Cre recombination was examined to prove 
it was unrearranged by the reduction. The copy number reduction showed 
no effect on the variegation of the transgenes. Given the known silencing 
effects of lacZ on adjacent sequences (Cohen-Tannoudji et a! 2000; Clark et a! 
1997 also show silencing from other reporter sequences), it seems likely that 
the continued variegation after reduction, was actually due to the presence of 
the lacZ sequence. It maybe that the lacZ has such a strong silencing effect 
on the keratin construct that even when any negative effects from repeat 
structures are removed the transgene is still variegated. Indeed, when a 
single lacZ insertion was targeted to the mouse actin locus, this resulted in 
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highly variegated expression of the targeted allele (Prof A.J. Clark; pers 
comm.) 
An important distinction between both previous published studies 
and this project is that the BLG transgene investigated is not a hybrid 
construct and it did not contain a reporter sequence. This allows the BLG 
transgene to be examined without the influence of inherent silencing effects 
from reporter sequence (i.e. from lacZ) within the construct. Again in 
contrast, BLG does not contain an LCR or specific enhancers, which may 
make it more prone as a single copy to position effects than the a-globin 
single copy. 
From the small number studies into repeat induced silencing in 
transgenic mice, it is clear that for some transgenic constructs repeat 
structures should be avoided i.e. the globin construct (Garrick et al 1998), 
while for others the construct may only efficiently express when present as a 
multicopy array, i.e. the BLG construct. 
6.7 	BUFFER MODEL OF VARIEGATION 
From the results in this thesis, silencing is highest among low copy 
number BLG arrays. In Chapter 4, two models were proposed to account for 
the reduction in expression after reduction in copy number. The reduction 
in the mammary gland was proposed to be too late in development to rescue 
the transgene from a silencing mark. However, the results from chapter 5 
238 
show that even if a reduction in copy number occurs very early in 
development, a reduction in expression is still seen. This makes the model 
proposing a developmental mark seem unlikely. The other model described 
in Chapter 4 whereby a buffer zone in multicopy arrays exists can explain the 
reduced expression. 	Having large numbers of a repeat allows some 
transgenes in the array to escape silencing, due to them being buffered 
against genome effects due to the large amount of copies that the genome 
must inactivate (figure 6.1). After reduction there would be no protection 
from the surrounding genome for the reduced array, therefore reducing the 
number of cells that manage to escape this genomic effect. Given that PEV 
in Drosophila is accompanied by heterochromatinization of transgenes (Dorer 
and Henikoff 1994) the large arrays of BLG may provide a buffer zone 
against this. 
The unmodified BLG gene has previously been used to rescue 
expression from poorly expressed hybrid constructs by co-microinjection 
(Clark et al 1992). This resulted in a high proportion of the founders that 
comprised both constructs at the same integration site. 	This led to a 
significant increase in the frequency of expression from the hybrid constructs. 
It was thought that the increase was due to changes associated with 
activation or transcription of the unmodified BLG spreading to the hybrid 
transgene. 	However, later work showed that the rescue effect was 
associated with transcription of the BLG, but not its translation (Yull et al 
1997). It was thought this represented the changes in chromatin structure 
round the BLG gene when it activates transcription spreading to the hybrid 
gene (Whitelaw 1995). Therefore it may be that the buffer zone described 
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here is also due to the changes in chromatin structure surrounding an active 
copy, being able to withstand the influences of the genome effects. 
An alternative theory is that the 17kb RV locus contains a inactive 
version of BLG that has an inhibitory effect on the remaining intact copy 
associated with it. Just as BLG can rescue poorly expressed transgenes, it 
may be possible that the inactive version is acting as a negative element 
attracting silencing machinery, which in turn reduces/abolishes the 
expression from the intact copy. To formally prove that the inactive copy is 
acting as a silencer, the 17kb RV locus would need to be cloned out from the 
mouse DNA, the two transgene copies separated and the intact copy used on 
its own at single copy to determine if the inactive version was indeed 
responsible. 
The availability of higher copy number BLG arrays (possibly 3-4 
copies) would allow investigations into whether there is a threshold for 
efficient expression at these locations. It must be considered that in other 
genomic locations low copy number BLG arrays can express (<5 copies gave 
uniform expression; Dobie et a! 1996). Therefore it may be that for the 
genomic location of the array studied in this project, the position effects from 
the surrounding genome are strong and that only high copy arrays can 
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Figure 6.1. Model of buffer effects from multiple copies. Having a high copy array would allow some transgenes within the 
array to escape the effects of the surrounding genome, leading to some expression in the tissue in a patchy manner. After reduction, 
this 'buffer' would be lost and so fewer cells would escape the genome effects. 
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Cre recombinase has been extensively used for genetic engineering in 
transgenic mice and was thought to catalyse base pair precise recombinations 
(Kilbey et a! 1993). However, in this study it use appears to have caused in 
some cases partial deletion within an array or specific deletions. Previous 
use of Cre recombinase to reduce copy number also produced rearrangement 
of a reduced single copy transgene (Garrick et a! 1998). It can be difficult to 
accurately determine the exact nature of transgenic loci and they can often 
integrate with duplications or filler sequence (Bishop 1997). It is clear that 
care must be taken to determine the structure of any array to be used with 
Cre recombinase, if they do not contain precise head to tail repeats unwanted 
recombination events may occur. 
It has been proposed that Cre recombinase be routinely used to reduce 
transgene copy number in attempts to avoid transgene silencing (Jasin et a! 
1996, Metzger and Feil 1999). Given the results from this thesis, reducing 
transgene copy number may not lead to improved transgene expression, and 
as with the example of BLG may indeed make the situation worse. The 
widespread use of Cre recombinase to reduce transgene copy number could 
also result in large numbers of rearranged transgenes, which may be 
functionally inactive. It is clear that great care must be taken in determining 
the structure of any 'reduced arrays' before conclusions are drawn. If the 
array does not contain exact head to tail arrays then the Cre catalysed 
recombination may give unwanted results. It is therefore possible that the 
use of Cre recombinase to reduce copy number on a routine basis may not be 
of benefit to improving transgene expression. 
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Variegation of transgene expression can be due to position effects or 
the structure of the array but it is probably best explained as a combination of 
the two, in that the structure of the array fails to overcome the position 
effects that it encounters. Therefore both the position and copy number are 
important factors in determining the expression of a transgene. From this 
study, it is clear that reduction of a high copy number line does not 
necessarily result in an increase in expression from a site of integration in the 
genome, which is subject to silencing. 	In fact, reduction can produce 
significantly more silencing. Repeat Induced Gene Silencing may therefore 
be due to the combination of location, copy number and the transgene itself, 
and does not apply to all high copy number lines. RIGS cannot therefore, be 
used to explain all the cases of variegated transgene expression in high copy 
number lines. In this study there appears to be a buffer effect, which has not 
been found with other transgenes, nevertheless, this effect may not be limited 
to BLG transgenes. In some cases, the repeated structure may allow a 
number of transgenes within an array to avoid silencing effects. 
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APPENDIX ONE 
Conversion of rpm into RCF 
Relative Centrifugal force (RCF; measured in x g) refers to the force during 
centrifugation that moves the particulate outwards from the centre of 
rotation. The force is proportional to the speed (rpm) squared and the rotor 
radius. It is calculated by the following equation: 
RCF = 1.12 r (rpm/100)2  
Where: 
r = the rotating radius between the particle being centrifuged and the axis of 
rotation in mm. r max values are equal to the distance between the axis of 
rotation and the bottom of the centrifuge tube as it sits in the rotor. The rmax 
can be obtained from the manufacturer. 
rpm = revolutions per minute (speed). 
Some examples of frequently used speeds on centrifuge rotors are shown in 
table A.1. 
Rotor 	 I r in mm rpm 	RCF 
Desktop microcentrifuge 83 13000 15700 
Sorval SS 34 rotor 107 8000 7670 
Sorval F16 rotor 88 5000 2464 
7000 4829 
Jouan CR3000 Swing bucket rotor 127 4500 2880 
Eppendorf 5810 R Swing bucket rotor 185 4000 3220 
Table A.1. Conversion table for rpm into RCF. 
244 
REFERENCES 
Adra, C.N., Boer, P.H. & McBurney, M.W. (1987). Cloning and expression of 
the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60, 
65-74. 
Al-Shawi, R., Kinnaird, J., Burke, J. & Bishop, J.O. (1990). Expression of a 
foreign gene in a line of mice is modulated by chromosomal position effect. 
Mo! Cell Biol 10, 1192-1198. 
Au, S. & Clark, A.J. (1988). Characterisation of the gene encoding ovine J3-
lactoglobulin. Journal of Molecular Biology 199, 415-426. 
Allen, D.N., Norris, M.L. & Surani, M.A. (1990). Epigenetic control of 
transgene expression and imprinting by genotype-specific modifiers. Cell 61, 
853-861. 
Anandalakshmi, R., Pruss, G.J., Ge, X., Marathe, R., Mallory, A.C., Smith, 
T.H. & Vance, V.B. (1998). A viral suppressor of gene silencing in plants. 
Proc Nat! Acad Sci USA 95, 13079-13084. 
Angerer, L.M. & Angerer, R.C. (1992). In situ hybridisation to cellular RNA 
with radiolabelled RNA probes. In In situ Hybridisation: A Practical Approach 
(Wilkinson, D.G., ed.), Oxford University Press, Oxford, pp.  15-31. 
Araki, K., Araki, M., Miyazaki, J.-I. & Vassalli, P. (1995). Site specific 
recombination of a transgene in fertilized eggs by transient expression of cre 
recombinase. Proc Nat! Acad Sci USA 92, 160-164. 
Archibald, A.L., McClenaghan, M., Hornsey, V., Simons, J.P. & Clark, A.J. 
(1990). High-level expression of biologically active human al-antitrypsin in 
the milk of transgenic mice. Proc Nat! Acad Sci USA 87, 5178-5182. 
Assaad, F.F., Tucker, K.L. & Signer, E.R. (1993). Epigenetic repeat-induced 
gene silencing (RIGS) in Arabidopsis. Plan t.Mol.Bio. 22, 1067-1085. 
245 
Baubonis, W. & Sauer, B. (1993). Genomic targeting with purified Gre 
recombinase. Nucleic Acids Res. 9, 2025-2029. 
Baulcombe, D.C. (1996). RNA as target and initiator of post-transcriptional 
gene silencing in transgenic plants. Plan t.Mol.Bio. 32, 79-88. 
Bell, A.C. & Felsenfeld, C. (2000). Methylation of a CTCF-dependent 
boundary controls imprinted expression of the Igf2 gene. Nature 405, 482-
485. 
Belyaeva, E.S., Demakova, O.V., Umbetova, G.H. & Zhimulev, I.F. (1993). 
Cytogenetic and molecular aspects of position-effect variegation in Drosophila 
melanogaster. 	V. Heterochromatin-associated protein HP1 appears in 
euchromatic chromosomal regions that are inactivated as a result of position-
effect variegation. Chromosoma 102, 583-590. 
Berg, P. (1981). Dissections and reconstructions of Genes and Chromosomes. 
Science 213, 296-303. 
Bernardi, G. (1995). The human genome: Organisation and evolutionary 
history. Annual Rev.Genet. 29, 445-476. 
Bestor, T.H. (1998). Methylation meets acetylation. Nature 393, 311-312. 
Bhattacharya, S.K., Ramchandani, S., Cervoni, N. & Szyf, M. (1999). A 
mammalian protein with specific demethylase activity for mCpG DNA. 
Nature 397, 579-583. 
BioRad. (2000). Quantity One User Guide for Version 4. 
Birchier, J.A., Pal-Bhadra, M. & Bhadra, U. (2000). Making noise about 
silencing: repression of repeated genes in animals. Current Opinion in 
Genetics and Development 10, 211-216. 
Birchier, J.A., Bhadra, U., Pal Bhadra, M. & Auger, D.L. (2001). Dosage-
dependent gene regulation in multicellular eukaryotes: implications for 
dosage compensation, aneuploid syndromes, and quantatitive traits. 
Dev.Biol. 234, 275-288. 
246 
Bird, A. & Woiffe, A.P. (1999). Methylation-Induced Repression - Belts, 
Braces, and Chromatin. Cell 99, 451-454. 
Bird, AP. (1995). Gene number,noise-reduction and biological complexity. 
Trends Genet. 11, 94-100. 
Bishop, J.O. & Smith, P. (1989). Mechanism of chromosomal integration of 
microinjected DNA. Mol.Biol.Med. 6, 283-293. 
Bishop, J.O. (1997). Chromosomal insertion of foreign DNA. In Trans genic 
Animals Generation and Use (Houdebine, L.-M., ed.), Harwood Academic 
Publishers, Amsterdam, pp.  219-223. 
Bonifer, C., Jagle, U. & Huber, M.C. (1997). The chicken lysozyme locus as a 
paradigm for the complex developmental regulation of eukaryotic gene loci. 
J.Biol.Chem 272, 26075-26078. 
Boyd, A.L. & Samid, D. (1993). Molecular biology of transgenic animals - 
Review. J.Animal Sci. 71, 1-9. 
Boyes, J. & Bird, A. (1991). DNA methylation Inhibits Transcription 
Indirectly via a Methyl-CpG Binding Protein. Cell 64, 1123-1134. 
Bradl, M., Larue, L. & Mintz, B. (1991). Clonal coat color variation due to a 
transforming gene expressed in melanocytes of transgenic mice. Proc Nati 
Acad Sci USA 88, 6447-6451. 
Bradley, A., Evans, M., Kaufman, M.H. & Robertson, E. (1984). Formation of 
germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 
309, 255-256. 
Brinster, R.L., Chen, H.Y. & Trumbauer, M. (1981). Somatic expression of 
Herpes Thymidine Kinase in Mice following Injection of a Fusion Gene into 
Eggs. Cell 27, 223-231. 
Brinster, R.L., Chen, H.Y., Traumbauer, M.E., Yagle, M.K. & Palmiter, R.D. 
(1985). Factors affecting the efficiency of introducing foreign DNA into mice 
by microinjecting eggs. Proc Nati Acad Sci USA 82, 4438-4442. 
247 
Bronson, S.K., Plaetn, E.G., Kluckman, J.R., Hagaman, J.R., Maeda, N. & 
Smithies, 0. (1996). Single copy transgenic mice with chosen site integration. 
Proc Nat! Acad Sci USA 93, 9067-9072. 
Brooks, A.R., Nagy, B.P., Taylor, S., Simonet, W.S., Taylor, J.M. & Levy-
Wilson, B. (1994). Sequences containing the second-intron enhancer are 
essential for transcription of the human apolipoprotein B gene in the livers of 
transgenic mice. Mol Cell Bio! 14, 2243-2256. 
Brown, C.J., Ballabio, A., Rupert, J.L., Lafreniere, R.G., Grompe, M., 
Tonlorenzi, R. & Willard, H.F. (1991). A gene from the region of the human x-
inactivation center is expressed exclusively from the inactive x-chromosome. 
Nature 349, 38-44. 
Brown, C.J. & Willard, H.F. (1994). The human X-inactivation centre is not 
required for maintance of X-chromosome inactivation. Nature 368, 154-156. 
Brown, K.E., Guest, S.S., Smale, S.T., Hahm, K., Merkenschlager, M. & Fisher, 
A.G. (1997). Association of transcriptionally silent genes with Ikaros 
complexes at centromeric heterochromatin. Cell 91, 845-854. 
Brownell, J.E. & Allis, C.D. (1996). Special HATs for special occasions: linking 
histone acetylation to chromatin assembly and gene activation. Current 
Opinion in Genetics and Development 6, 176-184. 
Bullock, D.W., Damak, S., Jay, N.P., Su, H.-Y. & Barrell, G.K. (1997). 
Improved wool production from Insulin-like Growth Factor 1 targeted to the 
wool follicle in transgenic sheep. In Trans genic Animals: Generation and Use 
(Houdebine, L.M., ed.), Harwood Academic Publishers, Amsterdam, pp.  507-
509. 
Bunting, M., Bernstein, K.E., Greer, J.M., Capecchi, M.R. & Thomas, K.R. 
(1999). Targeting genes for self-excision in the germ line. Genes Dev. 13, 1524-
1528. 
Burdon, T.G., Maitland, K.A., Clark, A.J. & Watson, C.J. (1994). Regulation of 
the sheep 13-lactoglobulin gene by lactogenic hormones is mediated by a 
transcription factor that binds an interferon-7 activation site-related element. 
Mol Endocrinol 8, 1528-1536. 
248 
Butner, K. & Lo, C.W. (1986). Modulation of tk Expresssion in Mouse 
Pericentromeric Heterochromatin. Mo! Cell Biol 6 (12), 4440-4449. 
Camper, S.A. (1987). Research applications of transgenic mice. Biotechniques 
5,638-650. 
Capecchi, M.R. (1989). Altering the genome by homologous recombination. 
Science 244, 1288-1292. 
Caterina, J.J., Ciavatta, D.J., Donze, D., Behringer, R.R. & Townes, T.M. 
(1994). Multiple elements in human -g1obin locus control region 5' HS 2 are 
involved in enhancer activity and position-independent, transgene 
expression. Nucleic Acids Res 22 (6), 1006-1011. 
Chada, K., Magram, J., Raphael, K., Radice, G., Lacy, E. & Costantini, F. 
(1985). Specific expression of a foreign 13-globin gene in erythroid cells of 
transgenic mice. Nature 314, 377-380. 
Choi, T., Huang, M., Gorman, C. & Jaenisch, R. (1991). A generic intron 
increases gene expression in transgenic mice. Mo! Cell Biol 11, 3070-3074. 
Clark, A.J., Cowper, A., Wallace, R. & Simons, J.P. (1992). Rescuing transgene 
expression by co-integration. Biotechnology 10, 1450-1454. 
Clark, A.J., Archibald, A.L., McClenaghan, M., Simons, J.P., Wallace, R. & 
Whitelaw, C.B.A. (1993). Enhancing the efficiency of transgene expression. 
Phil. Trans.R . Soc.Lond. B 339, 225-232. 
Clark, A.J., Bissinger, P., Bullock, D.W., Dmak, S., Wallace, R.M., Whitelaw, 
C.B.A. & Yull, F.E. (1994). Chromosomal position effects and the modulation 
of transgene expression. Reprod.Fert.Dev. 6, 589-598. 
Clark, A.J., Harold, C. & Yull, F.E. (1997). Mammalian cDNA and 
prokaryotic reporter sequences silence adjacent transgenes in transgenic 
mice. Nucleic Acids Res. 25, 1009-1014. 
Clark, A.J. (1998). The mammary gland as a bioreactor: expression frequency 
and production of recombinant proteins. Journal of Mammary Gland Biology 
and Neoplasia 3, 337-350. 
249 
Clark, A.J., Burl, S., Denning, C. & Dickinson, P. (2000). Gene targeting in 
livestock: a preview. Transgenic Res. 9, 263-275. 
Cockerill, P.N. & Garrard, W.T. (1986). Chromosomal loop anchorage of the 
kappa immunoglobulin gene occurs next to the enhancer in a region 
containing topoisomerase II sites. Cell 44, 273-282. 
Cogoni, C. & Maci, G. (1999). Gene silencing in Neurospora crassa requires a 
protein homologous to RNA-dependent RNA polymerase. Nature 399, 166-
169. 
Cohen-Tannoudji, M., Vandormael-Pournin, S., Drezen, J.-M., Mercier, C., 
Babinet, C. & Morello, D. (2000). lacZ sequences prevent regulated expression 
of housekeeping genes. Mechanisms of Development 90, 29-39. 
Cranston, A., Dong, C., Howcroft, J. & Clark, A.J. (2001). Chromosomal 
sequences flanking an efficiently expressed transgene dramatically enhance 
its expression. Gene 269, 217-225. 
Davis, B.P. & MacDonald, R.J. (1988). Limited transcription of rat elastase I 
transgene repeats in transgenic mice. Genes and Development 2, 13-22. 
Dellaire, G. & Chartrand, P. (1998). Direct evidence that transgene integration 
is random in murine cells, implying that naturally occurring double-strand 
breaks may be distributed similarly within the genome. Radiation Research 
149, 325-329. 
Denning, C., Burl, S., Ainslie, A., Braken, J., Dinnyes, A., Fletcher, J., King, T., 
Ritchie, M., Ritchie, W.A., Rollo, M., de Sousa, P., Travers, A., Wilmut, I. & 
Clark, A.J. (2001). Deletion of the a(1,3)galactosyl transferase (GGTA1) gene 
and the prion protein (PrP) gene in sheep. Nature Biotechnology 19, 559-562. 
deWit, T., Drabek, D. & Grosveld, F. (1998). Microirijection of Cre 
recombinase RNA induces site-specific recombination of a transgene in 
mouse oocytes. Nucleic Acids Res. 26, 676-678. 
Dobie, K.W., Lee, M., Fantes, J.A., Graham, E., Clark, A.J., Springbett, A.J., 
Lathe, R. & McClenaghan, M. (1996). Variegated transgene expression in 
mouse mammary gland is determined by the transgene integration locus. 
Proc Nati Acad Sci USA 93, 6659-6664. 
250 
Dobie, K.W., Mehtali, M., McClenaghan, M. & Lathe, R. (1997). Variegated 
gene expression in mice. Trends Genet. 13, 127-130. 
Dorer, D.R. & Henikoff, S. (1994). Expansions of transgene repeats cause 
heterochromatin formation and gene silencing in Drosophila. Cell 77, 993-
1002. 
Dorer, D.R. & Henikoff, S. (1997). Transgene repeat arrays interact with 
distant heterochromatin and cause silencing in cis and trans. Genetics 147, 
1181-1190. 
Dorer, D.R. (1997). Do transgene arrays form heterochomatin in vertebrates? 
Transgenic Res. 6, 3-10. 
Eissenberg, J.C., James, T.C., Foster-Hartnett, D.M., Hartnett, T., Ngan, V. & 
Elgin, S.C.R. (1990). Mutation in a heterochromatin-specific chromosomal 
protein is associated with suppression of position-effect variegation in 
Drosophila melanogaster. Proc Natl Acad Sci USA 87, 9923-9927. 
Eissenberg, J.C. & Elgin, S.C.R. (2000). The HP1 protein family: getting a grip 
on chromatin. Current Opinion in Genetics and Development 10, 204-210. 
Ellis, J., Tan-Un, K.C., Harper, A., Michalovich, D., Yannoutsos, N., Philipsen, 
S. & Grosveld, F. (1996). A dominant chromatin-opening activity in 5' 
hypersensitive site 3 of the human f3-globin locus control region. The EMBO 
Journal 15, 562-568. 
Evans, M.J. & Kaufman, M.H. (1981). Establishment in culture of 
pluripotential cells from mouse embryos. Nature 292, 154-156. 
Eyestone, W.H. (1994). Challenges and progress in the production of 
transgenic cattle. Reprod.Fert.Dev. 6, 647-652. 
Falls, J.G., Pulford, D.J., Wylie, A.A. & Jirtle, R.L. (1999). Genomic Imprinting: 
Implications for Human Disease. American Journal of Pathology 154, 635-647. 
Feinberg, A.P. & Vogeistein, B. (1984). A technique for radiolabeling DNA 
restriction endonuclease fragments to high specific activity. 
Addendum.Anal. Biochem. 137,266-267. 
251 
Festenstein, R., Tolaini, M., Corbella, P., Mamalaki, C., Parrington, J., Fox, M., 
Milou, A., Jones, M. & Kioussis, D. (1996). Locus control function and 
heterochromatin-induced position effect variegation. Science 271, 1123-1125. 
Festenstein, R., Sharghi-Namini, S., Fox, M., Roderick, K., Tolaini, M., 
Norton, T., Saveliev, A., Kioussis, D. & Singh, P. (1999). Heterochromatin 
protein 1 modifies mammalian PEV in a dose- and chromosomal-context-
dependent manner. Nat Genet 23, 457-461. 
Flavell, R.B. (1994). Inactivation of gene expression in plants as a 
consequence of specific sequence duplication. Proc Nati Acad Sci USA 91, 
3490-3496. 
Flower, D.R. (1996). The lipocalin protein family: Structure and function. 
Biochem J. 318,1-14. 
Francastel, C., Walters, M.C., Groudine, M. & Martin, D.I.K. (1999). A 
Functional Enhancer Suppresses SIlencing of a Transgene and Prevents Its 
Localization Close to Centromeric Heterochromatin. Cell 99, 259-269. 
Franklin, G.C., Donovan, M., Adam, G.I.R., Holmgren, L., Pfeifer-Ohlsson, S. 
& Ohlsson, R. (1991). Expression of the human PDGF-B gene is regulated by 
both positively and negatively acting cell type-specific regulatory elements 
located in the first intron. The EMBO Journal 10, 1365-1373. 
Fuks, F., Burgers, W.A., Brehm, A., Hughes-Davies, L. & Kouzarides, T. 
(2000). DNA methyltransferase Dnmtl associates with histone deacetylase 
activity. Nat Genet 24, 88-91. 
Fukushige, S. & Sauer, B. (1992). Genomic targeting with a positive-selection 
lox integration vector allows highly reproducible gene expression in 
mammalian cells. Proc Nati Acad Sci USA 89, 7905-7909. 
Gallie, D.R. (1998). Controlling gene expression in transgenics. Current 
Opinion in Plant Biology 1, 166-172. 
Garrick, D., Sutherland, H., Robertson, C. & Whitelaw, E. (1996). Variegated 
expression of a globin transgene correlates with chromatin accessibility but 
not methylation status. Nucleic Acids Res. 24, 4902-4909. 
252 
Garrick, D., Fiering, S., Martin, D.I.K. & Whitelaw, E. (1998). Repeat-induced 
gene silencing in mammals. Nat Genet 18, 56-59. 
Gasser, S.M., Paro, R., Stewart, F. & Aasland, R. (1998). Epigenetic control of 
transcription. Cellular and Molecular Life Sciences 54, 1-5. 
Gordon, J.W., Scangos, G.A., Plotkin, D.J., Barbosa, J.A. & Ruddle, F.H. 
(1980). Genetic transformation of mouse embryos by microinjection of 
purified DNA. Proc Nati Acad Sci USA 77, 7380-7384. 
Gressel, J. (2000). Molecular biology of weed control. Transgenic Res. 9, 355-
382. 
Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. & Rajewsky, K. (1994). 
Deletion of a DNA polymerase 3 gene segment in T cells using cell type-
specific gene targeting. Science 265, 103-106. 
Guo, F., Gopaul, D.N. & Van Duyne, G.D. (1997). Structure of Cre 
recombinase complexed with DNA in a site-specific recombination synapse. 
Nature 389, 40-46. 
Gutiérrez-Adán, A., Maga, E.A., Behboodi, E., Conrad-Brink, J.S., Mackinlay, 
A.G., Anderson, G.B. & Murray, J.D. (1999). Expression of bovine b-
lactoglobulin in the milk of transgenic mice. Journal of Dairy Research 66, 289-
294. 
Guy, L.-G., Kothary, R. & Wall, L. (1997). Position effects in mice carrying a 
lac-Z transgene in cis with the 13-globin LCR can be explained by a graded 
model. Nucleic Acids Res. 25, 4400-4407. 
Hamada, T., Sasaki, H., Seki, R. & Sakaki, Y. (1993). Mechanism of 
chromosomal integration of transgenes in microinjected mouse eggs - 
sequence analysis of genome-transgene and transgene-transgene junctions at 
two loci. Gene 128, 197-202. 
Hamilton, A.J. & Baulcombe, D.C. (1999). A Species of Small Antisense RNA 
in Posttranscriptional Gene Silencing in Plants. Science 286, 950-952. 
Hansen, R.S., Wijmenga, C., Stanek, A.M., Canfield, T.K., Weemaes, C.M.R. & 
Gartler, S.M. (1999). The DNMT3B DNA methyltransferase gene is mutated 
253 
in the ICF immunodeficiency syndrome. Proc Nat! Acad Sci USA 96, 14412-
14417. 
Hark, A.T., Schoenherr, C.J., Katz, D.J., Ingram, R.S., Levorse, J.M. & 
Tilghman, S.M. (2000). CTCF mediates methylation-sensitive enhancer-
blocking activity at the H19/1gf2 locus. Nature 405, 486-489. 
Harlow, E. & Lane, D. (1988). Antibodies A laboratory manual. Cold Spring 
Harbor Laboratory Publications New York, pp.  1-711. 
Harris, S., Ali, S., Anderson, S., Archibald, A.L. & Clark, A.J. (1988). 
Complete nucleotide sequence of the genomic ovine 13-lactoglobulin gene. 
Nucleic Acids Res. 16 (21), 10379-10380. 
Harris, S., McClenaghan, M., Simons, J.P., Ali, S. & Clark, A.J. (1991). 
Developmental regulation of the sheep -lactglobulin gene in transgenic 
mice. Dev Genet 12, 299-307. 
Heard, E., Mongelard, F., Arnaud, D. & Avner, P. (1999). Xist yeast artifical 
chromosome transgenes function as X-inactivation centers only in multicopy 
arrays and not as single copies. Mo! Cell Biol 19, 3156-3166. 
Henchoz, S., De Rubertis, F., Pauli, D. & Spierer, P. (1996). The dose of a 
putative ubiquitin-specific protease affects position effect variegation in 
Drosophila melanogaster. Mol Cell Biol 16, 5717-5725. 
Henikoff, S. (1990). Position-effect variegation after 60 years. Trends Genet. 
12,422-426. 
Henikoff, S. (1996). Dosage-dependent modification of position-effect 
variegation in Drosophila. BioEssays 18, 401-409. 
Hennighausen, L. & Robinson, G.W. (1998). Think globally, act locally: the 
making of a mouse mammary gland. Genes Dev. 12, 449-455. 
Hoess, R.H. & Abremski, K. (1984). Interaction of the bacteriophage P1 
recombinase Cre with the recombining site loxP. Proc Nat! Acad Sci USA 81, 
1026-1029. 
254 
Hoess, RB., Wierzbicki, A. & Abremski, K. (1986). The role of the loxP spacer 
region in P1 site-specific recombination. Nucleic Acids Res. 14, 2287-2300. 
Houdebine, L.M. (1997). Overview. In Transgenic Animals: Generation and Use 
(Houdebine, L.M., ed.), Harwood Academic Publishers, Amsterdam, pp.  1-6. 
Houdebine, L.M. (2000). Transgenic animal bioreactors. Transgenic Res. 9, 
305-320. 
Ibáflez, E., Foich, J.M., Vidal, F., Coil, A., Santaló, J., Egozcue, J. & Sanchez, A. 
(1997). Expression of caprine b-lactoglobuiin in the milk of transgenic mice. 
Transgenic Res. 6, 69-74. 
Irelan, J.T. & Selker, E.U. (1996). Gene silencing in filamentous fungi: RIP, 
MIP and quelling. Journal of Genetics 75 (3), 313-324. 
Jaenisch, R. & Mintz, B. (1974). Simian Virus 40 DNA sequences in DNA of 
helathy adult mice derived form preimplantation blastocysts injected with 
viral DNA. Proc Nati Acad Sci USA 71,1250-1254. 
Jaenisch, R. (1976). Germ line integration and Mendelian transmission of the 
exogenous Molony leukemia virus. Proc Nat! Acad Sci USA 73, 1260-1264. 
Jakowitsch, J., Papp, I., Moscone, E.A., van der Winden, J., Matzke, M.A. & 
Matzke, A.J.M. (1999). Molecular and cytogenetic characterization of a 
transgene locus that induces silencing and methylation of homologous 
promoter in trans. The Plant Journal 17, 131-140. 
James, R.M., Neil, C., Webster, J., Roos, S., Clark, A.J. & Whitelaw, C.B.A. 
(2000). Multiple copies of b-lactoglobulin promoter do not function as LCR. 
Biochem. Biophys .Res.  Comm. 272, 284-289. 
James, T.C., Eissenberg, J.C., Craig, C., Dietrich, V., Hobson, A. & Elgin, 
S.C.R. (1989). Distribution patterns of HP1, a heterochromatin-associated 
nonhistone chromosomal protein of Drosophila. European Journal of Cell 
Biology 50, 170-180. 
Jasin, M., Moynahan, M.E. & Richardson, C. (1996). Targeted transgenesis. 
Proc Nat! Acad Sci USA 93, 8804-8808. 
255 
Jeddeloh, J.A., Bender, J. & Richards, E.J. (1998). The DNA methylation locus 
DDM1 is required for maintance of gene silencing in Arabidopsis. Genes Dev. 
12,1714-1725. 
Jeddeloh, J.A., Stokes, T.L. & Richards, E.J. (1999). Maintance of genomic 
methylation requires a SWI2/SNF2-like protein. Nat Genet 22, 94-97. 
Jensen, S., Gassama, M.-P. & Heidmann, T. (1999). Taming of transposable 
elements by homology-dependent gene silencing. Nat Genet 21, 209-212. 
Jones, D.O., Cowell, I.G. & Singh, P.B. (2000). Mammalian chromodomain 
proteins: their role in genome organisation and expression. BioEssays 22, 124-
137. 
Kuhn, R. & Schwenk, F. (1997). Advances in gene targeting methods. Current 
Opinion in Immunology 9,183-188. 
Keohane, A.M., Lavender, J.S., O'Neill, L.P. & Turner, B.M. (1998). Histone 
acetylation and X inactivation. Dev Genet 22, 65-73. 
Kilby, N.J., Snaith, M.R. & Murray, J.A.H. (1993). Site-specific recombinases: 
tools for genome engineering. Trends Genet. 9, 413-421. 
Kooter, J.M., Matzke, M.A. & Meyer, P. (1999). Listening to the silent genes: 
transgene silencing, gene regulation and pathogen control. TIPS 4, 340-347. 
Kornberg, R.D. & Lorch, Y.L. (1999). Twenty-five years of the nucleosome, 
fundamental particle of the eukaryote chromosome. Cell 98, 285-294. 
Lakso, M., Sauer, B., Mosinger, J.B., Lee, E.J., Manning, R.W., Yu, S.-H., 
Mulder, K.L. & Westphal, H. (1992). Targeted oncogene activation by site-
specific recombination in transgenic mice. Proc Natl Acad Sci USA 89, 6232-
6236. 
Lakso, M., Pichel, J.G., Gorman, J.R., Sauer, B., Okamoto, Y., Lee, E., Alt, F.W. 
& Westphal, H. (1996). Efficient in vivo manipulation of mouse genomic 
sequences at the zygote stage. Proc Nati Acad Sci USA 93, 5860-5865. 
256 
Lallemand, Y., Luria, V., Haffner-Krausz, R. & Lonai, P. (1998). Maternally 
expressed PGK-Cre transgene as a tool for early and uniform activation of 
the Cre site-specific recombinase. Transgenic Res. 7, 105-112. 
Lamb, B.T. & Gearhart, J.D. (1995). YAC transgenics and the study of genetics 
and human disease. Current Opinion in Genetics and Development 5, 342-348. 
Lee, J.T., Davidow, L.S. & Warshawsky, D. (1999). Tsix, a gene antisense to 
Xist at the X-inactivation centre. Nat Genet 21, 400-404. 
Lee, J.T. & Lu, N. (1999). Targeted Mutagenesis of Tsix Leads to Nonrandom 
X Inactivation. Cell 99, 47-57. 
Li, E., Bestor, T.H. & Jaenisch, R. (1992). Targeted mutation of the DNA 
methyltransferase gene results in embryonic lethality. Cell 69, 915-926. 
Li, Z., Stark, G., Gotz, J., Rulicke, T., Muller, U. & Weissmann, C. (1996). 
Generation of mice with a 200-kb amyloid precursor protein gene deletion by 
Cre recombinase-mediated site-specific recombination in embryonic stem 
cells. Proc Natl Acad Sci USA 93, 6158-6162. 
Logan, J.S. (2000). Prospects for xenotransplantation. Current Opinion in 
Immunology 12,563-568. 
Ludwig, D.L., Stringer, J.R., Wight, D.C., Doetschman, T.C. & Duffy, J.J. 
(1996). FLP-mediated site-specific recombination in microinjected murine 
zygotes. Transgenic Res. 5, 385-395. 
Luff, B., Pawlowski, L. & Bender, J. (1999). An Inverted Repeat Triggers 
Cytosine Methylation of Identical Sequences in Arabidopsis. Molecular Cell 3, 
505-511. 
Lyko, F., Ramsahoya, B.H., Kashevsky, H., Tudor, M., Mastrangelo, M.-A., 
Orr-Weaver, T.L. & Jaenisch, R. (1999). Mammalian (cytosine-5) 
methyltransferases cause genomic DNA methylation and lethality in 
Drosophila. Nat Genet 23, 363-366. 
Lyon, M.F. (1998). X-Chromosome inactivation: a repeat hypothesis. 
Cytogenetics and Cell Genetics 80, 133-137. 
257 
Mack, A., Sauer, B., Abremski, K. & Hoess, R. (1992). Stoichiometry of the 
Cre recombinase bound to the lox recombining site. Nucleic Acids Res. 20, 
4451-4455. 
Maga, E.A. & Murray, J.D. (1995). Mammary gland expression of transgenes 
and the potential for altering the properties of milk. BiolTech. 13, 1452-1457. 
Marahrens, Y. (1999). X-inactivation by chromosomal pairing events. Genes 
Dev. 13, 2624-2632. 
Matzke, M.A. & Matzke, A.J.M. (1995). Homology-dependent gene silencing 
in transgenic plants: what does it really tell us? Trends Genet. 11, 1-3. 
Matzke, M.A., Matzke, A.J.M. & Eggleston, W.B. (1996). Paramutation and 
transgene silencing: a common response to invasive DNA? TIPS 1, 382-388. 
Matzke, M.A. & Matzke, A.J.M. (1998). Epigenetic silencing of plant 
transgenes as a consequence of diverse cellular defence reponses. Cellular 
and Molecular Life Sciences 54, 94-103. 
McBurney, M.W. (1999). Gene silencing in the development of cancer. 
Experimental Cell Research 248, 25-29. 
McCreath, K.J., Howcroft, J., Campbell, K.H.S., Colman, A., Schriieke, A.E. & 
Kind, A.J. (2000). Production of gene-targeted sheep by nuclear transfer from 
cultured somatic cells. Nature 405, 1066-1069. 
McFarlane, M. & Wilson, J.B. (1996). A model for the mechanism of precise 
integration of a microinjected transgene. Trans genic Res. 5, 171-177. 
Mehtali, M., LeMeur, M. & Lathe, R. (1990). The methylation-free status of a 
housekeeping transgene is lost at high copy number. Gene 179-184. 
Mercier, J.C., Gaye, P., Soulier, S., Huedelahaie, D. & Vilotte, J.L. (1985). 
Construction and identification of recombinant plasmids carrying cDNAs 
coding for ovine alpha-Si-casein, alpha-S2-casein, beta-casein, kappa-casein 
and beta-lactoglobulin - nucleotide sequence of alpha-Si-casein cDNA. 
Biochimie 67, 959-971. 
Metzger, D. & Feil, R. (1999). Engineering the mouse genome by site-specific 
recombination. Current Opinion in Biotechnology 10, 470-476. 
Mintz, B. & Bradl, M. (1991). Mosaic expression of a tyrosinase fusion gene in 
albino mice yields a heritable striped coat color pattern in transgenic 
homozygotes. Proc Natl Acad Sci USA 88, 9643-9647. 
Mochizuki, A., Takeda, Y. & Iwasa, Y. (1996). The evoution of Genomic 
Imprinting. Genetics 144, 1283-1295. 
Moore, T. & Haig, D. (1991). Genomic imprinting in mammalian 
development -a parental tug-of-war. Trends Genet. 7, 45-49. 
Morgan, H.D., Sutherland, H.G.E., Martin, D.I.K. & Whitelaw, E. (1999). 
Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23, 314-
318. 
Muller, H.J. (1930). Types of visible variations induced by X-rays in 
Drosophila. Journal of Genetics 12, 299-334. 
Nadeau, J.H. (2001). Modifier genes in mice and humans. Nature Reviews 
Genetics 2, 165-174. 
Nakajima, T., Uchida, C., ANderson, S.F., Lee, C.G., Hurwitz, J., Parvin, J.D. 
& Montminy, M. (1997). RNA helicase a mediates association of CBP with 
RNA polymerase II. Cell 90,1107-1112. 
Namciu, S.J.,  Blochlinger, K.B. & Fournier, R.E.K. (1998). Human Matrix 
Attachment Regions Insulate Transgene Expression from Chromsomal 
Position Effects in Drosophila melanogaster. Mol Cell Biol 18, 2382-2391. 
Nan, X., Ng, H.-H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, 
R.N. & Bird, A. (1998). Transcriptional repression by the methyl-CpG-
binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 
386-389. 
259 
Nicoll, C.S., & Tucker,A. (1965). Estimates of parenchymal, stromal, and 
lymph node deoxyribonucleic acid in mammary glands of C3H/Crgl/2 mice. 
Life Sciences 4, 993-1001. 
Old, R.W. & Primrose, S.B. (1994). The impact of recombinant DNA 
technology: the generation of novelty. In Principles of Gene Manipulation (Old, 
R.W. and Primrose, S.B., eds.), Blackwell Science Ltd, Oxford, pp.  369-407. 
Orban, P.C., Chui, D. & Marth, J.D. (1992). Tissue- and site-specific DNA 
recombination in transgenic mice. Proc Natl Acad Sci USA 89, 6861-6865. 
Pal-Bhadra, M., Bhadra, U. & Birchler, J.A. (1997). Cosuppression in 
Drosophila: Gene silencing of Alcohol dehydrogenase by white-Adh transgenes 
is Polycomb dependent. Cell 90, 479-490. 
Pal-Bhadra, M., Bhadra, U. & Birchier, J.A. (1999). Cosuppression of 
nonhomologous transgenes in Drosophila involves mutually related 
endogenous sequences. Cell 99, 35-46. 
Palmiter, R.D., Chen, H.Y. & Brinster, R.L. (1982). Differential regulation of 
metallothionein-thymidine kinase fusion genes in transgenic mice and their 
offspring. Cell 29, 701-710. 
Palmiter, R.D. & Brinster, R.L. (1985). Transgenic Mice. Cell 41, 343-345. 
Paro, R. & Hogness, D.S. (1991). The polycomb protein shares a homologous 
domain with a heterochromatiri-associated protein of Drosophila. Proc Nati 
Acad Sci USA 88, 263-267. 
Pervaiz, S. & Brew, K. (1985). Homology of Beta-lactoglobulin, serum retinol-
binding protein, and protein HC. Science 228, 335-337. 
Peterson, C.L. & Workman, J.L. (2000). Promoter targeting and chromatin 
remodeling by the SWI/SNF complex. Current Opinion in Genetics and 
Development 10, 187-192. 
Petters, R.M. & Sommer, J.R. (2000). Transgenic animals as models for human 
disease. Transgenic Res. 9, 347-351. 
Powers, J.A. & Eissenberg, J.C. (1993). Overlapping domains of the 
heterochromatin-associated protein HP1 mediate nuclear localisation and 
heterochromatin binding. The Journal of Cell Biology 120, 291-299. 
Pursel, V.G. & Rexroad Jr., C.E. (1993). Status of research with transgenic 
farm animals. J.Animal Sci. 71 (Suppi. 3), 10-19. 
Pursel, V.G. & Rexroad, G.E. (1993). Status of research with transgenic farm 
animals. J.Animal Sci. 71,10-19. 
Rakyan, V.K., Preis, J., Morgan, H.D. & Whitelaw, E. (2001). The marks, 
mechanisms and memory of epigenetic states in mammals. Biochem J. 356, 1-
10. 
Ramirez-Solis, R., Liu, P., Bradley,A. (1995). Chromosome engineering in 
mice. Nature 378 (6558), 720-724. 
Ramirez, A., Milot, E., Ponsa, I., Marcos-Gutiérrez, C., Page, A., Santos, M., 
Jorcano, J. & Vidal, M. (2001). Sequence and chromosomal context effects on 
variegated expression of Keratin 5/lacZ constructs in stratified epithelia of 
transgenic mice. Genetics 158, 341-350. 
Ratcliff, F., Harrison, B.D. & Baulcombe, D.C. (1997). A similarity between 
viral defense and gene silencing in plants. Science 276, 1558-1560. 
Reik, W. & Walter, J. (2001). Genomic imprinting: Parental influence on the 
genome. Nature Reviews Genetics 2, 21-32. 
Robertson, G., Garrick, D., Wu, W., Kearns, M., Martin, D.I.K. & Whitelaw, E. 
(1995). Position-dependent variegation of globin transgene expression in 
mice. Proc Nat! Acad Sci USA 92, 5371-5375. 
Rudolph, N.S. (1999). Biopharmaceutical production in transgenic livestock. 
Trends Biotech. 17, 367-374. 
Sabi, J.F. & Henikoff, S. (1996). Copy number and orientation determine the 
susceptibility of a gene to silencing by nearby heterochromatin in 
Drosophila. Genetics 142, 447-458. 
261 
Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989). Molecular cloning: a laboratory 
manual. Cold Spring Harbor Library Press Cold Spring Harbor, New York, 
Sapino, A., Macri, L., Gugliotta, P., & Bussolati, G. (1990). 
Immunocytochemical identification of proliferating cell types in mouse 
mammary gland. I His tochem Cytochem 38 (11), 1541-1547. 
Sapino, A., Macri, L., Tonda, L., & Bussolati, C. (1993). Oxytocin enhances 
myoepithelial cell differentiation and proliferation in the mouse mammary 
gland. Endocrinology 133 (2), 838-842. 
Sauer, B. (1987). Functional expression of the cre-lox site-specific 
recombination system in the yeast Saccharomyces cerevisiae. Mo! Cell Biol 7, 
2087-2096. 
Sauer, B. & Henderson, N. (1989). Cre-stimulated recombination at loxP-
containing DNA sequences placed into the mammalian genome. Nucleic 
Acids Res. 17,147-161. 
Sauer, B. '(1993). Manipulation of transgenes by site-specific recombination: 
Use of Cre recombinase. Methods in Enzymology 225, 890-900. 
Schedi, A., Montoliu, L., Kelsey, C. & Schütz, C. (1993). A yeast artificial 
chromosome covering the tyrosinase gene confers copy number-dependent 
expression in transgenic mice. Nature 362, 258-261. 
Schiebel, W., Pelissier, T., Riedel, L., Thalmeir, S., Schiebel, R., Kempe, D., 
Lottspeich, F., Sanger, H.L. & Wassenegger, M. (1998). Isolation of an RNA-
directed RNA polymerase-specific cDNA clone from tomato. Plant Cell 10, 
2087-2101. 
Schmidt, E.E., Taylor, D.S., Prigge, J.R., Barnett, S. & Capecchi, M.R. (2000). 
Illegitimate Cre-dependent chromosome rearrangements in transgenic 
mouse spermatids. Proc Nat! Acad Sci USA 97,13702-13707. 
Scrable, H. & Stambrook, P.J. (1999). A genetic program for deletion of 
foreign DNA from the mammalian genome. Mutation Research 429, 225-237. 
262 
Selbert, S., Bentley, D.J., Melton, D.W., Rannie, D., Lourenco, P., Watson, C.J. 
& Clarke, A.R. (1998). Efficient BLG-Cre mediated gene deletion in the 
mammary gland. Trans genic Res. 7, 387-396. 
Shard, M., Barash, I., Nathan, M., Ricca, G., Searfoss, G.H. & Dekel, I. (1992). 
Expression of human serum albumin in the milk of transgenic mice. 
Transgenic Res. 1, 195-208. 
Sharpe, J.A., Chan-Thomas, P.S., Lida, J., Ayyub, H., Wood, W.G. & Higgs, 
D.R. (1992). Analysis of the human a globin upstream regulatory element 
(HS -40) in transgenic mice. The EMBO Journal 11, 4565-4572. 
Siegfried, Z. & Cedar, H. (1997). DNA methylation: A molecular lock. 
Curr.Biol. 7, R305-R307 
Simons, J.P., McClenaghan, M. & Clark, A.J. (1987). Alteration of the quality 
of milk by expression of sheep 3-lactoglobu1in in transgenic mice. Nature 
328, 530-532. 
Southern, E.M. (1975). Detection of specific sequences among DNA 
fragments separated by gel electrophoresis. Journal of Molecular Biology 98, 
503-517. 
Stief, A., Winter, D.M., Stratling, W.H. & Sippel, A.E. (1989). A nuclear DNA 
attachment element mediates elevated and position-dependent gene activity. 
Nature 341, 343-345. 
Struhi, K. (1998). Histone acetylation and transcriptional regulatory 
mechanisms. Genes and Development 12, 599-606. 
Sutherland, H.G.E., Kearns, M., Morgan, H.D., Headley, A.P., Morris, C., 
Martin, D.I.K. & Whitelaw, E. (2000). Reactivation of heritably silenced gene 
expression in mice. Mammalian Genome 11, 347-355. 
Thorvaldsen, J.L., Duran, K.L. & Bartolomei, M.S. (1998). Deletion of the H19 
differentially methylated domain results in loss of imprinted expression of 
H19 and Igf2. Genes and Development 12, 3693-3702. 
263 
Thyagarajan, B., Guimarães, M.J., Groth, A.C. & Cabs, M.P. (2000). 
Mammalian genomes contain active recombinase recognition sites. Gene 
244,47-54. 
Townes, T.M., Lingrel, J.B., Chen, H.Y., Brinster, R.L. & Palmiter, R.D. (1985). 
Erythroid-specific expression of human -g1obin genes in transgenic mice. 
The EMBO Journal 4, 1715-1723. 
Tucker, H.A. (2000). Hormones, Mammary Growth and Lactation:a 41-Year 
Perspective. J.Dairy Sci. 83, 874-884. 
Turner, B.M. (1998). Histone acetylation as an epigenetic determinant of 
long-term transcriptional competence. Cellular and Molecular Life Sciences 54, 
21-31. 
Tycko, B. (2000). Epigenetic gene silencing in cancer. The Journal of Clinical 
Investigation 105 (4), 401-407. 
Urieli-Shoval, S., Gruenbaum, Y., Sedat, J. & Razin, A. (1982). The absence of 
detectable methylated bases in Drosophila melanogaster DNA. FEBS Lett. 146, 
148-152. 
Voinnet, 0., Vain, P., Angell, S. & Baulcombe, D.C. (1998). Systematic Spread 
of Sequence-Specific Transgene RNA Degradation in Plants is Initiated by 
Localized Introduction of Ectopic Promoterless DNA. Cell 95, 177-187. 
Wagner, K.U., Wall, R.J., St-Onge, L., Gruss, P., Wynshaw-Boris, A., Garrett, 
L., Li, M., Furth, P.A. & Hermighausen, L. (1997). Cre-mediated gene deletion 
in the mammary gland. Nucleic Acids Res. 25 (21), 4323-4330. 
Wall, R.J. & Seidel Jr, G.E. (1992). Transgenic farm animals - A critical 
analysis. Theriogenology 38, 337-357. 
Wall, R.J. & Burdon, T.G. (1997). The fate of microinjected genes in 
preimplantation embryos. In Trans genic Animals: Generation and Use 
(Houdebine, L.M., ed.), Harwood Academic Publishers, Amsterdam, pp.  215-
217. 
264 
Wallace, H., Ansell, R., Clark, J. & McWhir, J. (2000). Pre-selection of 
integration sites imparts repeatable transgene expression. Nucleic Acids Res. 
28,1455-1464. 
Webster, J., Wallace, R.M., Clark, A.J. & Whitelaw, C.B.A. (1995). Tissue-
specific, temporally regulated expression mediated by the proximal ovine - 
lactoglobulin promoter in transgenic mice. Cell.Mol.Biol.Res. 41, 11-16. 
Whitelaw, C.B.A., Harris, S., McClenaghan, M., Simons, J.P. & Clark, A.J. 
(1992). Position-independent expression of the ovine 3-lactoglobu1in gene in 
transgenic mice. Biochem J. 286, 31-39. 
Whitelaw, C.B.A., Springbett, A.J., Webster, J. & Clark, A.J. (1993). The 
majority of G(0) transgenic mice are derived from mosaic embryos. 
Transgenic Res. 2, 29-32. 
Whitelaw, C.B.A. (1995). Regulation of ovine 13-lactoglobulin gene expression 
during the first stage of lactogenesis. Biochem.Biophys.Res.Comm. 209, 1089-
1093. 
Whitelaw, C.B.A. (1996). Hormonal influences on -1actoglobulin transgene 
expression inferred from chromatin structure. Biochem. Biophys.Res. Comm. 
224,121-125. 
Whitelaw, C.B.A. (2000). Nucleosome organisation of the beta-lactoglobulin 
gene - Transcription complex formation. Biology of the Mammary Gland: 
Advances in Experimental Medicine and Biology 480, 147-153. 
Whitelaw, C.B.A., Grolli, S., Accornero, P., Donofrio, G., Farini, E. & Webster, 
J. (2000). Matrix attachment region regulates basal 13-lactoglobulin transgene 
expression. Gene 244, 73-80. 
Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J. & Campbell, K.H.S. (1997). 
Viable offspring derived from fetal and adult mammalian cells. Nature 385, 
810-813. 
Wolffe, A.P. (1997). Transcription control: Repressed repeats express 
themselves. Curr.Biol. 7, R796-R798 
265 
Woiffe, A.P., Jones, P.L. & Wade, P.A. (1999). DNA methylation. Proc Nat! 
Acad Sci USA 96, 5894-5896. 
Wu, C.-T. & Morris, J.R. (1999). Transvection and other homology effects. 
Current Opinion in Genetics and Development 9, 237-246. 
Yoder, J.A., Walsh, C.P. & Bestor, T.H. (1997). Cytosine methylation and the 
ecology of intragenomic parasites. Trends Genet. 13, 335-340. 
Yudkovsk, N., Logie, C., Hahn, S. & Peterson, C.L. (1999). Recruitment of the 
SWI/SNF chromatin remodelling complex by transcriptional activators. 
Genes and Development 13, 2369-2374. 
Yull, F.E., Binas, B., Harold, G., Wallace, R. & Clark, A.J. (1997). Transgene 
rescue in the mammary gland is associated with transcription but does not 
require translation of BLG transgenes. Transgenic Res. 6, 11-17. 
266 
